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Abstract 
The aim of this study was to evaluate new methods to improve detection and investigation 
of  the  effects  of  chronic  or  subclinical  infection  with  Trypanosoma  evansi  in  various 
mammalian species.  Some of the more resistant host species, including pigs and buffaloes, 
are present in large feral populations in the northern parts of Australia, the area where T. 
evansi is most likely to gain entry to the country.  Existing tests are not sufficiently reliable 
to detect all cases of disease and they cannot distinguish acute from chronic infections.  
Furthermore, the tests have different sensitivities in different host species. 
Surveillance for trypanosomiasis in Australia is problematic because of the need to work in 
remote parts of northern Australia where provision of a cold-chain for traditional blood and 
serum storage is difficult.  An existing dried blood storage system was modified by treating 
cotton lint filter paper (Whatman #903) with a commercial post coating buffer (TropBio, 
Queensland).  This treatment increased the longevity of antibodies to T. evansi in serum 
and blood stored on the paper (detected using an antibody-detection ELISA) compared to 
samples  stored  on  plain  paper,  especially  when  the  papers  were  stored  under  humid 
conditions and at high ambient temperatures. 
Attempts were made to improve the diagnostic utility and repeatability of antibody-ELISAs 
through the use of 2 recombinant T. brucei antigens (PFRA and GM6) and to optimize a 
competitive ELISA using RoTat 1.2 variable surface antigen and its monoclonal antibody.  
Antibody-detection  using  the  two  recombinant  proteins  was  not  sufficiently  specific  to 
enable their use for the detection of T. evansi.  The RoTat 1.2 cELISA had good sensitivity 
and  specificity  (75%  and  98%  respectively)  when  used  to  test  serum  from  cattle  and iv 
 
buffaloes experimentally infected with T. evansi and uninfected animals.  However, the test 
was not able to detect anti-T. evansi antibodies in serum from wallabies, pigs, a dog or a 
horse that were experimentally infected with T. evansi.  The inability of the cELISA to 
detect anti-T. evansi antibodies may be due to the small number of samples tested or the 
lack of RoTat 1.2 specific antibodies in the animals tested.   
The  feasibility  of  using  an  enzymatic  test  to  detect  trypanosome  aminotransferase  or 
antibodies to this enzyme was evaluated.  Prior publications suggested that the detection of 
TAT was an appropriate diagnostic tool for the detection of T. evansi infection in camels.  
However, the results from this study did not support the use of this test for the detection of 
T. evansi infection in cattle or buffaloes with low to moderate parasitaemia. 
Trypanosomiasis is an immunological disease that affects most of the body’s organs, with 
more severe disease developing over time.  Attempts were made to determine key cytokine 
and biochemical patterns that would distinguish infected from uninfected animals and acute 
from chronic infections.  The results from this study showed that there was no specific 
pattern in serum cytokines or serum biochemistry that could be used to distinguish infected 
from uninfected animals, or different stages of disease. 
Immunohistochemistry  was  used  on  tissues  from  buffaloes  and  mice  experimentally 
infected with T. evansi and T. brucei gambiense respectively to characterise the cellular 
immune  response  that  was  present.    The  immune  response  was  predominantly  cell 
mediated, with CD3+ T lymphocyte and macrophage infiltration occurring in most tissues.  
In end-stage disease there was often suppression of the immune system with disruption of 
the  architecture  of  the  spleen  and  a  decrease  in  B  lymphocytes  in  the  circulation.  v 
 
Trypanosomes were rarely visible in the tissues and were only seen in those animals with 
high parasitaemia.  Lesions generally became more severe over time, but there was a large 
variation between animals, which suggests that immunohistochemistry is unsuitable as a 
diagnostic tool. vi 
 vii 
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1  General Introduction 
Surra,  meaning  rotten,  is  a  disease  caused  by  infection  with  the  kinetoplastid 
Trypanosoma evansi.  It is endemic in many of the countries to the north of Australia, 
including Indonesia (though not Papua New Guinea) and there is a risk that it will 
spread to Australia.  Surra causes significant mortality and production loss in livestock 
where the infection is endemic, which leads to large financial losses.  Surra is most 
important in developing countries where people rely on livestock for draught power and 
as a source of wealth and food. 
Surra  affects  a  large  range  of  animals.    Cattle,  water  buffalo  and  horses  are  most 
commonly  affected  in  South  East  Asia,  although  T.  evansi  can  also  infect,  among 
others, pigs, goats, dogs, camels, elephants, rodents, capybaras, marsupials and even 
humans (Payne, Sukanto et al. 1991b;  Luckins 1999; Powar, Shegokar et al. 2006).  
Australian  marsupials  are  highly  susceptible  to  the  disease  and  die  with  massive 
parasitaemia soon after infection (Reid, Husein et al. 2001).  Horses are also inclined to 
develop  acute  disease  resulting  in  death  (Dieleman  1986;  Luckins  1994;  Silva, 
Arosemena et al. 1995).   
Trypanosoma  evansi  is  related  to  the  African  trypanosomes  and  is  thought  to  have 
evolved  from  Trypanosoma  brucei,  the  cause  of  nagana  (meaning  to  be  in  low  or 
depressed spirits in Zulu) in animals in Africa.  It is thought that T. evansi evolved from 
its ancestors along the edges of the tsetse fly belt in Africa and from there was spread 
via infected camels used for trade with India (Hoare 1967).  Hoare (1972) suggested 
that surra has become more pathogenic the further east it spread from Africa.  There are 
few studies to support this hypothesis, however, surra has a more significant impact on 2 
 
animals in the Philippines than it does in Africa, where the disease is often subclinical 
(Reid 2002). 
Trypanosoma evansi is no longer able to develop in tsetse flies (Glossina sp.) and is 
mechanically transmitted by biting flies, especially tabanids, which have large mouth 
parts and may feed on multiple hosts in a relatively short time.  These flies are found in 
many parts of the world, including Australia, which would enable the transmission of T. 
evansi should it enter that country. 
Infection  with  T.  evansi  can  be  difficult  to  detect  because  parasites  are  not  always 
detectable in the blood.  A number of methods have been developed to increase the 
sensitivity  of  parasitological  tests,  including  thick  and  thin  wet  blood  smears,  the 
microhaematocrit centrifugation technique and mouse inoculation.  Serological tests to 
detect antibody or antigen have been developed because parasitological tests have poor 
sensitivity.  Some of these tests are expensive and cumbersome to perform, which is 
important as the disease is found mainly in poor countries with limited facilities.  Most 
antibody tests have used whole or lysed trypanosomes as their antigen source, resulting 
in variability between batches of tests.  The large variety of animal species affected 
means that some tests have to be validated for use in each species. 
Surveillance  for  T.  evansi  in  Australia  is  constrained  by  the  difficulty  in  collecting 
suitable samples from potential host species in remote areas where it is most likely to 
enter.  There is limited access to many of these areas and no permanent facilities for 
storing samples  that  require refrigeration, which means  that sample collection is  an 
expensive operation and is only done infrequently by trained operators. 3 
 
2  Literature review 
2.1  Background 
2.1.1  Morphology 
Trypanosomes are unicellular parasites with a single flagellum, which belong to the 
order  kinetoplastida.    Kinetoplastid  protozoa,  including  the  genera  Leishmania  and 
Trypanosoma,  are  ancient  eukaryotic  organisms  (Beverley  1996)  that  infect  a  wide 
range of hosts, ranging from plants to invertebrates to mammals (Clayton, Hausler et al. 
1995).  The kinetoplast is a complex network of mitochondrial DNA (made up of mini 
and  maxicircles)  which  is  concentrated  in  part  of  the  parasite’s  single,  elongated 
mitochondrion and is attached to the basal body of the flagellum (Robinson and Gull 
1991).  Replication of the trypanosome occurs by binary fission with the flagellum and 
kinetoplast  dividing  together  (Robinson  and  Gull  1994;  Liu,  Liu  et  al.  2005).  
Diskinetoplastic forms (absent kinetoplast) are found in wild strains of trypanosomes 
due to mutation or after treatment with some trypanocides (Brun, Hecker et al. 1998).   
Trypanosoma  evansi  is  generally  monomorphic,  with  a  long  slender  form,  although 
pleomorphism can occur (Hoare 1972).  It is an extracellular parasite that is also found 
in  the  blood,  lymph  and  lymph  nodes  and  extravascularly  in  the  hosts’  interstitial 
connective tissues (Damayanti, Graydon et al. 1994; Tuntasuvan, Mimapan et al. 2000; 
Reid, Husein et al. 2001).  Trypanosomes in mammals may initially replicate in the 
dermal collagen and interstitial fluid of the skin at the site of inoculation before moving 
into the general circulation of the host (Luckins, McIntyre et al. 1991).   4 
 
2.1.2  Hosts ranges and vectors 
The two main types of trypanosome include those transmitted via the saliva of biting 
insects  (salivarian)  and  those transmitted via vector faeces  (stercorarian).  Common 
antigens  occur  despite  the  fact  that  these  species  diverged  many  millenia  ago 
(Desquesnes,  Bosseno  et  al.  2007).    It  is  possible  that  trypanosomes  evolved  from 
parasites  of  non-haematophagous  insects,  with  the  transition  to  mammalian  hosts 
occurring  when  the  insects  acquired  blood-sucking  habits  (Hoare  1967).    Many 
trypanosome species currently require an insect intermediate host (Jenni, Marti et al. 
1986; Lauricella, Stariolo et al. 2005). 
African  trypanosomes  are  in  the  salivarian  group.    The  subgenus  Trypanozoon 
comprises Trypanosoma brucei sp. (T. brucei group), T. evansi and the closely related 
T. equiperdum.  Tsetse flies (Glossina sp) are the invertebrate intermediate hosts of the 
T. brucei group, which is divided into T. b. brucei, a cause of nagana in animals and T. 
b.  rhodesiense  and  T.  b.  gambiense  that  cause  acute  and  chronic  human  sleeping 
sickness respectively (Maudlin, Holmes et al. 2004). 
Trypanosoma evansi is closely related to T. brucei.  It is likely that T. evansi originated 
in Africa from camels infected by T. brucei on the edge of the African tsetse fly belt and 
then  spread  via  camel  trade  and  transport  across  the  Sahara  into  North  Africa,  the 
USSR, Asia and the Middle East (Hoare 1967).  The two species are morphologically 
indistinguishable.  However, Trypanosoma evansi can no longer develop in tsetse flies, 
but  is  instead  mechanically  transmitted  by  haematophagous  biting  flies  such  as 
horseflies (Tabanidae) and stableflies (Stomoxys sp) (Luckins 1988; Sumba, Mihok et 
al. 1998).  Tsetse flies can act as mechanical vectors in the tsetse fly belt of Africa 
(Uilenberg 1998).  The adaptation to mechanical transmission has allowed T. evansi to 5 
 
move  beyond  the  confines  of  the  tsetse  fly  belt  in  Africa  and  become  the  most 
geographically dispersed trypanosome species (Jensen, Simpson et al. 2008).  In Central 
and  South  America  T.  evansi  is  also  believed  to  be  transmitted  by  vampire  bats 
(Desmodus rotundus) (Hoare 1972), which act as both hosts and vectors (Hoare 1965).  
T. evansi may also be spread by ingestion of fresh meat from infected animals and by 
fighting between dogs, coatis and capybaras (Herrera, Dávila et al. 2004).  
Trypanosoma evansi has a wide host range.  In most domestic and many wild animals T. 
evansi is pathogenic with clinical signs depending on strain pathogenicity, host species, 
general  stresses  on  the  host  and  local  epidemiological  conditions  (Hoare  1972; 
Dieleman 1986).  The most common clinical signs include fever, anaemia, oedema, 
emaciation, abortion and enlargement of lymph nodes, liver and spleen and occasional 
neurological signs.  Infection can be acute or chronic (Bengaly, Sidibe et al. 2002b).  T. 
evansi affects domestic animals including camels, horses and cattle (Hoare 1967), deer 
(Reid, Husein et al. 1999; Tuntasuvan, Mimapan et al. 2000), buffalo, mules, sheep, cats 
and pigs (Dieleman 1986).  Equines, camels, dogs, deer and Asian elephants are more 
frequently diagnosed with the disease than buffaloes and cattle, possibly because they 
show  more  severe  clinical  signs  (Hoare  1972;  Herrera,  Dávila  et  al.  2004;  Shehu, 
Ibrahim  et  al.  2006).    Horses  may  develop  subclinical  trypanosomiasis,  though  the 
disease generally causes multiple crises and relapses and is often fatal (Hoare 1972; 
Dieleman 1986).  Camels usually develop acute disease, though they may survive to 
develop chronic infection or even undergo spontaneous recovery (Gutierrez, Corbera et 
al. 2006).  The disease is usually fatal within six months in dogs (Morrison, Murray et 
al. 1981; Aquino, Machado et al. 2002).  Bovines are more likely to develop cryptic 
disease, especially in endemic areas (Hoare 1972).  Pigs can be infected, but have mild 
or no clinical signs and goats develop chronic infection (Dargantes, Reid et al. 2005a).  6 
 
Thus the severity of outcome of T. evansi infection in domestic species can be ranked 
from highest to lowest: camels, horses, dogs and Asian elephants are more susceptible 
than sheep and goats, which are more susceptible than bovines and pigs.   
Other wildlife species shown to be susceptible to T. evansi include coatis (Nasua nasua) 
and capybaras (Hydrochearis hydrochearis) in South America (Herrera, Aquino et al. 
2001; Herrera, Dávila et al. 2004).  Experimental infection of marsupials including agile 
wallabies (Macropus agilis) and dusky pademelons (Thylogale brunii) resulted in acute 
disease with 100% mortality (Reid, Husein et al. 2001).  It has been suggested that, 
unlike  in  tsetse-transmitted  trypanosomiasis,  wildlife  reservoirs  of  infection  are 
unimportant with T. evansi (Luckins 1996), although it is possible that South American 
coatis and capybaras are an exception to this (Herrera, Aquino et al. 2001; Herrera, 
Dávila et al. 2004).  Camels (in Africa) and horses are probably the main reservoir hosts 
in Africa and Asia (Hoare 1972). 
T. evansi is not generally infective to humans due to the presence of a resistance factor 
in human serum.  There has been at least one confirmed case in India (Powar, Shegokar 
et al. 2006) that has been attributed to the presence of a rare mutation in the ApoL-I 
gene of the patient (Vanhamme and Pays 2004).  Human ApoL-I is the key effector 
molecule responsible for trypanosome lysis in human serum (Poelvoorde, Vanhamme et 
al. 2004).  Lysis of trypanosomes by normal human serum can be neutralised when 
serum resistance associated protein (SRA) interacts with human apoL-I in the lysosome 
(Xong, Vanhamme et al. 1998; Vanhamme, Paturiaux-Hanocq et al. 2003; Poelvoorde, 
Vanhamme et al. 2004). 7 
 
2.1.3  Dynamics of Trypanosoma evansi infection in livestock 
populations 
There have been no definitive studies on the dynamics of transmission of T. evansi in 
livestock populations.  An increasing prevalence of infection associated with increasing 
age is  commonly observed  (Davison, Thrusfield et  al.  2000), which may be due to 
persistent infection or due to reduced infection in young animals as a result of them 
being held in protected housing conditions (Njiru, Constantine et al. 2004a).  It may also 
occur as a result of the behaviour of tabanids that feed less readily on young animals, 
which  exhibit  greater  defensive  behaviour  and  are  less  frequently  bitten  than  older 
animals (Torr and Mangwiro 2000; Kelly 2001; Torr, Wilson et al. 2001; Schofield and 
Torr 2002).  In one study there was increased seroprevalence of camels 7 to 10 years of 
age (Atarhouch, Rami et al. 2003), with acute disease more common in camel calves 
(Delafosse  and  Doutoum  2004)  often  resulting  in  death  and  a  subsequent  low 
prevalence of detectable infection.  Indonesian buffaloes are usually infected by 4 years 
of  age  (Davison,  Thrusfield  et  al.  2000)  and  models  show  that  they  may  recover 
spontaneously with annual reinfection (Coen, Luckins et al. 2001), though this remains 
to be proven (Atarhouch, Rami et al. 2003).   
Overcrowding of animals, especially near water, results in an increase in infection rate 
and  morbidity  associated  with  surra  (Atarhouch,  Rami  et  al.  2003).    Surra  is  more 
common in migratory herds compared to sedentary breeding herds.  Migratory herds 
experience more acute disease and increased risk of infection associated with movement 
over  large  distances,  presumably  because  of  increased  contact  between  camels  and 
parasites in certain areas (Delafosse and Doutoum 2004) and the stress associated with 
travel (Luckins 1988).  Animals may be more likely to develop acute surra if food 
supply is limited or if animals are worked strenuously (Dieleman 1986).  Furthermore, 8 
 
there is an increased risk of acute disease in the dry season, possibly related to nutrition 
(Delafosse and Doutoum 2004). 
2.1.4  Clinical signs and outcomes of infection 
More severe disease occurs in naïve animals (Payne, Waltner-Toews et al. 1991; Reid, 
Husein et al. 2001).  This is important when animals are imported from a disease-free 
area into an endemic region, for example if cattle/buffalo are imported from Australia 
into Indonesia (Luckins 1988; Payne, Waltner-Toews et al. 1991).  Disease in endemic 
areas becomes less frequent and less severe either due to continued exposure of animals 
to trypanosomes or the use of chemotherapy to treat infected animals (Losos 1980).  
Wider dissemination of T. evansi into adjacent regions may be associated with severe 
disease outbreaks with high rates of infection (Losos 1980).   
Horses and donkeys usually suffer acute disease with a high mortality rate (Luckins 
1994).  After a 1-2 week incubation period, they develop weakness, anorexia (that may 
recover), icterus and oedema, ocular and nasal discharges, warm swollen lymph nodes 
and  progressive  emaciation  despite  a  retained  appetite  (Luckins  1994).    Urticarial 
lesions  form  on  the  flanks  and  ventral  body  surfaces.    Later  clinical  signs  include 
posterior  weakness  and  paralysis  with  profuse  sweating  (Dieleman  1986;  Luckins 
1994).  Infected horses almost invariably die as a result of the disease.  Although there 
is a tendency to ascribe acute disease to horses and camels and milder disease to cattle, 
this is an unrealistic view as there is such a range of susceptibility and variability among 
animals (Luckins 1999). 
Cattle can become resistant to homologous strains of trypanosomes, resulting in “self 
cure”  (Nantulya,  Musoke  et  al.  1984).    This  could  be  due  to  the  development  of 
immunity to the entire range of variable antigens produced by a T. evansi strain, which 9 
 
suggests that animals treated and regularly reinfected may become resistant to surra 
(Nantulya, Musoke et al. 1984).  Naturally trypanotolerant cattle do not rely on immune 
mechanisms to control parasite growth, but rather possess an innate mechanism that is 
independent of T cells and antibodies (Naessens, Teale et al. 2002).  Two independent 
mechanisms  have  been  suggested  as  contributors  to  trypanotolerance:  control  of 
parasitaemia by non-immune means and control of anaemia by haemopoietic tissue of 
trypanotolerant origin (Naessens, Teale et al. 2002). 
2.1.5  Geographic distribution and economic impact 
Surra is endemic in many tropical and subtropical countries, wherever biting-fly vectors 
are present, with its most major impact in arid and semi-arid areas.  Cattle and water 
buffalo are important for draught power, meat, milk and capital investment for low-
income farmers in many areas where surra is endemic (Luckins 1988).  Surra occurs in 
most countries of Southeast Asia (Luckins 1988), North and East Africa, the Middle 
East, Indian subcontinent, central Asia, southern China and South America (Dieleman 
1986; Lun, Brun et al. 1992; Luckins 1994b; Dávila, Souza et al. 1999; Molina, Ruiz et 
al.  1999;  Reid  and  Copeman  2000;  Atarhouch,  Rami  et  al.  2003;  Delafosse  and 
Doutoum 2004; Njiru, Constantine et al. 2004a; Ul Hasan, Muhammad et al. 2006) and 
recently  in  the  Canary  Islands  (Molina,  Ruiz  et  al.  1999).    Trypanosoma  evansi  is 
endemic in Indonesia with the exception of Papua (Luckins 1988). 
2.1.6  Variable surface antigen 
African  trypanosomes  use  a  variant  surface  antigen  coat  to  evade  their  mammalian 
hosts’ immune system.  The entire parasite surface, including the flagellum, is covered 
by 5x10
6 dimers of variable surface glycoproteins (VSGs) that make up approximately 
15-20% of the protein content of the cell and up to 95% of the external surface protein 10 
 
(Barry and McCulloch 2001).  The surface coat is so tightly packed that only a limited 
section of the N-terminal of their amino acid sequence is accessible to their host and it 
shields  non-variant  proteins  from  host  immune  recognition  (Pays  and  Nolan  1998; 
Vincendeau and Bouteille 2006).  This surface coat is attached to the outer membrane of 
the trypanosomes by glycosylphosphatidylinositol (GPI) anchors (Magez, Stijlemans et 
al. 1998), which make the variable surface antigen water-insoluble and may contribute 
to  the  host’s  immune  response  to  trypanosome  infection  (Pays  and  Nolan  1998; 
Campos,  Almeida  et  al.  2001).    A  new  variant  (variable  antigenic  type,  VAT)  is 
produced approximately every 1 in 100 divisions of the parasite, which then multiplies 
rapidly (Turner and Barry 1989).  This switching time occurs at a constant rate in a 
particular VAT, but differs between VAT combinations (Turner and Barry 1989) and is 
independent of immune pressure.  The trypanosome genome contains an estimated 1000 
genes encoding VSGs and pseudo-VSGs (Van der Ploeg, Bernards et al. 1982; Van der 
Ploeg, Valerio et al. 1982b), which means that more than 20% of the T. brucei genome 
is associated with antigenic variation. 
Usually only one variable surface antigen is expressed at any one time, although there 
are exceptions (Van der Ploeg, Bernards et al. 1982; Baltz, Giroud et al. 1986; Turner 
1999).  The unexpressed VSGs are scattered among different chromosomes, but the 
more frequently expressed VSGs have so far been located near the telomeres (Van der 
Ploeg, Valerio et al. 1982b; Cross, Wirtz et al. 1998; Pays and Nolan 1998).  Thus, in a 
given strain, some VSGs are fairly consistently found early in the disease, whereas 
others are only observed later, during chronic infection.  However, VSG-specific DNA 
sequences  are  extremely  variable  between  parasite  isolates  and  VSG  repertoires  are 
highly variable between strains (Pays and Nolan 1998).  Trypanosomes such as T vivax 
appear to have a smaller antigenic repertoire compared to T. brucei or T. congolense and 11 
 
self-cure may occur once homologous immunity has developed, although the animal can 
still be infected by heterologous strains (Nantulya, Musoke et al. 1986).  It is likely that 
the VSG repertoire of T. evansi is smaller than that of trypanosomes with a tsetse fly 
intermediate host because exchange of genetic information and rearrangement of VSG 
repertoires occurs in this vector (Jenni, Marti et al. 1986). 
Trypanosomes  also  evade  the  immune  system  as  a  result  of  their  high  rate  of 
endocytosis, which allows ingestion and turnover of the entire surface coat every 12 
minutes together with any attached antibody complexes.  These complexes are removed 
and “clean” VSGs recycled to the trypanosome surface, thus slowing host recognition 
(Morgan, Hall et al. 2002; Pays 2005; Bisser, Ouwe-Missi-Oukem-Boyer et al. 2006).  
The invariant, functionally conserved surface glycoproteins (ISGs), which are shielded 
by the VSGs, are present in relatively low abundance (100-10,000 times less) compared 
to variable surface glycoproteins (Pays and Nolan 1998). 
2.1.7  Treatment and control 
Non-pharmaceutical means of controlling T. evansi infection are limited because of the 
large number of biting fly species capable of transmitting the parasite mechanically.  
There is no obvious way of developing exclusion zones for animals on grazing land and 
limited likelihood that vector control will be successful compared to tsetse-transmitted 
trypanosomes (Luckins 1996; Jones and Dávila 2001). 
Treatment of surra depends largely on four drugs: suramin, diminazene, cymelarsan and 
quinapyramine.  These drugs are not new (the newest was developed more than 50 years 
ago)  and  reduced  sensitivity  or  drug  resistant  strains  have  developed  in  different 
locations around the world depending on which drugs  are most frequently used  (El 
Rayah, Kaminsky et al. 1999; Geerts, Holmes et al. 2001; Gillingwater, Buscher et al. 12 
 
2007).  Suramin (acid naphthylamine) has been the mainstay of treatment for all host 
species for over 70 years and remains the drug of choice in Indonesia (Jones, Payne et 
al. 1996).  Treatment is most effective in the early stages of infection, with late-stage 
treatment and animals with nervous signs often relapsing (WHO 2001).  Although T. 
brucei is an extra-cellular parasite, it is possible that organisms may cross the blood-
brain barrier via a paracellular route (Nikolskaia, Kim et al. 2006).  Parasites that cross 
the blood brain barrier and remain viable could re-infect the host after treatment with 
drugs that are not able to cross the barrier.  This could result in a relapse that is not due 
to the presence of resistant parasites once treatment is withdrawn (Brun and Lun 1994).   
Cymelarsan (melarsomine hydrochloride, Mel Cy) is a water soluble trivalent arsenical 
agent which is broken down to melarsen oxide more quickly than older compounds such 
as MelW and MelB (Berger and Fairlamb 1994).  It is therefore more effective for the 
treatment of acute infections and, though there is little evidence to suggest that it is 
better with chronic/cerebral infections, it is used for treating second stage disease in 
humans (Legros, Ollivier et al. 2002).  Cymelarsan is effective against  T. evansi in 
Indonesia  (Payne,  Sukanto  et  al.  1994)  and  China  (Zhang,  Giroud  et  al.  1992).  
Trypanosoma brucei brucei stocks resistant to diminazene aceturate showed increased 
resistance  to  cymelarsan,  though  resistance  to  suramin  and  quinapyramine  did  not 
reduce the efficacy of cymelarsan on T. evansi stocks (Zweygarth and Kaminsky 1990; 
Barrett and Fairlamb 1999).  Suramin and cymelarsan do not induce cross-resistance to 
each other (Zhang, Giroud et al. 1993).  A single intraperitoneal injection of 6.3mg/kg 
cymelarsan cured mice infected with the most resistant isolate of T. brucei (Zweygarth 
and Kaminsky 1990).  In one study resistance to cymelarsan caused cross-resistance in 
T. evansi strains to both berenil (diminazene) and pentamidine (Zhang, Giroud et al. 
1993).  However, resistance to cymelarsan may develop rapidly (Ross and Barns 1996; 13 
 
Suswam, Taylor et al. 2001), which could be due to the presence of a kinetoplastid gene 
encoding for an arsenate reductase (Donelson, Gardner et al. 1999). 
Drugs are often given on an individual basis rather than on a herd basis (Luckins 1992).  
It  has  been  found  that  cattle  that  have  recovered  from  or  been  treated  for 
trypanosomiasis  are  resistant  to  re-infection  with  the  same  strain  of  trypanosome 
(Nantulya, Musoke et al. 1984).  Thus treatment of infected animals may eventually 
lead  to  a  resistant  host  population  in  a  given  area,  though  exposure  to  different 
serodemes could still result in disease. 
2.2  Tests for detecting Trypanosoma evansi  
2.2.1  Parasitological tests 
Isolation of T. evansi parasites from the infected host provides a definitive diagnostic 
test, but, because of the fluctuating nature of the parasitaemia, this is insensitive and 
parasites cannot always be demonstrated  (Nantulya 1990;  Truc, Bailey et al. 1994).  
Indeed, parasitaemia may never be demonstrable in some serologically positive hosts 
(Garcia, Jamonneau et al. 2000).   
Microscopic examination of blood is performed using wet or dry preparations.  Wet 
preparations allow the identification of live parasites under bright-field or phase contrast 
microscopy.  It does not require the use of stains and parasites are readily seen due to 
their  energetic  movement,  although  it  is  difficult  to  detect  trypanosomes  in  wet 
preparations when there are less than 1x10
4 per ml of blood (Turner 1999).  Dried 
preparations  include  Giemsa-stained  thin  dried  blood  smears,  thick  blood  films  and 
buffy-coat smears.  Microscopic examination can also be performed using cerebrospinal 
fluid and lymph node aspirates.  The main advantage of blood smear examination is that 14 
 
no specialised equipment is needed apart from a microscope, making it a cheap and 
technically simple way of detecting parasitaemia.  It is therefore the most commonly 
used diagnostic test in developing countries in which T. evansi is endemic (Killick-
Kendrick 1968). 
The haematocrit centrifugation technique (HCT) involves centrifugation of blood in a 
capillary tube and microscopic examination of the buffy coat-plasma interface to detect 
the presence of motile trypanosomes (Woo 1969; Paris, Murray et al. 1982; Davison, 
Thrusfield et al. 1999; Reid, Husein et al. 2001b).  The limit of detection of the HCT is 
approximately 83 T. evansi per millilitre of blood (Reid, Husein et al. 2001b).   
Mini-anion  exchange  chromatography  (MAECT)  with  DEAE  cellulose  uses  either 
whole blood (Lumsden, Kimber et al. 1977; Lumsden, Kimber et al. 1979; Reid, Husein 
et al. 2001b) or the buffy coat, which results in increased sensitivity (Reid, Husein et al. 
2001b).  Parasites were detected in 40% of samples containing 1.25 parasites in 2ml of 
blood when using the buffy coat MAECT (Reid, Husein et al. 2001b).   
Inoculation of laboratory mice (MIT) (Reid, Husein et al. 2001b; Chappuis, Loutan et 
al. 2005) is more sensitive compared to other parasitological tests (Paris, Murray et al. 
1982; Reid, Husein et al. 2001b; Tuntasuvan, Jarabrum et al. 2003) and is generally 
considered the gold standard test, especially if the buffy coat is used for inoculation 
rather than whole blood (Reid, Husein et al. 2001b).  In 95% of cases the sensitivity of 
the MIT was 3-25 parasites per ml of bovine blood and this was increased 10-fold by 
substituting the whole blood for buffy coat (Reid, Husein et al. 2001b). 
Direct  microscopic  examination  should  be  performed  as  soon  after  collection  as 
possible because trypanosomes are rapidly immobilised and lysed.  They are killed by 15 
 
direct sunlight but can survive for a few hours if kept in a cool, dark place (Holland, 
Claes et al. 2001b; Chappuis, Loutan et al. 2005).  Mouse-inoculation should also be 
undertaken as soon as possible after sample collection.  However, Reid et al. (2001b) 
found that test sensitivity was not measurably reduced if the blood was refrigerated for 
up to 21 hours if the parasitaemia is relatively high (1,000 T. evansi per ml of blood).  
This means that refrigerated transport of samples to a laboratory could be used as an 
alternative to maintaining laboratory mice in the field. 
2.2.2  Serological tests 
Serology is commonly used to detect T. evansi infection.  Standardisation of tests is 
difficult because of the use of poorly defined antigens (Nantulya 1990).  Serological 
tests  include  the  complement  fixation  test,  indirect  fluorescent  antibody  test,  latex 
agglutination  test,  card  agglutination  test  for  trypanosomiasis/T.  evansi  (CATT/T. 
evansi) and enzyme-linked immuno-sorbent assays. 
Suratex
®  latex  agglutination  test  (Nantulya  1994;  Reid  and  Copeman  2003)  is  an 
antigen  detection  test  using  latex  particles  coated  in  anti-trypanosome  antibodies 
adapted from a method by Büscher et al. (1991).  Reid and Copeman (2003) found that 
the  test  had  poor  specificity  when  used  to  test  serum  from  Australian  cattle.    The 
LATEX/T.  evansi  (Verloo,  Holland  et  al.  2000)  is  a  similar  method  using  purified 
RoTat 1.2 antigen bound to latex particles using a method adapted from Lejon et al. 
(1998).    The  diagnostic  accuracy  of  the  LATEX/T.  evansi  was  comparable  to  the 
CATT/T. evansi (Verloo, Holland et al. 2000), however the test is not commercially 
available. 
The CATT/T. evansi  is an agglutination  test  which uses formaldehyde-fixed freeze-
dried trypanosomes stained with Coomassie Blue (Bajyana Songa and Hamers 1988).  16 
 
The CATT was initially developed for the detection of T. b. gambiense and used the 
LiTat 1.3 VAT (Bajyana Songa, Kageruka et al. 1987).  The CATT/T. evansi based on 
the RoTat 1.2 VAT was developed because the LiTat 1.3-based CATT was shown to 
have poor sensitivity for the detection of T. evansi (Bajyana Songa and Hamers 1988).  
Reid and Copeman (2003) showed that the CATT had higher sensitivity (83%) but 
lower  specificity  (96%)  when  cattle  serum  was  diluted  1/4  compared  to  a  lower 
sensitivity (72%) but higher specificity(98%) when serum was diluted 1/8. 
Antibody  and  antigen  enzyme-linked  immuno-sorbent  assays  (ELISAs)  have  been 
developed and used to detect infection in various animal species (Nantulya, Bajyana 
Songa et al. 1989; Nantulya, Lindqvist et al. 1989b; Pathak, Arora et al. 1993; Monzon, 
Jara et al. 1994; Luckins 1996; Davison, Thrusfield et al. 2000; Reid and Copeman 
2003;  Holland,  Thanh  et  al.  2005).    Antibody  ELISAs  are  able  to  detect  T.  evansi 
antibodies within 7 to 42 days after experimental infection (Verloo, Magnus et al. 2001; 
Claes, Verloo et al. 2002; Holland, Thanh et al. 2002; Holland, Thanh et al. 2005).  The 
diagnostic utility of Ab-ELISAs may be limited because the test can remain positive for 
extended periods after treatment (Luckins 1996; Monzon, Mancebo et al. 2003) and 
some animals do not develop a detectable immune response.  Furthermore, in early 
infections  an  IgM  ELISA  was  shown  to  be  a  more  sensitive  indicator  of  infection 
compared to an IgG ELISA, though later in infection this pattern is reversed (Luckins 
1996).  Antigen-capture ELISAs that were developed to detect T. evansi infection were 
shown  to  be  more  sensitive  compared  to  microscopic  parasite  detection  methods 
(Nantulya, Lindqvist et al. 1989b; Pathak, Arora et al. 1993).  Antigen ELISAs detected 
trypanosome antigen within 7 to 42 days after infection and this persisted for a variable 
period after treatment (Nantulya, Bajyana Songa et al. 1989; Nantulya, Lindqvist et al. 
1989b).  This  suggests  that antigen  detection tests may not  be better than antibody 17 
 
detection  tests  in  distinguishing  between  infected  animals  and  animals  soon  after 
successful treatment. 
In addition there is a wide variation in the amount of antigen available early in infection 
(Luckins 1994b) and tests based on antigen detection may not detect antigenaemia until 
sufficient antigens have been released from dying trypanosomes (Donelson, Gardner et 
al.  1999).    Antigen  may  also  be  caught  in  antibody  complexes  (Nantulya,  Bajyana 
Songa et al. 1989) or there could be interference by serum components. 
Comparisons between antigen and IgG antibody ELISAs and CATT found CATT was 
the most specific and the antibody ELISA the most sensitive for the detection of T. 
evansi infection in buffaloes (Davison, Thrusfield et al. 1999).  This is in contrast to 
another study which showed that CATT was the most sensitive and the antibody ELISA 
the most specific at detecting infection with T. evansi in Indonesian cattle (Reid and 
Copeman 2003).  Use of fractionated antigen in this antibody ELISA could account for 
this discrepancy, resulting in greater specificity than found with some other antibody 
ELISAs.    
2.2.3  Trypanosome antigens used for detecting 
trypanosomiasis 
ELISAs have historically been based on crude antigen with batch-to-batch variation, 
though standardisation has been improved with  modifications such as a monoclonal 
capture  antibody  (Rebeski,  Winger  et  al.  1999)  and  fractionation  of  crude  antigen 
(Pathak, Arora et al. 1993; Reid and Copeman 2003). 
Trypanosomes are known for their variable surface antigen coats and most antibodies 
produced  by  the  hosts  are  directed  against  these  variable  surface  antigens.    Many 18 
 
serological  tests  are  therefore  based  on  variable  surface  antigens  produced  by  the 
trypanosomes.  Although variable surface glycoprotein sequences are subject to change, 
it is possible that, in the case of T. evansi, which is non-cyclically transmitted and thus 
has limited genetic variation (Boid 1988), VSGs may be preserved.  The VSG repertoire 
of a single stock of T. evansi is limited and thought to be relatively small (Yang, Suo et 
al. 2007) and there can be shared variable antigen types (VATs) between related stocks 
of T. evansi, with more closely related strains sharing more VATs (Yang, Suo et al. 
2007).  Infected hosts also produce antibodies to minor non-variable antigens (Shapiro 
and Murray 1982).  It is possible that the host immune response to conserved antigens 
participates  in  control  of  the  trypanosome  infections  in  Cape  buffaloes  (Guirnalda, 
Murphy et al. 2007) and trypanotolerant N’Dama cattle (Authie, Muteti et al. 1993), 
possibly  by  neutralising  toxic  or  pathogenic  molecules  produced  by  the  parasite 
(Naessens, Teale et al. 2002). 
2.2.3.1 RoTat 1.2 
Rode Trypanozoon antigen type 1.2 (RoTat 1.2) is a variable antigen type (VAT) which 
was cloned from T. evansi isolated from an Indonesian water buffalo in 1982 (Bajyana 
Songa and Hamers 1988; Urakawa, Verloo et al. 2001).  It is one of the predominant 
VATs and has been found early in the infection in the majority of T. evansi strains.  
Rabbits infected with stocks and clones from different parts of the world developed 
antibodies to RoTat 1.2 within 32 days of infection (Verloo, Magnus et al. 2001; Claes, 
Verloo et al. 2002).  Tests using RoTat 1.2 do not cross react with antibodies to T. 
theileri or other pathogenic trypanosomes, although they cannot distinguish between 
infections  with  trypanosomes  currently  classified  as  T.  evansi  and  T.  equiperdum 
(Claes, Verloo et al. 2002; Claes, Radwanska et al. 2004).  The RoTat 1.2 gene is a 
fairly specific marker for T. evansi type A strains, but is not present in T. evansi type B 19 
 
strains isolated from Kenya, which may limit its diagnostic utility (Claes, Radwanska et 
al. 2004; Ngaira, Olembo et al. 2005; Njiru, Constantine et al. 2006).  It is not known 
whether type B strains exist in Asia.   
2.2.3.2 GM6 
GM6 is a minor non-variant trypanosome antigen.  A partial sequence of GM6 was 
identified when a cDNA library from T. brucei gambiense was screened using sera from 
cattle soon after they were infected with T. brucei (Muller, Hemphill et al. 1992).  GM6 
is a large protein with a repetitive structure (units of 68 amino acids) that is located at 
the  flagellum-cell  body  interface  (Muller,  Hemphill  et  al.  1992).    It  is  a  structural 
calpain-like protein (Ersfeld, Barraclough et al. 2005) that plays an essential role in the 
immune  response  because  it  is  targeted  by  a  number  of  micro-RNA  genes  in  the 
trypanosome genome (Mallick, Ghosh et al. 2008).  GM6 is well conserved between 
different species of salivarian trypanosomes, though there are slightly less similarities 
between the salivarian and the stercorarian species.  Analogues are also present in some 
species of Leishmania (Muller, Hemphill et al. 1992). 
2.2.3.3 Paraflagellar rod protein A 
Each trypanosome has a single flagellum which exits from a flagellar pocket where 
endo/exocytosis takes place.  Trypanosomes swim with the flagellum leading, dragging 
the cell behind it.  Functions of the flagellum include motility, probably to reach and 
invade host cells (reviewed by (Bastin, McRae et al. 1999), to attach the parasite to host 
surfaces and as an environment sensor.  The flagellum is attached to the cell body along 
its entire length at the flagellar attachment zone (FAZ).  The flagellum contains an 
axoneme which is well conserved throughout eukaryotic evolution and consists of nine 
peripheral microtubule doublets plus two single central microtubules (Bastin, Pullen et 20 
 
al. 2000).  T. brucei forms a new flagellum whilst retaining the old one.  The flagellum, 
flagellar pocket and pellicular membrane are covered by a variable surface glycoprotein 
coat, though glycoprotein on the pocket membrane appears to be a different to those on 
the other surfaces (Bastin, Pullen et al. 2000). 
The trypanosome flagellum contains an extra-axonemal paraflagellar rod (Bastin, Pullen 
et al. 2000) which is vital for trypanosome motility (Bastin, Sherwin et al. 1998).  The 
paraflagellar rod (PFR) is present from the flagellar exit at the flagellar pocket to the 
distal tip of the flagellum.  The crescent-shaped paraflagellar rod is made up of fibres 
crossing at defined angles (de Souza and Souto-Padron 1980; Bastin, Matthews et al. 
1996).  It is 150nm in diameter and attached strongly to axoneme microtubules 4-7 via 
fibres that are very strong, and is difficult to remove (Bastin, Pullen et al. 2000).  A 
paraflagellar rod has only been found in three groups of protists so far: kinetoplastids, 
euglenoids (Hyams 1982) and dinoflagellates and is not restricted to parasitic species.  
A morphologically similar structure is present in Giardia and Tritrichomonas sp., with 
further work to characterise similar structures in other protozoa ongoing (Bastin, Pullen 
et al. 2000).  The paraflagellar rod is made up of PFR1 (C) and PFR2 (A) proteins.  
These proteins are found in all other organisms with a paraflagellar rod  (Gallo and 
Schrevel 1985).  PFR1 and PFR2 are well conserved between species and isolates, with 
only  the  ends  showing  significant  diversity.    The  first  monoclonal  antibody  to  a 
paraflagellar  rod  protein  from  euglena  recognized  both  PFR1  and  PFR2  and  cross 
reacted with all trypanosomes tested, including T. brucei (Gallo and Schrevel 1985), 
although the physical structure of the euglena PFR is different to that of trypanosomes 
(Hyams 1982).  Anti-PFR protein antisera exclusively recognized the flagellum (Bastin, 
Pullen et al. 2000). 21 
 
PFR is immunogenic and immunisation of mice with PFR elicits a strong T helper 1 
response, which results in protection against trypanosomiasis.  Alum preparations result 
in the strongest immunity by causing an increase in IFN-γ and IL-2 (Michailowsky, 
Luhrs et al. 2003).  Although it is present in low copy numbers, PFRA has been targeted 
using  a  loop-mediated  isothermal  amplification  (LAMP)  test  to  diagnose 
trypanosomiasis (Kuboki, Inoue et al. 2003).  This immunogenic non-variable antigen 
could be useful for detecting infection with pathogenic trypanosomes. 
2.2.4  Molecular techniques 
Tests based on amplification of specific nucleic acid  sequences  are becoming more 
frequently  used  for  the  diagnosis  of  trypanosomiasis  because  they  are  essentially 
antigen  detection  tests.    This  is  because  the  tests  are  designed  to  demonstrate  the 
presence of the parasite rather than the host response to the parasite.  Indeed, DNA is 
broken down in blood within 1 to 2 days after treatment (Desquesnes 1997; Holland, 
Claes  et  al.  2001b)  and  a  positive  PCR  test  is  therefore  synonymous  with  active 
infection.  Tests include the polymerase chain reaction (PCR), PCR-ELISA, real-time 
PCR and LAMP. 
Conventional gel-based PCR was found to be the most accurate test for the detection of 
T. evansi parasitaemia in camels (Singh, Pathak et al. 2004; Njiru, Constantine et al. 
2005) and more sensitive in water buffaloes compared to microscopic parasitological 
tests (Holland, Claes et al. 2001b).  The advantage of PCR compared to parasitological 
techniques is that DNA from clinical samples can be stored for extended periods of time 
and samples do not require refrigeration (Holland, Claes et al. 2001b).  Primers for 
detecting organisms from the Trypanozoon subgroup (Moser, Kirchhoff et  al. 1989; 
Wuyts,  Chokesajjawatee  et  al.  1994;  Njiru,  Constantine  et  al.  2005)  and  T.  evansi 22 
 
specific primers have been developed (Artama, Agey et al. 1992; Njiru, Constantine et 
al. 2006).  PCR can also be used to detect the presence of parasites in invertebrate hosts 
and is more reliable than the dissection method (Njiru, Makumi et al. 2004b). 
Trypanosoma  evansi  can  be  distinguished  from  T.  brucei  and  T.  equiperdum  using 
probes based on kinetoplast minicircle DNA (Masiga and Gibson 1990; Li, Gasser et al. 
2007).  However, the diagnostic utility of PCRs based on kinetoplast DNA may be 
limited by the presence of dyskinetoplastic strains of T. evansi (Njiru, Constantine et al. 
2006; Li, Gasser et al. 2007).  PCRs have also been developed using the presence of the 
RoTat 1.2 gene to distinguish between T. evansi, T. equiperdum and T. brucei (Claes, 
Radwanska et al. 2004).   
A PCR using primers to amplify the internal transcribed spacer 1 (ITS1) of ribosomal 
DNA that is able to distinguish between different pathogenic trypanosomes has been 
developed and evaluated in a number of studies (Agbo, Majiwa et al. 2001; Desquesnes, 
McLaughlin  et  al.  2001;  Njiru,  Constantine  et  al.  2005).    A  mixture  of  up  to  four 
trypanosomes species could be differentiated in a single reaction because the ITS region 
varies in size between trypanosome species (Desquesnes, McLaughlin et al. 2001; Njiru, 
Constantine  et  al.  2005).    ITS1  was  not  amplified  in  any  of  the  non-pathogenic 
trypanosomes tested (Njiru, Constantine et al. 2005). 
A PCR-ELISA, where PCR products are used as ELISA reagents, has been developed 
and shown to be highly specific and more sensitive than many conventional PCRs when 
this  test  was  used  to  detect  trypanosomes  in  cattle  and  mosquitoes  (Chansiri, 
Khuchareontaworn et al. 2002).  However, this platform has not been adopted widely 
probably  because  there  is  no  practical  benefit  to  using  PCR-ELISA  compared  to 
standard gel-based PCRs.   23 
 
A real-time or quantitative PCR (qPCR) has been developed for detecting infection with 
T. evansi in animals (Taylor, Boyle et al. 2008) and T. brucei (Becker, Franco et al. 
2004)  and  T.  cruzi  (Piron,  Fisa  et  al.  2007)  in  humans.    Conventional  PCRs  are 
cumbersome and time-consuming to run, with  a risk of contamination by post-PCR 
product.  A qPCR is much less labour-intensive than a conventional PCR, is accurate 
and performed in a closed-tube system and therefore does not require post-PCR sample 
handling, thus minimising carry-over contamination (Heid, Stevens et al. 1996).  The 
TaqMan qPCR to detect T. evansi infection is based on the internal transcribed spacer 1 
(ITS-1) region of ribosomal RNA used in some conventional PCRs mentioned above 
and  is  therefore  able  to  detect  other  pathogenic  trypanosomes  as  well  as  T.  evansi 
(Taylor, Boyle et al. 2008). 
Loop-mediated  isothermal  amplification  (LAMP)  rapidly  amplifies  a  few  copies  of 
DNA to 10
9 copies in less than an hour under isothermal (60-65ºC) conditions (Notomi, 
Okayama et al. 2000).  It uses six or eight primers to recognise four or six target sites 
respectively (Notomi, Okayama et al. 2000; Kuboki, Inoue et al. 2003; Njiru, Mikosza 
et  al.  2008a;  Njiru,  Mikosza  et  al.  2008b)  to  produce  a  stem-loop  structure,  with 
multiple repeats creating a cauliflower-like structure (Notomi, Okayama et al. 2000).  
The use of a number of primers targeting multiple target sites is expected to amplify 
target sequences with high specificity (Notomi, Okayama et al. 2000). 
LAMP does not require sophisticated technology and can be performed using a water 
bath held at a constant (isothermal) temperature.  Amplification of the LAMP product 
can be monitored visually either by observing an increasing turbidity or after adding a 
fluorescent dye (Kuboki, Inoue et al. 2003; Njiru, Mikosza et al. 2008a).  However, 
false positives  may occur because of contamination by  end-product when tubes  are 24 
 
opened to add the indicator dye (Njiru, Mikosza et al. 2008a).  Further work is required 
to produce a closed reaction system which can be used in the field (Boehme, Nabeta et 
al. 2007). 
LAMP-based assays have been developed to detect T. brucei and T. evansi infections in 
animals and they appear to have good sensitivity and specificity (Kuboki, Inoue et al. 
2003; Thekisoe, Inoue et al. 2005; Thekisoe, Kuboki et al. 2007; Njiru, Mikosza et al. 
2008a).  Dried blood samples stored on Whatman FTA cards can also be used in the 
LAMP  test  (Kuboki,  Inoue  et  al.  2003).    LAMP  was  less  sensitive  than  mouse 
inoculation for detecting trypanosomes in a field trial (Thekisoe, Inoue et al. 2005), 
although this could be improved with appropriate primer design.  It is also possible to 
use unprocessed template without the need for nucleic acid extraction (Njiru, Mikosza 
et al. 2008b) thereby reducing processing time and costs.  Further work is required 
before this is can be used as a routine test. 
Nucleic acid based tests are generally sensitive, although they are not always reliable.  
False negatives can occur in individuals with very low parasitaemias, for example in 
chronic infections (Moser, Kirchhoff et al. 1989), or if DNAse or other inhibition such 
as haemoglobin are present.  In addition false positives can result from contamination 
by post-PCR product (Nantulya 1990; Luckins 1992; Luckins, McIntyre et al. 1992; 
Zarlenga and Higgins 2001).   
2.2.5  Enzyme detection – tyrosine aminotransferase 
A number of studies have been conducted to evaluate enzyme production by parasites.  
They include the discovery of multiple transaminase activity in Leishmania donovani 
(Chatterjee  and  Ghosh  1957),  acid  phosphatases  in  trypanosomes  and  Leishmania 
donovani (Borowy, Schell et al. 1991), tyrosine transaminase in Crithidia fasciculata 25 
 
(Constantsas, Levis et al. 1971; Rege 1987) and African trypanosomes (Stibbs and Seed 
1976),  peptidase  in  trypanosomes  (Knowles,  Abebe  et  al.  1989)  and  lactate 
dehydrogenase in Plasmodium falciparum (Makler and Hinrichs 1993). 
Tyrosine  aminotransferase  activity  was  identified  in  Crithidia  fasciculata,  a 
trypanosomatid  of  invertebrates  (Constantsas,  Levis  et  al.  1971).    The  transaminase 
activity from C. fasciculata was 20 to 30 times greater compared to the levels in normal 
rat liver (Constantsas, Levis et al. 1971).  Constantsas et al. (1971) showed that the 
majority of the enzyme activity occurred in the soluble fraction of the cell during the 
parasite’s  logarithmic  growth  phase  and  in  the  insoluble  cell  fraction  during  the 
stationary phase of the trypanosomatid growth cycle. 
Enzymes from parasites may be useful for parasite detection because a small amount of 
enzyme can change a large amount of substrate, resulting in a detectable reaction (El 
Sawalhy and Seed 1998a).  In addition, enzymes are unlikely to undergo mutational 
change and the tests to detect enzyme activity are easy to perform and have potential for 
field use. 
Pathogenic trypanosomes are extremely active and their continuous movement requires 
a large amount of energy, which may contribute to hypoglycaemia in the host (Tizard, 
Nielsen et al. 1978).  Trypanosomes depend largely on the metabolism of amino acids, 
with or without the presence of glucose  (Mancilla, Naquira et al. 1967; Von Brand 
1973).  Trypanosoma brucei gambiense and Crithidia fasciculata transaminate amino 
acids to regenerate methionine from alpha-ketomethiobutyrate (Berger, Dai et al. 1996; 
Berger, Wilson et al. 2001).  Phenylalanine is broken down into the aromatic amino acid 
tyrosine, which is a precursor for catecholamines, including neurotransmitters dopamine 
and norepinephrine (Wellner and Meister 1981).  It is also the precursor of the thyroid 26 
 
hormones  thyroxine and triiodothyronine, necessary  for many functions in  the body 
(Wellner  and  Meister  1981).    The  breakdown  products  of  enol  acids,  including 
phenylpyruvate and hydroxyphenylpyruvate, may cause neurological signs in the host 
should they accumulate in the body (Newport, Page et al. 1977a; Wellner and Meister 
1981). 
These enol acids are usually not present in the urine of healthy individuals except where 
there are errors in amino acid metabolism resulting in serious consequences (Wellner 
and  Meister  1981).    The  incomplete  oxidation  of  alpha-ketoacids  results  in  excess 
generation of H+ ions causing acidosis.  There is a significant metabolic loss to the host 
at a time when energy is needed for defense and repair (Hall, Seed et al. 1985).  It is 
possible that some of the clinical signs, especially neurological signs (lethargy, ataxia, 
increased  sleep  periods,  etc.)  observed  in  humans  suffering  from  chronic  African 
trypanosomiasis could be attributed to increases in tyrosine aminotransferase activity 
and the resultant deficiency in tyrosine and elevation of its catabolites (Stibbs and Seed 
1976).   Indeed, a marked reduction in  serum tyrosine levels  was  observed in  voles 
(Microtus montanus) experimentally infected with T. b. gambiense (Newport, Page et 
al. 1977a).  Tyrosine was the only amino acid found to be markedly decreased in the 
brain (45%), liver (32%) and muscle (45%), which suggested that a relatively specific 
decrease in free tyrosine concentration has been induced (Newport, Page et al. 1977a).  
This  decrease  in  free  tyrosine  concentration  suggests  an  alteration  in  either  host 
metabolism or parasitic utilization of this amino acid because amino acids other than 
tyrosine  and  tryptophan  were  only  slightly  reduced  (Newport,  Page  et  al.  1977a; 
Newport and Page 1977b). 27 
 
Stibbs  and  Seed  (1976)  showed  that  serum  and  hepatic  tyrosine  aminotransferase 
activity was increased in voles chronically infected with T. b. gambiense.  A subsequent 
study found elevated tyrosine aminotransferase levels in the liver but not in the serum 
(Seed, Sechelski et al. 1987).  The serum tyrosine aminotransferase levels in the former 
study correlated well with parasitaemia;  but  poorly with  liver tyrosine transaminase 
levels suggesting that the elevated serum transaminase activity could be attributed to the 
trypanosomes. 
It is possible that the increase in alpha keto acids was due to either an overload by 
parasite metabolic products or by specific inhibition of normal host pathways (Hall and 
Seed  1984).  However,  trypanosomes  contain  high  levels  of  endogenous  tyrosine 
aminotransferase, which may have contributed to the levels in the serum as a result of 
release from lysis of intravascular parasites (Stibbs and Seed 1975; Stibbs and Seed 
1976).   
Increased levels of tyrosine catabolites in the urine of infected animals, which decreased 
to normal levels within 24 hours of treatment with Suramin, provided evidence that the 
transaminase originated from the trypanosomes (Seed 1980).  Seed (1980) concluded 
that  the  rapid  reduction  in  urine  hydroxyphenylpyruvate  levels  after  treatment  is 
evidence that the enzyme is of parasite origins.  This is because enzyme levels would 
normally take longer to return to normal if they are caused by an abnormality or kidney 
damage. 
A further study showed that the urinary excretion of both aromatic (phenylpyruvate and 
hydroxyphenylpyruvate)  and  aliphatic  (pyruvate  and  alpha-ketoglutarate)  keto  acids 
were increased (Hall, Seed et al. 1985).  However, there was no apparent correlation 
between the level of parasitaemia and the amount of keto acid excretion in chronically 28 
 
infected animals (Hall, Seed et al. 1985).  There have, however, been reports that camel 
owners in Sudan can accurately diagnose surra in camels by the rusty colour and odour 
of their urine, which smells like rotten watermelon (Hunter 1986).  Keto-acid excretion 
increased in the urine of infected mice (Hall and Seed 1984) and was directly correlated 
with T. evansi parasitaemia in some mice (El Sawalhy and Seed 1998a), though not in 
others (Hall, Seed et al. 1985).  Trypanosome tyrosine aminotransferase causes a broad 
disturbance in amino acid metabolism, resulting in multiple alpha-keto aciduria, unlike 
the more limited disturbances observed in many heritable metabolic disorders which 
have discrete enzymatic defects. 29 
 
 
Tests for detecting infection with trypanosomes and their advantages and disadvantages 
can be summarised in the following table 
Test  Advantages  Disadvantages 
Parasitological 
tests 
Definitive diagnosis if 
parasites are seen. 
Little equipment is required. 
Can be cheap and easy to 
perform 
Poor sensitivity in cases with 
low parasitaemia. 
Technical expertise required. 
Serological tests: 
Antigen detection 
Multiple samples can be run in 
a multi-sample format. 
Moderately cheap to run. 
Little expertise required 
Poor sensitivity in cases with 
low parasitaemia. 
 
Serological tests: 
Antibody 
detection 
Antibodies can be detected in 
cases with chronic disease, 
despite low parasitaemia 
Moderately cheap to run. 
Little expertise required 
Cannot distinguish between 
infected and recovered 
animals.   
Early infection prior to 
antibody development 
cannot be detected. 
Molecular 
techniques 
Sensitive for the detection of 
infection. 
Can be used to differentiate 
between infected and treated 
animals. 
Although generally more 
sensitive than parasitological 
tests, tests can miss cases 
with low parasitaemia. 
Due to sensitivity of tests 
contamination can result in 
false positive test results. 
Expensive to perform. 
Enzyme detection  Potential for detecting low-
level parasitaemia 
Non-specific as enzymes 
may be produced by many 
different organisms. 
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2.3  Immune response 
2.3.1  Introduction 
Dead  or  dying  trypanosomes  generate  breakdown  products  and  enzymes  that  are 
capable of metabolic and cellular disruption in the host, suppressing the immune system 
(Tizard, Nielsen et al. 1978).  Pathogenic trypanosomes cause prolonged parasitaemia 
with destruction of large numbers of trypanosomes causing pathology by accumulation 
of  weakly  toxic  breakdown  products  (Tizard,  Nielsen  et  al.  1978).    In  addition, 
trypanosomes  disrupt  the  gut  integrity  of  their  host,  resulting  in  elevated  levels  of 
circulating endotoxins and associated clinical signs (Nyakundi, Crawley et al. 2002).  
Subclinical  disease  may  increase  the  risk  of  intercurrent  disease  or  vaccine  failure.  
Onah et al. (1998) showed that significant immunosuppression occurred in sheep and 
goats  experimentally  infected  with  T.  evansi  as  evidenced  by  decreased  cellular 
responses to vaccine antigens.  In addition, Payne et al. (1994) found that treating cattle 
infected  with  T.  evansi  increased  their  weight  gain  compared  to  untreated  infected 
cattle, but that the weight gain still remained lower compared to uninfected cattle.  This 
suggests that there are factors other than the presence of the parasite responsible for 
decreased productivity. 
Inbred mouse strains exhibit different susceptibilities to disease.  For example, A/J and 
C3H  mice  are  most  susceptible  and  C57BL/6  mice  show  the  greatest  resistance  to 
infection  with  T.  evansi  (Morrison,  Roelants  et  al.  1978).    Morrison  et  al  (1978) 
observed  that  there  was  no  difference  in  the  susceptibility  to  infection  between  the 
mouse strains, although the more resistant strains developed a lower parasitaemia with 
fewer infiltrating splenic lymphocytes (Morrison, Roelants et al. 1978). 31 
 
2.3.2  Immune response 
Trypanosomiasis is a disease affecting the immune system of the host animal (Lutje, 
Mertens et al. 1995; Dargantes, Campbell et al. 2005b; Campbell unpublished review).  
Although  the  immune  system  is  designed  to  protect  a  host  from  pathogens  it  can 
sometimes  be  overwhelmed,  respond  inappropriately  or  result  in  immune  mediated 
disease with clinical signs that are related to the immune response rather than the initial 
pathogen (Fairweather,  Kaya et  al.  2001;  Dargantes, Campbell  et  al.  2005b;  Bisser, 
Ouwe-Missi-Oukem-Boyer  et  al.  2006).    During  trypanosomiasis  the  genetic 
backgrounds of both the host and parasite contribute to the course of the disease and the 
immune response and severity of disease can also be affected by interactions between 
infectious agents (Cox 2001). 
Circulating  trypanosomes  are  rarely  observed  in  individuals  suffering  from  chronic 
disease and studies of infection with T. cruzi have failed to show a correlation between 
the  intensity  of  inflammation  and  the  level  of  parasitaemia  (Olivares-Villagomez, 
McCurley et al. 1998).  This may be because the immune response is directed against 
both parasites and self antigens (Soares, Pontes-De-Carvalho et al. 2001).  The parasites 
might  achieve  this  through  molecular  mimicry  or  inflammation  and  tissue  damage 
leading to the release of tissue proteins which stimulates the formation of self antigens 
(Soares and Santos 1999; Fairweather, Kaya et al. 2001).  Re-infection in endemic areas 
may also induce the release of autoantigens (Soares, Pontes-De-Carvalho et al. 2001).  
The most significant molecular response to Trypanosoma congolense infection in cattle 
is detected only after parasites are apparent in the peripheral blood, with the largest 
changes occurring between 13 and 23 days post-infection when parasite load is at its 
greatest (Hill, O’Gorman et al. 2005). 32 
 
B cell responses can be T cell-dependent, meaning that activated T cells are required to 
stimulate antibody production by B cells, or T cell-independent.  T cell-dependent B 
cell stimulation results in a significantly stronger and larger antibody response, although 
trypanosome infections can be controlled by T cell-independent antibody production 
(Reinitz and Mansfield 1990).  T cell-dependent mechanisms are essential for a B cell 
response  to  specific  trypanosome  antigens  and  dead  trypanosomes  (Reinitz  and 
Mansfield 1990). 
Major histocompatibility complex I (MHC I) presents antigen mainly from intracellular 
viruses and tumour cells and is expressed during peak parasitaemia in cattle infected 
with trypanosomes (Hill, O’Gorman et al. 2005).  MHC I complexes are recognized by 
CD8
+ T cells (Natural Killer (NK) cells), which kill affected presenting cells.  Patients 
with chronic T. cruzi infections may develop gradual clonal exhaustion of CD8+ T cells 
associated  with  increased  disease  severity,  possibly  due  to  continuous  antigenic 
stimulation (Albareda, Laucella et al. 2006).  MHC II complexes, which are present on 
specialised antigen presenting cells such as macrophages and dendritic cells, present 
antigens from extracellular as well as intracellular organisms (Meuer, Schlossman et al. 
1982) and are recognized by CD4+ (helper) T lymphocytes, resulting in their activation 
and two possible outcomes.  Small doses of antigen usually stimulate a T helper (Th)1 
response and large doses stimulate a Th2 response (Hosken, Shibuya et al. 1995).  The 
types of CD4+ T lymphocytes are differentiated by the cytokines they produce.  Th1 
activation results in secretion of cytokines including interleukin (IL)-2 and interferon 
gamma (IFN-γ) with a resultant delayed type hypersensitivity response.  Th2 activation 
results in increased levels of IL-4, IL-5, IL-6 and IL-10 and antibody production by B 
lymphocytes (Cher and Mosmann 1987; Cherwinski, Schumacher et al. 1987).  The Th1 
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and Th1 dominant responses are often associated with inflammation and tissue injury 
(Abbas, Murphy et al. 1996). 
Trypanosomiasis has been found to suppress the Th1 cell-mediated immune response 
(Mansfield and Wallace 1974).  Suppressor macrophages that suppress T cell function 
have been demonstrated in the lymph nodes and spleen (Flynn and Sileghem 1991).  
Depletion  in  T  cell  subsets  does  not  prevent  an  inflammatory  response  in  acute  or 
chronic  T.  cruzi  infection.    Instead  it  results  in  increased  parasite  numbers  and  an 
increased inflammatory response (Tarleton, Sun et al. 1994).  This suggests that the 
inflammatory  response  in  chronic  T.  cruzi  infection  is  due  to  the  presence  of  the 
intracellular parasite rather than specific T cells or autoantigens (Tarleton, Sun et al. 
1994).    CD8+  T  cells  are  the  predominant  cell  type  present  in  acute  and  chronic 
chagasic  cardiomyopathy  and  the  ratio  of  CD4+  to  CD8+  cells  remains  constant 
throughout the course of infection (Tarleton, Sun et al. 1994) with virtually no B cells 
present.  Mice depleted of CD4+ T cells after the acute phase of the infection exhibited 
higher parasitaemia levels and they survived infection (Tarleton, Sun et al. 1994).  Mice 
depleted of CD8+ cells did not survive the parasitaemia (Tarleton, Sun et al. 1994).  It is 
possible  that  CD4+  T  cells  are  necessary  for  the  initial  induction  of  CD8+  cell 
infiltration (Tarleton, Sun et al. 1994).  However, CD8+ cells were stimulated by the 
trypanosome infection to produce cytokines and proliferate (causing a mononuclear cell 
response) with or without the presence of CD4+ cells (Bakhiet, Buscher et al. 1996). 
Trypanosomes are cleared from the blood of infected individuals mainly by antibody-
mediated  phagocytosis,  though  this  response  cannot  effect  a  cure  (Dempsey  and 
Mansfield 1983a).  Although the monocyte-macrophage system (MPS) is important in 
removal of parasites from the blood, an intact immune system with a critical level of 34 
 
antibody is necessary to clear an infection (Dempsey and Mansfield 1983b).  The liver 
plays a crucial role in parasite clearance and is not impaired by the parasite burden in 
the blood (Dempsey and Mansfield 1983a).  On the other hand the spleen exhibits no 
appreciable uptake of parasites (Dempsey and Mansfield 1983a).  The MPS itself is not 
depressed  even  in  terminally  infected  mice,  even  though  these  mice  showed  severe 
immunosuppression and mice re-infected with the same strain after treatment failed to 
exhibit a characteristic secondary immune response (Dempsey and Mansfield 1983b). 
In a rat model T. b. brucei parasites were able to pass through the blood-brain barrier 
and could be observed in the white matter of the brain without any apparent disruption 
of the tight junctions of the blood-brain barrier (Mulenga, Mhlanga et al. 2001).  A T 
cell-dependent  B  cell  immune  response  characterized  by  lymphoid  and  plasma  cell 
infiltration  occurred  in  the  leptomeninges  of  the  cerebrum  and  cerebellum  of  rats 
infected with T. b. gambiense, extending into the white matter in some areas (Anthoons, 
Van Marck et al. 1989).  Anthoons et al. (1989) demonstrated the presence of IgM, but 
not IgG, in the leptomeminges using immunohistochemistry.  It was uncertain whether 
the response was triggered by parasite antigens, autoantigens or both (Anthoons, Van 
Marck et al. 1989).  Other studies found cytokine-expressing cells in the choroid plexus 
with few cells present in the white matter, suggesting that parasites don’t enter or cause 
inflammation  in  the  brain  (Quan,  Mhlanga  et  al.  1999).    Dargantes  at  al.  (2005b) 
showed that there was meningeal lymphocyte infiltration that did not penetrate into the 
brain substance in goats experimentally infected with T. evansi. 
Some affected organs may not just be innocent bystanders of the immune response 
during  trypanosomiasis.    Machado  et  al.  (2000)  showed  that  cardiomyocytes  in  the 
hearts  of  mice  infected  with  T.  cruzi  secreted  cytokines  and  nitrous  oxide  which 35 
 
attracted  inflammatory  cells  to  control  intracellular  replication  of  parasites.  
Chemokines  may  be  secreted  by  infected  cells  and  mediate  resistance  to  infection 
(Aliberti, Machado et  al. 1999).  Chemokines may also  be involved in  attracting T 
lymphocytes  and  macrophages  to  the  brain  during  infection  with  African 
trypanosomiasis, which might result in the development of brain lesions (Sharafeldin, 
Eltayeb et al. 2000).   
Animals infected with T. evansi show a decreased immune response to other parasites 
(Onah and Wakelin 1999) and antigens (Onah and Wakelin 1999; Holland, My et al. 
2001), including vaccines (Onah, Hopkins et al. 1998; Holland, Do et al. 2003), which 
may be due to a decrease in an effective T cell response.  This immunosuppression is an 
important consideration for vaccination programmes in T. evansi endemic areas and 
may indicate a need for treatment with trypanocidal drugs before vaccinating (Holland, 
Do et al. 2003).  Indeed, higher morbidity and mortality was observed in cattle that were 
simultaneously infected with  Haemonchus contortus and T. congolense compared to 
individuals  that  were  infected  with  either  parasite  alone  (Kaufmann,  Dwinger  et  al. 
1992). 
The mechanisms controlling T cell depression differ between sites and during the acute 
and chronic phases of trypanosomiasis (Mabbott, Coulson et al. 1998).  Differences in 
the dose, route and virulence of the organism have been shown to influence the clinical 
outcome of disease (Dargantes, Reid et al. 2005a).  Intravenous infection, for example, 
is more likely to induce a clinical infection in experimental studies (Dargantes, Reid et 
al. 2005a).  The speed at which antibody is produced by the host is possibly influenced 
by the size of the infecting dose (Reid, Husein et al. 2001b).  An increased parasite load 
may also cause increased immunosuppression.  Dargantes et al (2005a) observed that 36 
 
leukocyte numbers were reduced in goats with high parasitaemia compared to those 
with lower parasitaemia and that leukocyte numbers plummeted in terminal disease of 
heavily parasitaemic animals, which suggests failure of the immune system.  However, 
parasites are not always present at the time of death, which illustrates the unreliability of 
parasitaemia in the diagnosis of surra. 
Nutrition  also  plays  an  important  part  in  the  development  of  clinical  signs  of 
trypanosomiasis.  Low energy and protein diets result in greater production losses and 
increased  recovery  time  following  treatment  (Holmes,  Katunguka-Rwakishaya  et  al. 
2000).  Better nutrition does not influence the onset of anaemia and weight loss, but 
does  result  in  less  rapid  disease  progression  and  reduced  severity  of  clinical  signs 
(Holmes, Katunguka-Rwakishaya et al. 2000).  It is interesting that improved nutrition 
has also been shown to cause higher levels of parasitaemia in experimentally infected 
animals (Katunguka-Rwakishaya, Parkins et al. 1995; Holmes, Katunguka-Rwakishaya 
et al. 2000). 
2.3.3  Antibodies 
Both IgG and IgM antibodies are produced in response to trypanosome infection.  IgM 
is produced early in infection followed by the more specific IgG, which plays a key role 
in  the  control  of  parasitaemia  (Buza  and  Naessens  1999;  Magez,  Radwanska  et  al. 
2006). 
Autoantibodies produced in response to  repeated contact with trypanosome antigens 
(Landsteiner  and  van  der  Scheer  1927)  may  contribute  to  the  pathogenicity  of  the 
disease.    The  level  of  autoantibodies  is  lowest  during  mild  infections  and  in 
trypanotolerant cattle (Naessens, Teale et al. 2002).  Trypanosome-specific antibodies 
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trypanosomes usually belong to the IgM subclass  (Vincendeau and Bouteille 2006).  
These so-called “natural” IgM antibodies, produced by CD5+ B cells (Buza, Sileghem 
et al. 1997) provide innate protection against pathogens and toxins (Ochsenbein and 
Zinkernagel  2000).    The  large  increase  in  polyclonal  antibodies  observed  during 
trypanosome  infections  could  therefore  be  an  expansion  of  non-specific  antibodies 
normally associated with the immune system rather than direct stimulation of B cells by 
the trypanosomes (Buza and Naessens 1999). 
The polyclonal B cell activation induced by trypanosome infections (Hudson, Byner et 
al. 1976) is characterised by a predominantly IgM response with limited IgG production 
(Luckins  1976;  Sacks,  Selkirk  et  al.  1980).    Sacks  et  al.  (1980)  hypothesised  that 
penetration of IgM into tissues where trypanosomes replicate may be impeded because 
it is a larger molecule compared to IgG and that this may lead to chronic infections, 
because of the presence of tissue reservoirs, whilst preventing uncontrolled growth by 
the parasite in the circulation.  IgM is detectable during parasitaemia but IgG levels are 
detectable  only  after  remission  of  parasitaemia  (Dempsey  and  Mansfield  1983b).  
Therefore elimination of the infecting VAT appears to be associated mainly with an 
IgM response, although both IgM and IgG responses to the VSG occur during infection 
(Vincendeau  and  Bouteille  2006).    In  some  animals,  such  as  the  Cape  buffalo, 
parasitaemia is maintained at a cryptic level of between 1 and 100 trypanosomes per ml 
of blood (Grootenhuis, Dwinger et al. 1990) and parasitaemia is suppressed by low 
levels  of  IgG.    Removal  of  IgG  from  the  serum  of  these  animals  restores  its 
trypanosome growth-supporting activity in vitro (Guirnalda, Murphy et al. 2007). 
Serum levels of IgM remain high throughout infection and are not related to parasite 
load (Baltz, Baltz et al. 1981).  There may be a possible link between high IgM levels 38 
 
and immunodepression when suboptimal anti-parasite responses allow the parasite to 
evade  host  immunity  (Hudson,  Byner  et  al.  1976).    It  has  been  suggested  that 
trypanosome-induced  polyclonal  B  cell  activation  in  the  presence  of  a  continuous 
trypanosome  infection  could  result  in  depletion  of  antigen-reactive  B  lymphocytes, 
which  possibly  become  secretory  cells  without  proliferating  (Hudson,  Byner  et  al. 
1976).  Immunodeficiency appears to be influenced by the level of parasitaemia (and 
living parasites) rather than B cell clonal exhaustion (Baltz, Baltz et al. 1981). 
2.3.4  Cytokines 
Cytokines are peptide/glycoprotein mediators which act as intracellular signals.  They 
usually act locally, though they are sometimes found systemically (Oppenheim, Rossio 
et al. 1993).  Cytokines are found in serum and plasma samples, tissue specimens and 
urine and can be used as indicators of disease progression and activity (Oppenheim, 
Rossio et al. 1993).  It is possible that these by-products of T cell activation could also 
play a role in tissue damage and other serious consequences of autoimmune disease 
(Meuer, Schlossman et al. 1982; Davies, Wallis et al. 1990). 
The level of cytokine expression by cells is thought to be continuously distributed and 
the distinction between T cell clones may depend on the threshold of cytokine detection 
rather than on a fixed value of physiological significance (Kelso 1995).  In persistent 
infections the cytokine response tends to polarise towards either a Th1 or Th2 response.  
However,  it  is  difficult  to  classify  T  cell  populations  as  either  Th1  or  Th2  subsets 
(Abbas,  Murphy  et  al.  1996)  because  cytokine  production  can  be  heterogeneous 
between  individual  cells  even  if  they  are  cloned  (Bucy,  Panoskaltsis-Mortari  et  al. 
1994).    It  could  be  that  a  change  in  T  cell  response  is  achieved  by  shifting  the 
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between  two  distinct  T  cell  subsets  (Kelso  1995).    However,  one  study  found  that 
cytokine  gene  activation  in  T  cells  tends  to  be  all  or  nothing  rather  than  a  graded 
response,  which  suggests  that  cells  are  either  positive  or  negative  for  the  cytokine 
production  (Bucy,  Panoskaltsis-Mortari  et  al.  1994).    It  is  more  likely  that  the 
classification of T cells as Th1 or Th2 is dependent on assay sensitivity and that they are 
not  distinct  subpopulations  (Kelso  1995)  especially  as  some  T  cells  can  secrete 
cytokines classified as Th1 or Th2 simultaneously. 
T cell subsets originate from the same precursor cells, which produce mainly interleukin 
2 (IL-2) when first stimulated.  It was originally thought that IL-4 was produced only 
after Th2 differentiation (Mosmann, Cherwinski et al. 1986).  However, it is likely that 
small amounts are produced by T lymphocytes after their initial activation and IL-4 
accumulates with increasing lymphocyte activation eventually reaching a threshold that 
causes a switch towards Th2 differentiation (Schmitz, Thiel et al. 1994).  Therefore Th2 
responses  tend  to  become  more  pronounced  with  repeated  T  cell  stimulation.    In 
standardised T cell clones Th1 cells only respond to IL-2 (not IL-4) and do not require 
an additional co-factor while Th2 cells replicate in response to both IL-2 and IL-4, but 
require IL-1 as a co-factor (Kurt-Jones, Hamberg et al. 1987).  Th1 T lymphocytes 
secrete IL-2, resulting in an autocrine cycle, whereas Th2 cells, while responding to IL-
2, do not secrete IL-2 and produce IL-4 instead (Kurt-Jones, Hamberg et al. 1987).  This 
means  that  IL-2  causes  a  general  proliferation  of  the  bystander  T  cell  population 
whereas IL-4 only affects other Th2 cells.   
Mixed cytokine patterns usually occur early after lymphocyte activation (Kelso 1995).  
Th1 and Th2 responses may initially be interconvertible, but repeated stimulation results 
in irreversible commitment to one pathway (Murphy, Shibuya et al. 1996).  A polarised 40 
 
Th1  or  Th2  immune  response  is  generally  an  endpoint  of  chronic  immunisation  or 
chronic disease because these two immune responses may be mutually exclusive and 
pathogenic  (Fiorentino,  Bond  et  al.  1989;  Alwan,  Kozlowska  et  al.  1994).  
Transforming growth factor beta (TGF-β) produced by regulatory cells may inhibit both 
Th1 and Th2 responses (Swain, Huston et al. 1991).  Many cells cannot be classified 
into either of these two subsets by cytokine pattern production (Kelso 1995).  These 
cells may secrete a mixture of cytokines and are sometimes called Th0 cells (Abbas, 
Murphy et al. 1996).  It is possible that a counter-inflammatory immune response occurs 
in late stage human african trypanosomiasis, resulting in normal levels of Th1 cytokines 
in the CSF of human patients (MacLean, Odiit et al. 2006).  This is in contrast to a 
finding of inflammatory cytokine expression in brain parenchyma of mice with late-
stage trypanosomiasis (Kennedy 1999). 
To  some  extent  the  host  immune  response  depends  on  the  nature  of  the  antigen 
macrophages are exposed to (O'Garra 1998; Mansfield and Paulnock 2005), the genetic 
background  of  the  host  and  the  dose  and  route  of  infection  (O'Garra  1998).  
Macrophages and peritoneal exudate cells harvested from mice and exposed to soluble 
VSG in vitro produced TNF-α, IL-6 and nitrous oxide (Th2 response), whereas the same 
cell populations exposed to membrane-form VSG caused increased levels of IL-1 and 
IL-12, with a resultant Th1 response (Magez, Stijlemans et al. 1998).  Trypanosomes 
therefore  appear  able  to  regulate  the  host  response  by  release  of  either  soluble  or 
membrane-associated VSG. 
Cytokines have varying effects on chemokine production (Teixeira, Gazzinelli et al. 
2002).    Chemokines  are  produced  in  response  to  parasites  and  are  sustained  by 
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each cell type and chemokines have agonistic as well as antagonistic activity (Loetscher 
and  Clark-Lewis  2001).    Cell  migration  is  affected  by  cytokine  and  chemokine 
production and the state of cell activation (Moser and Loetscher 2001).  Chemokines 
may  be  produced  by  the  infected  cells  themselves  (Machado,  Martins  et  al.  2000).  
Chemokines work synergistically to attract cells down one concentration gradient before 
switching to another when the cell receptors are saturated with that chemokine, thus 
forming a sequential chemokine pathway (Foxman, Campbell et al. 1997). 
Th1 and Th2 lymphocytes can be distinguished by their pattern of cytokine production.  
Methods  used  to  investigate  cytokines  include  image  morphometry  and  quantitative 
analysis of cell population markers (Gunnes, Valheim et al. 2003), ELISPOT (Anthony 
and Lehmann 2003) and ELISAs (Fiorentino, Zlotnik et al. 1991b; Okomo-Assoumou, 
Daulouede et al. 1995; McWaters, Hurst et al. 2000; Nyakundi, Crawley et al. 2002b; 
Molina 2005a).  Th1 and Th2 cells have different bioactivities, helper functions and 
biosynthetic labeling patterns allowing separation of distinct groups of cells.  Mosmann 
et al (1986) found that Th1 cells secrete detectable amounts of IL-2 or IFN-γ, which can 
eradicate intracellular pathogens.  On the other hand Th2 cells do not secrete IL-2 or 
IFN-γ but they do produce other cytokines with IgG and IgE enhancing activities. 
2.3.4.1 IFN-γ 
Interferon gamma (IFN-γ), produced by Th1 (Cherwinski, Schumacher et al. 1987) and 
CD8+  T  cells  (Reis,  Higuchi  Mde  et  al.  1997;  Baetselier,  Namangala  et  al.  2001; 
Namangala, Noel et al. 2001b) is a principle Th1 cytokine that activates macrophages 
and CD8+ cytotoxic T lymphocytes and stimulates the production of IgG2a and IgG3 
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IFN-γ is probably the first cytokine produced during a trypanosome infection and causes 
contradictory effects  (Bisser, Ouwe-Missi-Oukem-Boyer  et  al.  2006).  Resistance to 
African trypanosomiasis has been related to IFN-γ production and a bias towards a Th1 
immune  response  (Hertz,  Filutowicz  et  al.  1998).    IFN-γ  may  therefore  limit  early 
parasite replication mainly due to activation of macrophages.  The production of high 
levels are required early in the disease process to influence resistance (Silva, Morrissey 
et al. 1992; Baetselier, Namangala et al. 2001; Bisser, Ouwe-Missi-Oukem-Boyer et al. 
2006).    Mice  deficient  in  IFN-γ  production  died  rapidly  when  infected  with 
trypanosomes (Magez, Radwanska et al. 2006).  High levels of IFN-γ were induced 
early in infection in the brain and spleen, whereas low levels of TNF-α, IL-4 and IL-10 
were found in the first 96 hours after rats were infected with T. b. brucei (Sharafeldin, 
Hamadien et al. 1999).  IFN-γ production was downregulated after 48 hours possibly 
because it is only important early in infection (Sharafeldin, Hamadien et al. 1999).  IFN-
γ stimulates the production of TNF-α and nitrous oxide (Farrar and Schreiber 1993; 
Hertz and Mansfield 1999) resulting in a partially damaged parasite that is possibly 
more prone to opsonisation by IgG and subsequent phagocytosis (Magez, Radwanska et 
al. 2006).  Nitrous oxide production alone did not increase mouse susceptibility to the 
infection (Hertz and Mansfield 1999).  
Sustained production of IFN-γ in mice infected with T. b. brucei resulted in systemic 
pathology and reduced survival (Namangala, Noel et al. 2001b; Shi, Pan et al. 2003).  
Circulating  IFN-γ  profoundly  inhibits  bone  marrow  proliferation  in  mice  and  its 
influence  over  certain  cell  subpopulations  may  regulate  the  immune  response 
(Gajewski, Goldwasser et al. 1988).  Although IFN-γ is associated with resistance to 
African  trypanosomes  it  also  appears  to  alter  the  permeability  of  the  basement 
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across  the  blood  brain  barrier  (BBB)  and  into  the  brain  parenchyma  (Masocha, 
Robertson  et  al.  2004;  Masocha,  Rottenberg  et  al.  2007).    Biomarkers  of  IFN-γ 
produced  during  penetration  of  the  brain  may  be  a  useful  aid  in  disease  staging 
(Masocha, Robertson et al. 2004).  Manipulation of IFN-γ levels could also be used to 
supplement  treatment  strategies  by  preventing  parasite  tissue  penetration  across  the 
BBB when using the slow-acting drugs to clear systemic infection (Masocha, Robertson 
et al. 2004). 
2.3.4.2 IL-6 
IL-6 is a cytokine produced mainly by antigen presenting cells (APCs), although it is 
also produced by other cell types including endothelial cells and fibroblasts (Van Snick 
1990;  Rincon,  Anguita  et  al.  1997).    IL-6  appears  to  suppress  pro-inflammatory 
cytokines while not compromising the level of anti-inflammatory cytokines (Shanley, 
Foreback et al. 1997; Tilg, Dinarello et al. 1997; Xing, Gauldie et al. 1998).  It is an 
acute-phase protein and may be involved in immune-pathogenesis (Hirano, Yasukawa 
et al. 1986) where it helps differentiate CD4+ T cells into Th2 cells by working in 
combination  with  IL-4  (Rincon,  Anguita  et  al.  1997).    It  also  plays  a  role  in  local 
inflammatory reactions via leukocyte recruitment (Romano, Sironi et al. 1997).  Normal 
cells  do  not  produce  IL-6  unless  they  are  stimulated  by  antigens  from  potential 
pathogens (Akira, Taga et al. 1993).  IL-6 receptors are only present on activated B 
cells, i.e. in the late phase of differentiation, which results in an increase in IgM, IgA 
and IgG levels without stimulating B cell proliferation (Akira, Taga et al. 1993).  IL-6 
results in activation, growth and differentiation of T cells (Akira, Taga et al. 1993). 
IL-6  is  produced  by  endothelial  cells  during  infections  with  parasites  such  as 
Schistosoma mansoni where it acts as a regulatory cytokine, reducing damage caused by 44 
 
the immune response and increasing parasite survival (Angeli, Faveeuw et al. 2001).  
Reis et al. (1997) found that there was good correlation between the number of IL-6 and 
IFN-γ producing cells in the hearts of human patients infected with  T. cruzi, which 
suggests that IL-6 plays a protective role in patients with chronic T. cruzi infection.  
However, high levels of IL-6 in serum has also been found in patients with severe 
bacterial infections and an associated poor outcome (Calandra, Gerain et al. 1991). 
IL-6 is a non-specific marker of early inflammation and may play a role in cachexia 
(Akira, Taga et al. 1993).  It has been suggested that elevated IL-6 may be a marker for 
disease severity, with sustained elevation of IL-6 being a predictor of organ damage and 
fatality (Mertens, Taylor et al. 1999). 
2.3.4.3 IL-8 
IL-8 is a T cell and neutrophil attractant and activator and appears to be one of the 
cytokines  produced  in  response  to  tissue  injury  or  immune-mediated  inflammation 
(Larsen, Anderson et al. 1989a; Larsen, Anderson et al. 1989b).  IL-8 levels may be 
increased in the CSF of human patients suffering from late stage trypanosomiasis, with 
levels dropping after treatment (Lejon, Lardon et al. 2002). 
2.3.4.4 TNF-α 
Trypanosome infections induce the production of tumour necrosis factor α (TNF-α) by 
macrophages (Daulouede, Bouteille et al. 2001) and T cells (Cherwinski, Schumacher et 
al. 1987).  One study showed that there was an early increase in serum TNF-α and an 
associated acute drop in packed red cell volume (PCV) in cattle infected with T. vivax 
compared to a more gradual onset of anaemia with no detectable serum TNF-α levels in 
cattle infected with T. congolense (Sileghem, Flynn et al. 1994).  Elevation in TNF-α 45 
 
has also been associated with disease severity in human patients infected with T. b. 
gambiense (Okomo-Assoumou, Daulouede et al. 1995).  However, there did not appear 
to be a significant difference in TNF-α levels in early or late stages of disease (Okomo-
Assoumou, Daulouede et al. 1995).  A more recent study found that PCV dropped less 
in TNF-α-knock-out mice infected with T. b. rhodesiense than in wild-type mice but 
there was no apparent difference between these mouse types when they were infected 
with T. congolense (Naessens, Kitani et al. 2005).  This indicates that more than one 
mechanism  controls  the  development  of  anaemia  in  animals  infected  with 
trypanosomes.  Different levels of TNF-α have been observed in mice infected with 
different  species  of  African  trypanosomes  (Iraqi,  Sekikawa  et  al.  2001)  as  well  as 
different strains of the same species resulting in more rapid and severe clinical signs 
(MacLean, Chisi et al. 2004).  TNF-α levels were also observed to increase over time in 
the choroid plexus of mice infected with T. b. gambiense (Quan, Mhlanga et al. 1999). 
TNF-α can have both harmful and beneficial effects on the host because it influences 
both  the  host  and  the  parasite.    In  the  host  TNF-α  causes  signs  of  morbidity  and 
immunopathology associated with trypanosomiasis but controls parasitaemia (Sileghem, 
Flynn et al. 1994; Magez, Radwanska et al. 1999; Machado, Martins et al. 2000; Iraqi, 
Sekikawa et al. 2001; Naessens, Kitani et al. 2005).  TNF-α plays a role in parasite 
elimination either directly (Lucas, Magez et al. 1994; Daulouede, Bouteille et al. 2001) 
or indirectly with nitrous oxide induction (Kitani, Black et al. 2002).  Indirect parasite 
elimination is probably more common as evidenced by the failure of recombinant TNF-
α  to  inhibit  T.  b.  brucei  in  culture  (Kitani,  Black  et  al.  2002).    Furthermore, 
trypanosomes show a heterogeneous sensitivity to TNF-α, even if they are selected from 
a morphologically homogeneous population (Magez, Geuskens et al. 1997).  It appears 46 
 
that only late-stage bloodstream-form trypanosomes are susceptible to TNF-α mediated 
lysis while other forms are unaffected (Magez, Geuskens et al. 1997). 
The presence of TNF-α induces a decrease in the multiplication of T. brucei in vitro, 
which may allow an antibody mediated immune response sufficient time to suppress or 
eliminate  the  parasites  (Daulouede,  Bouteille  et  al.  2001).    TNF-α  also  affects  the 
activation,  proliferation  and  differentiation  of  B  cells  and  may  contribute  to 
hypergammaglobulinaemia  in  trypanosomiasis  (Kehrl,  Miller  et  al.  1987;  Roldan, 
Rodriguez  et  al.  1992).    Thus,  in  early  disease  TNF-α  may  contribute  to  the 
inflammatory  reaction,  immunosuppression  and  autoantibody  production  with 
elimination of the parasite and in late disease it may contribute to an altered blood-brain 
barrier  with  infiltration  of  cellular  and  humoral  elements,  thus  participating  in 
pathophysiology of the disease (Okomo-Assoumou, Daulouede et al. 1995; Daulouede, 
Bouteille et al. 2001). 
2.3.4.5 IL-2 
IL-2 plays a central role in T cell activation and proliferation (Sileghem, Hamers et al. 
1986) and B cells are an abundant source of IL-2 (Heinzel, Sadick et al. 1991).  The 
immune  response  can  be  manipulated  from  a  Th1  towards  a  Th2  immunity  by 
decreasing IL-2 production (Heinzel, Sadick et al. 1991).  The level of IL-2 and IL-2 
receptor expression are suppressed in mice infected with T. brucei (Sileghem, Hamers et 
al. 1986; Sileghem, Darji et al. 1989) possibly because of the activation of suppressor 
cells that interfere at the level of IL-2 secretion.  However, it has been shown that T. 
cruzi  causes  suppression  of  two  components  (p55  and  p70)  of  high-affinity  IL-2 
receptors in vitro (Kierszenbaum, Cuna et al. 1989). 47 
 
In one study of chronic chagasic cardiomyopathy expression of IL-2 and its receptors 
was  very  low  (Reis,  Higuchi  Mde  et  al.  1997).    This  is  likely  to  be  due  to  an 
immunological imbalance with IL-2 suppression.  There were moderate numbers of IL-
4  and  TNF-α  secreting  cells  in  chronic  chagasic  cardiomyopathy  cases  and  high 
numbers of the same cells in cases with numerous myocardial parasites, suggesting a 
Th2 shift related to the dissemination of T. cruzi parasites (Reis, Higuchi Mde et al. 
1997). 
2.3.4.6 IL-4 
Interleukin 4 (IL-4) is a signature cytokine of the Th2 response and induces B cell 
switching to IgE, stimulates B lymphocytes and results in production of high levels of 
IgM and IgG1 (non-complement fixing IgG) (Davies, Halablab et al. 1998).  The net 
result of a Th2 response is to inhibit inflammation and regulate the immune response.  
However, IL-4 is necessary for protective immunity and a sustained, though not initial, 
response by CD8+ T cells, which contradicts suggestions that IL-4 secreting CD4+ T 
cells are mainly anti-inflammatory (Carvalho, Sano et al. 2002).  IL-4 appears to be at 
the top of the cytokine cascade and is secreted upstream of IL-12.  It thus influences the 
type  of  T  helper  response  that  develops  by  directly  or  indirectly  instructing  T  cell 
priming and differentiation (Stager, Alexander et al. 2003).  IL-4 secretion is stimulated 
by natural antibody (e.g. IgM and IgG) and immune complexes.  Natural antibodies 
which  recognise  pathogen-derived  antigens  induce  IL-4  secretion  by  mononuclear 
phagocytes (Stager, Alexander et al. 2003) and not B, CD4+ T or NK cells, as was 
previously thought (Teixeira, Teixeira et al. 2006).  It is not known whether the same 
cytokines are always needed for CD8+ T cell responses or whether the level of each 
cytokine varies depending on virulence of the organism, tissue compartment affected 
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recent  study  strongly  suggest  that  IgM  natural  antibodies  initiate  the  primary  IL-4 
response (Stager, Alexander et al. 2003). 
The Th2 response is generally present late in infection to limit injurious effects of Th1 
protective immunity (reviewed by Abbas, Murphy et al. 1996).  IL-4 expression tends to 
dominate  earlier  in  the  course  of  disease  with  IL-10  dominating  later  (Bucy, 
Panoskaltsis-Mortari et al. 1994).  Therefore IL-4 directly promotes a Th2 response 
whereas IL-10 inhibits some APCs from stimulating a Th1 response (Hsieh, Heimberger 
et  al.  1992).    IL-4  and  IL-10  have  been  found  in  the  late/chronic  phase  of 
trypanosomiasis and may be more important than IFN-γ for survival of infected mice 
because the absence of IL-10 correlates with extreme susceptibility of mice to T. brucei 
(Baetselier,  Namangala  et  al.  2001).    Although  IL-4  is  needed  for  resistance  to 
trypanosomiasis  (Inoue,  Inoue  et  al.  1999;  Mertens,  Taylor  et  al.  1999)  enhanced 
production may be toxic and contribute to the death of the host (Bakhiet, Jansson et al. 
1996b).    The  ability  of  the  host  to  produce  IL-4  may  therefore  be  correlated  to 
susceptibility to trypanosome infections (Bakhiet, Jansson et al. 1996b). 
2.3.4.7 IL-10 
IL-10  is  an  important  Th2  cytokine  that  is  associated  with  host  susceptibility  to 
protozoan parasites.  It was originally thought to be solely a Th2 product but has been 
shown to be secreted by both Th1 and Th2 cells and activated macrophages (Sornasse, 
Larenas  et  al.  1996;  Steinke  and  Borish  2006).    IL-10  can  down-regulate  T  cell 
responses by regulating antigen presenting cell components necessary for Th1 cytokine 
(IFN γ and IL-2) secretion (Fiorentino, Zlotnik et al. 1991a; Silva, Morrissey et al. 
1992) and decrease IFN-γ utilization (Ghalib, Piuvezam et al. 1993).  IL-10 suppresses 
the release of TNF-α, IL-1 and IL-6 by macrophages (Bogdan, Vodovotz et al. 1991; 49 
 
Fiorentino, Zlotnik et al. 1991b; Ralph, Nakoinz et al. 1992) and down regulates class II 
MHC  expression  and  inflammatory  cytokine  production  by  monocytes  (de  Waal 
Malefyt, Abrams et al. 1991).  IL-10 associated with a Th2 response may affect IFN-γ 
function by down regulating its production and inhibiting its effects (Hsieh, Heimberger 
et al. 1992; Silva, Morrissey et al. 1992; Drennan, Stijlemans et al. 2005).  Therefore it 
has  important  regulatory  effects  on  immunological  and  inflammatory  responses  and 
may regulate both macrophage function and T cell activation, which suggests that there 
is potential for its use as an anti-inflammatory therapy (Fiorentino, Zlotnik et al. 1991b).  
IL-10  appears  to  be  crucial  for  regulation  of  the  balance  between  protective  and 
pathogenic cellular immune responses during trypanosomiasis because its absence is 
associated with reduced survival and increased inflammatory changes in mice infected 
with T. b. brucei (Namangala, Noel et al. 2001b). 
It has been suggested that measurement of IL-10 in serum and CSF may be useful for 
African trypanosomiasis stage determination because levels were observed to decrease 
after successful treatment of human patients (MacLean, Odiit et al. 2001; Lejon, Lardon 
et al. 2002).  However, no IL-10 was found in the CSF of rats infected with T. brucei 
(Quan, Mhlanga et al. 1999). 
2.3.4.8 IL-12 
IL-12 is a cytokine which is produced by macrophages and dendritic cells and induces a 
Th1 response (Macatonia, Hosken et al. 1995).  In African trypanosome infections it 
appears that IFN-γ and IL-12 production, associated with a corresponding strong Th1 
response, is linked to host resistance, rather than IL-4 production and the associated Th2 
antibody response (Hertz, Filutowicz et al. 1998; Kaushik, Uzonna et al. 2000). 50 
 
2.3.5  Immunopathology 
The pathology associated with trypanosomiasis is largely due to the immune response 
induced  by  trypanosome  antigens.    The  pathology  associated  with  trypanosomiasis 
includes  lymphadenopathy,  splenomegaly,  hepatomegaly,  anaemia,  testicular 
enlargement,  haemosiderosis  and  consolidation  of  the  anterior  lung  lobes  (Biswas, 
Choudhury  et  al.  2001; Dargantes, Campbell  et  al.  2005b).   These changes  are not 
considered  pathognomonic  for  the  disease,  except  if  trypanosomes  are  present 
(Dargantes, Campbell et al. 2005b).  Cellular lesions are characterised by mononuclear 
infiltration of interstitial tissues and minor associated cellular damage (Goodwin 1970).  
B and especially T cell responses are present in the spleen, bone marrow and lymph 
nodes (Damayanti, Graydon et al. 1994; Dargantes, Campbell et al. 2005b).  In time, 
immune  exhaustion  occurs  characterised  by  decreased  cell  numbers  and  cell 
degeneration  in  the  germinal  centres  of  the  spleen,  lymph  nodes  and  bone  marrow 
(Dargantes, Campbell et al. 2005b).  The bone marrow is initially hyperplastic, but later 
shows decreased cellular activity (Dargantes, Campbell et al. 2005b), perhaps partly due 
to trypanosomal cytotoxicity, though nitrous oxide produced by the host in response to 
acute trypanosomiasis may also be a cause of anaemia (Mabbott, Coulson et al. 1998).  
In  chronic  infection  T  cell  unresponsiveness  and  anaemia  appear  to  occur  despite 
diminished  nitrous  oxide  synthesis  (Mabbott,  Coulson  et  al.  1998).    Goats  develop 
normocytic normochromic anaemia, which is a result of dyshaemopoiesis or increased 
red  cell  destruction  (Amole,  Clarkson  et  al.  1982;  Dargantes,  Reid  et  al.  2005a).  
Increased  red  cell  destruction  may  be  due  to  immune  complexes  or  autoantibodies 
bound to red blood cell surfaces with resultant removal by the local macrophage system 
(Facer, Crosskey et al. 1982). 51 
 
T. b. brucei may show different tissue distribution in mice with different genetically-
based susceptibilities that may vary over the course of the disease.  Studies using radio-
labeled trypanosomes for early disease showed that trypanosomes were more rapidly 
cleared  from  the  blood  in  resistant  mice  and  accumulated  in  the  spleen,  liver  and 
kidneys in the first 24 hours after intravenous infection (Anderson and Banks 1982). 
2.4  Surveillance for Trypanosoma evansi in Australia 
The introduction of exotic diseases to many countries is becoming more of a threat due 
to globalisation, climate change, migration and political instability (Sutherst 2001) and, 
although Australia is surrounded by water, the northern part of the landmass is close to 
South East Asia.  T. evansi has been recognised as a threat to Australian wildlife and 
livestock industries for many years, especially due the widespread availability of native 
and feral reservoir hosts and tabanid vectors, which would make control and eradication 
of the disease difficult (Thompson 2001; McCarthy and Garrow 2002).  T. evansi is 
endemic in Indonesia and there is a risk that it will be introduced into Papua province 
that shares a border with Papua New Guinea (PNG) via the importation of infected 
livestock (Reid and Copeman 2000).  If T. evansi were to become endemic in Papua 
then it could be easily introduced into PNG by migration of infected wild animals that 
are abundant in the border area (Reid, Husein et al. 1999).  The concern for Australia is 
that animals from PNG may be transported to the Torres Strait Islands and thence to the 
Australian  mainland  (Thompson,  Owen  et  al.  2003).    Another  risk  comes  from 
Indonesian fishing vessels that can house animals such as dogs, rats and birds, as well as 
Indonesian  products  carrying  exotic  diseases,  which  sometimes  reach  the  northern 
shores (Gibbons 2006; Lee 2006; Vince 2007). 52 
 
The north of Australia is sparsely populated with limited infrastructure and difficult 
access.    Much  of  the  land  is  owned  by  Aboriginal  communities  with  restricted 
allowances for tourism.  Populations of feral water-buffalo, pigs and cattle, as well as 
camels, horses, dogs and dingoes live in this area.  Should T. evansi enter the northern 
parts  of  Australia,  it  may  be  firmly  established  before  it  is  detected  by  casual 
observation.  Therefore, the Northern Australia Quarantine Strategy (NAQS) branch of 
the Australia Quarantine and Inspection Service (AQIS) conducts surveillance in the 
region (Thompson, Owen et al. 2003).  Twice a year feral animals are culled, checked 
for obvious disease by post mortem and blood and tissue samples collected to be tested 
for an array of diseases which are considered a threat to Australia (Emma Watkins, 
personal communication).  Members of remote communities are encouraged to report 
unusual conditions seen in plants or animals as well as the unauthorized landings of 
vessels and play a key role in helping to achieve quarantine objectives  (Thompson, 
Owen et al. 2003). 
2.5  Paper-based blood collection 
Filter paper made of cotton lint was first used to collect capillary blood from heel pricks 
in newborn infants to diagnose phenylketonuria (Guthrie and Susi 1963).  Discs of the 
blood-soaked  filter  paper  were  placed  on  minimal  culture  inoculated  with  Bacillus 
subtilis and excess phenylalanine in the blood allowed the bacteria to grow (Guthrie and 
Susi  1963).    The  blood  collection  cards,  which  became  known  as  Guthrie  cards, 
revolutionised population screening for this human disease (Scriver 1998). 
A variety of filter papers have since been used for the collection and detection of DNA 
(Renshaw, Ellingsen et al. 2001; Bereczky, Martensson et al. 2005; Luo, Yang et al. 
2005),  RNA  (Cassol,  Gill  et  al.  1997),  IgM  (de  Swart,  Nur  et  al.  2001;  Helfand, 53 
 
Keyserling et al. 2001) and IgG antibodies (Zicker, Smith et al. 1990; Jafri, Torrico et 
al. 1998; Fenollar and Raoult 1999; Holland, Thanh et al. 2002), therapeutic and elicit 
blood drug levels (Henderson, Powell et al. 1997; Mei, Hannon et al. 1998) and iron 
deficiency (Cook, Flowers et al. 1998).  Blood collected on filter paper has also been 
used in the diagnosis of various diseases including HIV (Fortes, Menitove et al. 1989; 
Beebe and Briggs 1990; Behets, Kashamuka et al. 1992; Arya 1993), where it has been 
used in large-scale anonymous surveys for HIV antibodies in women of childbearing 
age in America (Beebe and Briggs 1990) and Zaire (Behets, Kashamuka et al. 1992).  
Whatman  FTA
®  (Flinders  Technology  Associates)  cards  (Whatman,  U.K.)  are  filter 
paper  cards  impregnated  with  patented  substances  for  easier  DNA  handling,  which 
increase the longevity of nucleic acids.  Unfortunately the chemicals in FTA cards cause 
protein degradation and cannot be used to preserve antibodies (Rajendram, Ayenza et al. 
2006). 
There are advantages and disadvantages to the use of filter paper for blood collection.  
The biggest advantage is that blood samples stored on filter paper can be kept at room 
temperature for extended periods of time without the need for refrigeration.  Therefore, 
paper-based blood sample collection is especially suited for use in remote areas with 
limited facilities in terms of refrigeration, road and laboratory access.  The dried-blood 
matrix stabilizes many analytes at ambient temperatures (Mei, Alexander et al. 2001), 
whereas liquid blood samples have to be processed to harvest serum within 2 days of 
collection.    In  addition,  serum  must  be  stored  chilled  or  frozen.  Paper-based  blood 
sample  collection  is  simple  and  reliable  and  its  use  in  serological  tests  produce 
comparable  results  to  serum  samples  (Holland,  Thanh  et  al.  2002).    Noireau  et  al. 
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human sleeping sickness (Testryp-CATT) with results equivalent to a 1/8 dilution of 
serum.  
Transportation of samples stored on paper is simple because no special packaging is 
required and there are no associated costs for keeping samples cool in transit.  Handling 
of paper samples during transport is also safer because there is less chance of sample 
loss  through  leakage.  Many  viruses  are  inactivated  by  drying,  although  some  may 
remain viable (Resnick, Veren et al. 1986), especially in cases with high viral titres 
(Bond, Favero et al. 1981; Parker and Cubitt 1999). 
One  of  the  most  significant  disadvantages  of  a  filter  paper-based  blood  collection 
system is the size of the sample collected.  On specimen collection paper (Schleicher & 
Schuell, Grade 903 paper) a whole blood sample of approximately 75μl, equivalent to 
approximately  35μl  of  plasma,  covers  a  circle  of  approximately  15mm  in  diameter 
(Behets, Kashamuka et al. 1992).  Sample processing time in the laboratory is increased 
slightly  and  the  elution  yield  from  samples  may  vary  between  laboratories  (Chace, 
Adam et al. 1999).  Quantitative analyses require the use of standardised amounts of 
serum, which can be difficult to estimate from a dried blood spot.  The quantities of 
viable  antibodies  present  in  the  samples  depend  on  haematocrit,  size  of  blood  spot 
(Adam, Alexander et al. 2000; Mei, Alexander et al. 2001) and storage temperature and 
humidity over time.  IgM is less reliably preserved than IgG, thus IgM titres diminish 
more rapidly than IgG titres  (Fenollar and Raoult 1999; de Swart, Nur et al. 2001; 
Helfand, Keyserling et al. 2001). 
Storage conditions that can lead to a decrease in detectable antibodies in dried blood 
spots include exposure to tropical climates, which results in a progressive decline in the 
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samples that have low antibody titres (Behets, Kashamuka et al. 1992).  Humidity is the 
main contributor to analyte instability, although variation in storage temperature is also 
a  factor,  especially  at  higher  temperatures.    Storage  in  hot,  humid  climates  is  best 
performed using gas-impermeable containers containing desiccant.  One study found 
that anti-HIV antibody levels declined when dried blood spots on paper were subjected 
to different environmental conditions (Behets, Kashamuka et al. 1992).  Rapid sample 
degradation was observed when samples were stored at ambient temperatures and above 
as evidenced by declining detectable antibody levels (Behets, Kashamuka et al. 1992).  
Storage of samples at 4°C and -20°C did not significantly alter antibody levels (Behets, 
Kashamuka et al. 1992).  Similar observations were also made in other studies (Cook, 
Flowers et al. 1998; Mei, Hannon et al. 1998; Fenollar and Raoult 1999; McDade and 
Shell-Duncan 2002).  A 10% reduction in protein levels occurred in dried blood spots 
stored for 28 days at 37°C with desiccant and significantly greater reduction in protein 
levels at the same temperature without desiccant (Cook, Flowers et al. 1998).  However, 
there was no significant deterioration observed in the protein level of samples stored at 
room temperature or 4°C (Fortes, Menitove et al. 1989; Cook, Flowers et al. 1998).  The 
authors  recommended  that  specimens  exposed  to  high  temperatures  and  humidity 
should be tested within 2 weeks of collection (Fortes, Menitove et al. 1989). 
The quality of plasma eluted from filter papers can vary.  The optimum elution of serum 
from paper samples was achieved using phosphate-buffered saline (PBS) plus 0.05% 
Tween 20 at room temperature or 4°C for times varying between 2 and 12 hours (Cook, 
Flowers et al. 1998).  An alternative method of elution involved continuous sonication 
for 15 minutes in PBS plus 0.05% Tween 20, which was more rapid and produced 
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It is important to standardise protocols used for collection, storage and elution of blood 
using filter papers.  This is because of significant differences between the results of 
serological tests performed using plasma eluted from different areas of a blood spot 
(McDade and Shell-Duncan 2002).  This problem can be easily overcome by using the 
same area of a blood spot for all tests or by using a known volume of blood and eluting 
the  entire  sample  (Cook,  Flowers  et  al.  1998).    It  is  important  to  place  a  sample 
correctly on paper so that it is absorbed evenly because smeared or layered samples may 
lead to sample error (McDade and Shell-Duncan 2002).  However, if blood samples 
collected on filter paper are standardised by using a constant sample size and elution 
protocols between laboratories there is a higher concordance between results obtained 
from serum and dried blood spots (Fenollar and Raoult 1999; Helfand, Keyserling et al. 
2001). 
2.6  Aims 
The goal of this project is to develop tools to improve the detection of T. evansi in 
animals in Australia.  To achieve this goal the following objectives were pursued: 
1.  Develop a paper-based serum collection system 
2.  Develop a competitive ELISA for the detection of antibodies to T. evansi in 
multiple animal species 
3.  Evaluate the use of a tyrosine aminotransferase assay to detect infection with T. 
evansi 
4.  Determine key immunological determinants of chronic T. evansi in serum from 
infected animals 
5.  Determine the key immunological determinants of chronic T. evansi infection in 
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3  Modified paper-based blood collection 
3.1  Introduction 
The collection and storage of blood dried onto filter paper is a valuable tool for use in 
surveillance programmes in remote areas where there is limited infrastructure and cold-
chain storage options are limited or unavailable.  The major drawback of storing blood 
on filter paper is that significant antibody degradation occurs over time especially if the 
papers are exposed to high ambient temperature and humidity (Behets, Kashamuka et al. 
1992). 
Different preservatives and preservative buffers were systematically evaluated to 
determine the most effective combination for maximum stability of antibodies to T. 
evansi in serum and blood samples dried onto filter paper. 
3.2  Materials and methods 
3.2.1  Details of serum and blood samples 
Positive control serum was collected from a calf experimentally infected three times 
with  T.  evansi  at  the  Indonesian  Research  Institute  for  Veterinary  Science  (IRIVS) 
(Reid and Copeman 2003).  Negative control serum was prepared from a pooled sample 
from  five  uninfected  cattle  from  Townsville,  as  previously  described  (Reid  and 
Copeman 2003). 
Serum  samples  used  for  validation  experiments  were  collected  from  45  Indonesian 
cattle  infected  with  T.  evansi  and  from  45  uninfected  cattle  from  Townsville  in 
Queensland (Reid and Copeman 2002b; Reid and Copeman 2003). 58 
 
Whole blood samples were collected from buffaloes (Bubalus bubalis) experimentally 
infected with T. evansi at the IRIVS and from uninfected water buffaloes that were part 
of another study performed under a research project funded by the Australian Centre for 
International Agricultural Research (Project AS1/2000/009). 
3.2.2  Optimisation of preservatives used to coat filter paper 
Different substances and papers were tested during two separate experiments to evaluate 
the effect of each on the preservation of serum antibody detection.  In the first trial 
substances were dissolved in distilled water and in the second trial they were dissolved 
in PBS pH 8.  Substances evaluated individually and/or mixed together are outlined in 
Table 3-1. 
Whatman® #903 lint filter paper (Whatman Ltd, U.K.) cut into 5cm squares was soaked 
in  solutions  of  individual  or  combined  substances  by  dipping  the  paper  into  each 
solution for 5 to 10 seconds until the paper was saturated.  The paper was then allowed 
to dry for 7-14 days at ambient temperature and humidity.  Untreated glass fibre filter 
paper and lint filter paper were also prepared. 
Aliquots  (50μl)  of  positive  and  negative  control  serum  were  pipetted  onto  separate 
sheets of each paper type and allowed to dry at room temperature overnight.  Two 
sheets  of  each  paper  type,  one  with  positive  control  serum  samples  and  one  with 
negative control serum, were placed in plastic zip lock bags.  These bags were stored at 
4°C without desiccant, 4°C with desiccant, room temperature with desiccant and 37°C 
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Table 3-1:  Substances evaluated for their ability to preserve antibodies to Trypanosoma 
evansi in serum from an infected calf and uninfected cattle dried on filter paper. 
  Substance  Manufacturer  Concentration 
1  Albumin from chicken egg white  
grade V 
Sigma-Aldrich  40g/L 
2  Borax (Sodium tetraborate 
decahydrate)  S9640-25 
Sigma Aldrich  200mM solution 
3  Bovine serum albumin (fraction V)  Sigma-Aldrich  80, 40 and 20g/L 
4  D-Glucose  Sigma Ultra  1M solution 
5  Dimethylsulphoxide (DMSO)  Sigma-Aldrich  10% solution 
6  Ethylenediaminetetraacetic acid di-
sodium salt (EDTA) 
Ajax Firechem  100mM solution 
7  Fungizone (Amphotericin B)  Invitrogen  2µl/ml 
8  Gelatin from porcine skin (for 
electrophoresis) 
Sigma-Aldrich  0.5% and 0.25% 
w/v 
9  Glass fibre filter paper  Whatman®, GF52   
10  Mixed protease inhibitors (Sigmafast 
protease inhibitor tablets) 
Sigma Aldrich  1x solution 
11  Phenylmethylsulphonyl fluoride 
(PMSF) 
Roche Applied 
Science 
1mM solution 
12  Post Coating Buffer (PCB) pH 7.9  TropBio, 
Queensland 
Undiluted 
13  Sodium dodecyl sulphate (SDS)  Sigma-Aldrich  0.02% 
14  Skim milk powder    5% w/v 
15  Sodium azide  Sigma Ultra  0.02% w/v 
16  Sodium chloride  Chem Supply  1M and 2M 
solution 
17  Trishydroxymethylaminomethane 
(Tris) pH 8 
Sigma Aldrich  100mM solution 
18  Tween 20  Bio-Rad  0.05% 
19  Whatman/Schleicher & Schuell #903 
cotton lint filter paper 
Whatman   
 
Initial  experiments  were  performed  with  replicate  serum  samples  blotted  onto  filter 
paper to determine the optimum elution protocol.  Experiments were performed using 
4mm diameter discs of filter paper containing dried serum (cut using a 4mm skin biopsy 60 
 
punch).  Elutants included phosphate buffered saline (PBS) pH 8, Tris-buffered saline 
(TBS) pH 8, both with and without the addition of 0.05% Tween 20 (Bio-Rad, USA) 
and ELISA diluent (TropBio, Queensland).  Elution protocols included soaking samples 
overnight  at  4°C  then  shaking  on  ice  for  1  hour,  shaking  for  2  hours  at  room 
temperature and shaking for 2 hours on ice.  All the elutants and elution methods gave 
similar results.  All subsequent elution was done by adding ELISA diluent (TropBio) to 
the samples, soaking them at 4°C overnight, then placing samples on a shaker at room 
temperature for 1 hour. 
Positive and negative control sera (125μl) were dried onto filter paper impregnated with 
each  preservative  tested  (see  Table  3-1).    Sera  were  eluted  from  1  positive  and  1 
negative dried serum sample from each paper type and tested every 2 weeks for 12 
weeks for the presence of antibodies to T. evansi using an antibody ELISA, as described 
previously (Reid and Copeman 2003).  In addition, a matched aliquot of serum stored at 
–20C  was  also  tested  at  the  same  time  to  provide  a  comparison.    Briefly,  round-
bottomed  96  well  microtitre  plates  (Sarstedt)  were  coated  with  100μl  of  a  1/1000 
dilution of 40-50% fraction of crude T. evansi antigen in carbonate buffer (pH 9.6) and 
incubated  overnight  in  a  humid  chamber  at  4°C.    Serum  samples  on  paper 
(approximately 5μl in size) were incubated in 500µl of ELISA diluent (TropBio) buffer 
overnight at 4°C and then agitated for an hour at 320rpm on a rotary shaker.  Frozen 
serum samples were diluted at 1/100 in ELISA diluent (TropBio, Queensland).  Each 
solution (100µl) was placed in duplicate ELISA plate wells and the plates incubated for 
1 hour in a humid chamber at 37°C.  Plates were washed three times using TEN-T pH 8 
buffer and 100μl of horseradish peroxidase-conjugated goat anti-bovine IgG (Jackson 
Immuno Research, USA) diluted 1/4000 in ELISA diluent (TropBio, Queensland) was 
added to each well and plates incubated for 1 hour in a humid chamber at 37°C.  Plates 61 
 
were washed three times as before and 100µl ABTS peroxidase substrate (Kirkegaard 
Perry Ltd, USA) was added to each well and the plates covered and incubated for 90 
minutes at room temperature.  The plates were read using a Bio-Rad 680 ELISA plate 
reader at 415nm and 570nm wavelengths.   The final sample OD was  calculated by 
subtracting the OD570nm from the OD415nm. 
3.2.3  Validation of filter paper-based serum collection system 
Filter paper (Whatman®, #903, U.K.) was cut into 180 strips approximately 2mm wide 
and  210  mm  long.    Ninety  strips  were  soaked  in  PCB  (TropBio,  Queensland)  and 
allowed to dry for 7-10 days at room temperature.  Untreated filter paper strips (n=90) 
were stored at room temperature in a dry place. 
Pairs of dried plain and treated paper strips were numbered and clamped into position 
between plastic rulers to prevent touching or overlapping. Nine 5µl replicates of 45 
serum samples from Indonesian cattle infected with  T. evansi and 45 samples from 
uninfected cattle were aliquoted onto the plain and treated filter paper strips and allowed 
to dry at room temperature (approx 22°C) overnight.  The dry paper samples were then 
placed in airtight containers containing an excess of fresh silica gel desiccant (Whatman 
Bioscience, U.K.) at 37°C.  The desiccant was visually checked each week for any 
change in colour from blue to pink (indicating hydration of the gel) and replaced if 
necessary. 
Serum samples dried on the paper were tested using the Ab-ELISA as described above 
after 1 month, 3 months and 6 months.  The optical density (OD) was compared to the 
OD of the ELISA using the matched serum samples stored at -20°C.  Each sample was 
tested three times in duplicate at each time point. 62 
 
3.2.4  Effect of humidity on persistence of antibody activity 
Four chambers with different levels of humidity were constructed one week prior to the 
start of the experiment and allowed to equilibrate at 37°C (see Figure 3-1).  These were 
constructed using 2L plastic watertight containers holding approximately 1.5cm depths 
of filtered water (96-98% relative humidity (RH)), a slurry of sodium chloride (Chem 
Supply, USA) with 1-2 mm of liquid on the surface (79% RH), a slurry of calcium 
nitrate (Sigma Aldrich, USA) (39% RH) or silica gel desiccant sachets (Whatman) (17-
19% RH).  In each humid chamber polystyrene platforms were placed on the solutions 
and covered with upturned 7cm high glass jars.  Relative humidity and temperature 
were monitored in each container using a digital thermometer-hygrometer (EAI TMH-
250, Thermo Products, USA).   
Short paper strips (n=160) were prepared as before and 5μl aliquots of positive and 
negative control serum samples were blotted onto treated and untreated paper strips, 5 
samples per strip.  The strips were placed in 5ml sterile screw-top plastic tubes which 
were either left open to ambient conditions or closed with two 1g sachets of desiccant 
inside (see Figure 3-1).  The desiccant sachets were not replaced for the duration of the 
3-month  experiment.    The  plastic  tubes  containing  the  filter  paper  strips  were  then 
placed under glass jars (see Figure 3-1).   63 
 
 
Figure 3-1:  Diagram showing the typical layout of one of the humidity chambers used 
to test the longevity of anti-Trypanosoma evansi antibodies in cattle serum dried onto 
plain  filter  paper  and  filter  paper  treated  with  post  coating  buffer  (TropBio, 
Queensland). 
Serum  from  dried  samples  was  eluted  in  ELISA  diluent  (TropBio,  Queensland)  as 
before and tested using an Ab-ELISA 1, 2, 4, 6, 8 and 12 weeks after drying the sera on 
the filter paper.   The  OD obtained was compared to  the OD obtained  from  testing 
matched serum samples stored at -20°C. 
In  a  further  experiment  the  efficacy  of  casein  and  albumin  was  compared  to  PCB-
treated and plain filter paper.  Casein (Sigma, USA) solutions of 10%, 1% and 0.1% and 
bovine serum albumin (Sigma) solutions of 40g/l, 20g/l and 10g/l were made up using 
TEN-T containing 1mM PMSF.  Filter papers (Whatman
® #903, U.K.) were either left 
plain  or  treated  with  these  solutions  above  to  make  four  strips  of  each  paper  type.  
Aliquots of positive and negative control serum (5μl) were placed on separate strips and 
assigned to humidity chambers at 19%RH and 79% RH at 37ºC.  Ab-ELISAs were run 64 
 
as before after 2 and 6 weeks and results compared to each other and to the results from 
testing matched serum samples stored at -20°C. 
3.2.5  Preservation of whole blood on preservative-treated filter 
paper 
Whole  blood  and  serum  were  collected  each  week  for  17  weeks  from  9  buffaloes 
(Bubalus  bubalis)  infected  with  T.  evansi  and  6  uninfected  buffalo  at  the  IRIVS 
Indonesia.  Sera were stored at -20C until used and treated filter paper strips were 
immersed in whole blood samples and allowed to dry.  Dried filter paper samples were 
stored in envelopes in a desiccation chamber for up to a year before testing. 
Blood was eluted from approximately 10mm
2 pieces of each strip and eluted in 500µl of 
ELISA diluent (TropBio, Queensland) overnight at 4°C, then shaken at 240rpm on an 
orbital shaker for 1 hour at room temperature.  It is assumed that the above protocol will 
yield  a  1/100  dilution  of  serum  given  that  10mm
2  of  filter  paper  contained 
approximately  10l  of  blood,  which  is  equivalent  to  5l  of  serum  (i.e.  serum  is 
approximately 50% of total blood volume).  The ELISA was performed as described 
above, except that HRP-conjugated Protein G (Sigma, USA) diluted 1/4000 was used as 
the secondary antibody. 
3.2.6  Data analysis 
Baseline OD values (no serum added to the wells) were subtracted from all the ELISA 
plate readings prior to calculations.  The significance of any differences in the mean 
ODs from the Ab-ELISA used to test samples stored on plain filter paper, PCB-treated 
filter paper and serum samples stored at -20ºC were determined using one way analysis 
of  variance  (ANOVA)  with  Tukey’s  Honestly  Significant  Difference  test  and  the 65 
 
independent sample T-test.  Analysis was performed using the Statistical Package for 
Social Sciences version 15 (SPSS Inc v.15, California, USA).  Differences in ELISA 
ODs and standard errors were calculated using Excel
® 2007 (Microsoft Corporation, 
USA). 
The mean difference between the ELISA OD results from frozen serum and the ELISA 
OD results obtained from plain and PCB-treated filter paper were calculated and plotted 
on a scatter plot. 
3.3  Results 
3.3.1  Optimisation of preservatives used to coat filter paper 
There was little difference in OD values of the Ab-ELISA when used to test serum 
eluted from filter paper using PBS, TBS and ELISA diluent (TropBio, Queensland).  
There was also minimal difference in the OD values of the Ab-ELISA when used to test 
serum  that  had  been  eluted  overnight  at  4°C,  for  2  hours  and  on  ice  or  at  room 
temperature.  Therefore all further work  was  completed by  eluting dried blood  and 
serum  with  ELISA  diluent  (TropBio,  Queensland)  overnight  at  4C  then  shaking 
samples at 360rpm for one hour at room temperature.  
Results from testing frozen control serum and matched serum dried onto different filter 
paper preparations for 12 weeks with an Ab-ELISA to detect antibodies to T. evansi are 
summarized in Table 3-2 and Table 3-3.  The OD of the ELISA using serum eluted 
from cotton-lint filter paper containing bovine albumin alone or in combination with 
borax, mixed protease inhibitors, fungizone and/or Tween 20 and post coating buffer 
(TropBio, Queensland) were higher compared to results obtained from serum dried onto 
plain filter paper.  In general the OD of the ELISA was highest when it was used to test 66 
 
serum dried on paper that was stored at ambient temperature with desiccant compared to 
those stored at ambient temperatures without desiccant, or from those stored at 37°C.  
There was a measurable decrease in the OD of the ELISA when used to test serum dried 
on the remaining filter  paper preparations  and onto  glass fibre paper.  Post  coating 
buffer was selected for all further work because it provided the highest OD and contains 
bacterial inhibitors. 
Table  3-2:    OD  results  from  testing  positive  control  serum  dried  onto  different 
preparations of filter paper using an antibody-detection ELISA. 
  Ambient temperature  4°C  37°C  -20°C 
Substance  No 
desiccant 
With 
desiccant       
Plain  0.049  0.040  1.308  0.317   
BSA  0.565  0.123  1.88  1.239   
Glucose  0.295  0.244  1.202  0.226   
NaN3  0.058  0.034  1.371  0.529   
BSA + glucose  0.363  0.206  1.415  0.295   
Egg albumin + glucose  0.454  0.247  1.513  0.274   
Glucose + NaN3  0.165  0.115  1.032  0.155   
BSA + glucose + NaN3  0.327  0.122  1.341  0.262   
Glass fibre paper  0.029  0.038  0.931  0.055   
2.5M NaCl  0.063  0.042  1.598  0.786   
1M NaCl  0.038  0.033       
Positive control serum          1.315 
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Table  3-3:    OD  results  from  testing  positive  control  serum  dried  onto  different 
preparations of filter paper using an antibody-detection ELISA. 
  Ambient temperature  4ºC  37ºC  -20ºC 
Substance 
No 
desiccant 
With 
desiccant       
Plain  0.320  0.783  1.365  0.445   
BSA 80g/l + Fungizone  1.173  1.467  1.091  1.020   
BSA 40g/l + Fungizone  0.804  0.917  1.118  1.017   
BSA 20g/l + Fungizone  1.0185  1.331  1.386  0.946   
Gelatin 0.5%  0.375  0.765  1.149  0.474   
Gelatin 0.25%  0.509  1.281  1.482  0.828   
Milk 5%  0.651  0.779  1.188  0.303   
Post coating buffer  1.409  1.407  1.245  1.623   
Borax  0.113  0.741  1.166  0.301   
BSA + borax  0.707  1.331  1.118  1.309   
Gelatin + Borax  0.164  0.705  1.104  0.450   
Gelatin + Borax + 
Fungizone  0.171  0.630  1.099  0.399   
BSA + MPI + EDTA + 
Fungizone  1.115  1.191  1.159  0.907   
BSA + MPI + SDS  0.983  0.548  1.026  0.562   
BSA + MPI + Tween 20  0.930  1.208  1.282  0.838   
Gelatin + MPI + 
Fungizone + Tween 20  0.503  0.872  1.104  0.387   
Milk + Tris + DMSO  0.273  1.076  1.189  0.306   
PBS Buffer  0.335  0.822  0.997  0.258   
MPI + EDTA + DMSO  0.857  0.761  1.270  0.516   
TEN-TC buffer  0.323  0.560  0.948  0.283   
Positive control serum          0.974 
3.3.2  Validation of filter paper-based serum collection system 
There was no significant difference in the OD of the ELISA using serum eluted from 
PCB-treated paper or plain filter paper stored with desiccant at 37°C for six months 68 
 
compared to frozen serum.  However, there was a larger difference between the mean 
ELISA OD from frozen serum compared to dried serum samples stored on plain paper 
than between frozen serum samples and dried serum samples stored on PCB-treated 
paper tested at the 12 and 24 week time points.  Scatter plots of the mean difference 
between the ELISA OD results from frozen serum samples and the ELISA OD results 
from plain and PCB-treated filter paper are presented in Figure 3-2 and Figure 3-3.   
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Figure 3-2:  Scatter plots of the difference between the ELISA OD from dried serum 
samples from cattle infected with T. evansi stored on plain and PCB-treated filter paper 
at ambient temperatures compared to frozen serum after (a) 1 day, (b) 12 weeks and (c) 
24 weeks. 
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Figure 3-3:  Scatter plots of the difference between the ELISA OD from dried serum 
samples from uninfected cattle stored on plain and PCB-treated filter paper at ambient 
temperatures compared to frozen serum after (a) 1 day, (b) 12 weeks and (c) 24 weeks. 
3.3.3  Effect of humidity on persistence of antibody activity 
There was no significant difference between the OD of the ELISA using serum stored 
on PCB-treated filter paper or plain filter paper at 19% RH compared to the ELISA 
using frozen serum at each time point for the 12 week experimental period (see Figure 
3-4a). 71 
 
There was a significant decrease in the OD of the ELISA using serum samples stored on 
plain filter paper stored without desiccant  at  39% RH at  week 12 compared to  the 
ELISA using frozen serum (p<0.05).  There was no significant difference in the ELISA 
OD from serum stored on PCB-treated filter paper without desiccant at 39% RH or from 
samples stored on plain or PCB-treated filter paper with desiccant at 39% RH compared 
to that for frozen serum for the 12 week experimental period (see Figure 3-4b). 
There was no significant difference between the OD of the ELISA using serum samples 
stored on either filter paper type with desiccant at 79% RH for the first 8 weeks, though 
there was a decrease in OD from all the paper samples at week 12.  The ELISA ODs 
from testing samples stored on plain filter paper without desiccant at 79% RH were 
significantly lower than those from samples on the other paper types or from frozen 
serum samples by week 2 (p<0.05) and antibodies were undetectable by week 12 (see 
Figure 3-4c). 
There was a significant decrease in the ELISA OD from testing serum eluted from plain 
paper stored at 96% RH without desiccant by weeks 1 and 2 compared to the ODs from 
testing all other serum samples (p<0.05).  A drop in OD by approximately 50% was 
observed after 2 weeks, reaching undetectable levels by week 4.  The ELISA OD from 
testing serum stored on PCB-treated paper without desiccant at 96% RH was slightly 
lower  than  the  ELISA  OD  from  testing  frozen  serum  samples  after  2  weeks  and 
significantly higher than from samples eluted from plain paper stored under equivalent 
conditions  (p<0.05)  (see Figure 3-4d).  ELISA  ODs  from  testing samples  on PCB-
treated  paper  stored  without  desiccant  had  decreased  further  by  week  4  and  were 
undetectable by week 6.  ELISA ODs from testing serum samples stored on plain filter 
paper stored with desiccant in the 96% RH atmosphere had decreased by approximately 72 
 
50% by week 12 and were significantly lower than the ELISA OD from testing samples 
eluted from PCB-treated filter paper stored with desiccant (p<0.05) (see Figure 3-4d). 
Desiccant kept in airtight plastic tubes at 96% RH began to hydrate after 2-4 weeks, as 
shown  by  a  change  in  indicator  colour.    This  change  was  not  evident  in  the  other 
humidity chambers during the experimental period.  Both treated and plain filter paper 
strips stored at 96% RH without desiccant became mouldy after 2-3 weeks and had to 
be discarded before the end of the experiment.   
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Figure 3-4:  Results from testing serum from a calf infected with Trypanosoma evansi 
stored on plain and PCB-treated filter paper at 37°C at (a) 19%RH, (b) 39%RH, (c) 
79%RH and (d) 96%RH compared to frozen serum using an antibody-detection ELISA.   
A summary of the results obtained from testing dried serum samples stored on filter 
paper at different relative humidities with the Ab-ELISA is displayed in Table 3-4. 74 
 
Table 3-4:  Summary of results from testing samples stored on plain and PCB-treated 
filter  paper  at  different  humidities  at  37ºC  with  an  ELISA  to  detect  antibodies  to 
Trypanosoma evansi compared to frozen serum samples over a 12 week period.   
  19% RH  39% RH  79% RH  96% RH 
Plain paper 
without desiccant 
Good  ELISA OD 
start to 
decrease from 
week 8 
ELISA OD 
decrease by 
week 2, 
undetectable 
by week 8 
50% decrease 
in ELISA OD 
by week 1 
PCB-treated paper 
without desiccant 
Good  Good  Good  50% decrease 
in ELISA OD 
by week 4 
Plain paper with 
desiccant 
Good  Good  Good  50% decrease 
in ELISA OD 
by  week 12 
PCB-treated paper 
with desiccant 
Good  Good  Good  Good 
 
After 6 weeks the ELISA ODs from the positive control serum stored on PCB-treated 
paper were higher than the ELISA ODs from the papers impregnated with casein or 
bovine serum albumin at any of the concentrations used (see Figure 3-5). 75 
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Figure 3-5:  Comparison of ELISA ODs from serum samples stored on plain filter 
paper, PCB-treated filter paper, casein -treated filter paper and albumin -treated filter 
paper for 6 weeks at 19%RH and 79%RH. 
3.3.4  Preservation of whole blood on preservative-treated filter 
paper 
There was no significant difference between the optical densities from testing blood 
dried  on  PCB-treated  filter  paper  and  frozen  serum  from  buffaloes  experimentally 
infected with T. evansi and uninfected buffaloes (see Figure 3-6). 
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Figure 3-6:  Scatter plot of the difference in ELISA ODs between dried whole blood 
samples stored on PCB-treated filter paper at ambient temperature for  over 9 months, 
compared to matched frozen serum samples. 76 
 
3.4  Discussion 
The  results  from  testing  the  capacity  of  different  filter  paper  materials  to  enable 
preservation of antibodies in cattle serum showed that cotton lint paper was the most 
effective support material for antibody preservation.  Cotton lint filter paper was chosen 
for this study because it doesn’t contain potentially damaging acids and bleaches, which 
are present in wood-based papers.  Guthrie cards are made from Whatman® #903 filter 
paper, which is rigorously tested for consistency regarding absorption properties and 
structure (Mei, Alexander et al. 2001).  It is fairly thick (460-580μm) though light (160-
195g/m
2) with good absorption properties.  By comparison the glass filter paper used 
here  is  thinner  and  less  absorptive,  which  may  explain  why  serum  antibodies 
deteriorated more quickly on this compared to cotton-lint paper.  Whatman #3 filter 
paper may have provided a suitable alternative substrate for serum because, although it 
is slower to absorb blood than Whatman #903 filter paper, it has a similar capacity for 
preservation of antibodies (Fachiroh, Prasetyanti et al. 2008).  
Albumin dried onto paper extended the preservation time of antibodies.  This may be 
similar to adding bovine serum albumin to proteins and enzymes in solution to stabilise 
them  because  dilute  protein  solutions  are  more  readily  degraded  than  concentrated 
protein solutions (Tucker, Bass et al. 2000).  Gelatin did not have the same effect as 
albumin, which is at odds with previous studies that found that both plasma and gelatin 
have a protective effect on red blood cells by preventing haemolysis of the cells during 
washing (Rous and Turner 1916).  
Borax did not appear to improve antibody detection from dried serum at temperatures 
greater than 4ºC.  This is interesting because borax has a stabilising effect on enzymes 77 
 
such  as  proteases,  thereby  preventing  protein  digestion  in  situ 
(http://www.borax.com/detergents/stabilization.html, 2008). 
Neither glucose nor sodium chloride improved long-term antibody detection from dried 
serum  spots,  which  was  unexpected  because  sugars  have  been  shown  to  stabilise 
proteins in solution (Wimmer, Olsson et al. 1997).  Wimmer et al (1997) showed that 
the initial stabilising effects are observed at 250mM concentrations and increase with 
higher concentrations.  Sodium chloride and sugars have also been used to preserve 
food since early times and sugar has a preservative effect on red blood cells in solution 
(Rous and Turner 1916).  Sugars and salts are likely to have their effect by exerting 
osmotic pressure, which inhibits microbial growth (Davis 1995; Lee 2004).   
Dimethylsulphoxide (DMSO)-impregnated filter paper did not improve ELISA results 
from dried serum spots.  DMSO was included in this study because it is frequently 
added to laboratory solutions, especially where DNA preservation is required (Frantzen, 
Silk et al. 1998; Hanner, Schindel et al. 2005).  DMSO is a by-product of the wood 
industry (Muir 1996) and has been used in multiple medical treatments.   
Mixed protease inhibitors and PMSF are manufactured to inhibit serine, cysteine and 
metaloproteases  in  solution.    Inhibition  of  these  proteases  may  result  in  decreased 
protein breakdown.  Ethylenediamine-tetraacetic acid (EDTA) is a metal chelating agent 
used  commonly  as  an  anticoagulant  in  stored  blood.    It  acts  as  a  preservative  by 
chelating metal ions, thereby making them unavailable to co-enzymes and preventing 
enzyme-catalysed reactions such as proteolysis.   
There was no clear benefit or disadvantage to using Amphotericin B (fungizone) as an 
additive to prolong protein preservation on filter paper.  The anti-fungal agent was used 78 
 
in combination with other substances in this experiment in an attempt to slow mould 
growth when the paper samples were kept in humid conditions.   
The finding that samples were not better preserved on the glass filter paper, which is 
made up of borosilicate crystals, was unexpected.  This paper is chemically inert and 
does not degrade like lignin-based papers.  However, the type used in this experiment 
was thin, presenting a large surface area to the air, which could explain why antibodies 
were not preserved better on this substrate. 
Results  showing  that  sodium  azide  provided  no  benefit  for  the  preservation  of 
antibodies in dried serum are surprising given that it is commonly used as a chemical 
preservative in hospitals and laboratories (U.S.D.H.H.S. 1991).  Furthermore, Inns and 
colleagues (1989) showed that it was possible to preserved progesterone for up to 7 days 
in blood samples with addition of sodium azide.  Sodium azide is used to generate 
nitrogen gas in motor vehicle airbags and aeroplane safety chutes and in detonators and 
explosives, but also has a broad spectrum biocidal activity when used as an agricultural 
pesticide and herbicide.  It is possible that the biocidal activity of sodium azide alone is 
not sufficient to preserve dried complex proteins. 
ELISA results using paper coated with post coating buffer (TropBio, Queensland)  were 
most similar to results from frozen serum samples.  Post coating buffer is a proprietary 
product used as a blocking agent on Western blots and for ELISA plate coating after 
antigen binding.  Post coating buffer is prepared from casein from bovine milk, with no 
serum  proteins,  making  it  unlikely  to  cause  cross-reactions  unless  an  animal  has 
antibodies to casein (a possibility with some vaccines).  It contains PMSF as a protease 
inhibitor and sodium azide for its preservative and anti-microbial effects (Janice Smith, 
TropBio, personal communication).  The reason that post coating buffer-impregnated 79 
 
paper allowed improved antibody detection from dried blood spots may be due to the 
properties of casein.  Casein forms worm-like chains which may fold into a compact 
structure shaped a bit like a flower (Horne 2002).  These form micelles especially in the 
presence of calcium and/or phosphate ions.  Casein does not have fixed tertiary folding 
but rather an open flexible structure. 
The  most  marked  effect  of  albumin  or  post  coating  buffer  (TropBio,  Queensland) 
compared to plain filter paper on sample quality occurred under suboptimal (i.e. hot and 
humid) storage conditions.  These are the conditions expected in remote tropical areas 
where  surveys  for  T.  evansi  are  currently  conducted.    In  Australia  average  relative 
humidity of over 70% is common in Broome, Darwin and Cairns during the wet season, 
whereas  39%  RH  is  more  common  in  climates  like  Perth’s  over  the  drier  summer 
months (CSIRO 2004; bom.gov.au 2007).   
Humidity chambers were created using saturated solutions of various salts (Winston and 
Bates 1960).  The salts were made up to form a slurry with minimal amounts of free 
water on the surface.  Sodium chloride (NaCl) slurry results in a relative humidity of 
75% at 30°C and calcium nitrate (Ca(NO3)2) has a relative humidity of 47% at 30°C 
(Winston and Bates 1960).  At 37°C sodium chloride slurry gave a relative humidity of 
79% and calcium nitrate of 39%.  Humid chambers containing dry desiccant had a RH 
of 19% and distilled water 96% RH. 
High  relative  humidity  resulted  in  accelerated  degradation  in  of  antibodies  in  dried 
serum sample, especially at high ambient temperatures.  The desiccant also showed a 
diminished effectiveness after two months in humid conditions, even when stored in 
sealed plastic containers, as indicated by a change in indicator colour.  This means that 80 
 
in  humid  climates  dried  samples  stored  with  desiccant  will  be  subjected  to  some 
moisture if the desiccant is not replaced regularly.   
The technique used to elute plasma from dried blood spots is best kept constant, though 
in  our  case  there  was  little  difference  between  leaving  the  samples  to  elute  at  4°C 
overnight with an hour of agitation at room temperature and agitating for 2 hours on ice 
or at room temperature.  Antibodies eluted equally well in Tris buffered saline (TBS), 
phosphate  buffered  saline  (PBS)  and  TropBio  ELISA  diluent,  though  in  previous 
studies phosphate buffered solutions have given the best results (Cook, Flowers et al. 
1998). 
When dried blood spots were stored at low relative humidity with fresh desiccant, there 
was only a small decrease in ELISA OD from the samples stored on plain filter paper 
compared to those stored on PCB-treated paper and frozen serum samples.  When dried 
blood spots are kept under optimal storage conditions there is little need to use PCB-
treated filter paper rather than untreated Whatman
® #903 filter paper. 
Results from testing serum stored on plain filter paper showed that antibody activity 
declined rapidly as temperature and RH increased.  Results from testing serum stored on 
PCB-treated filter paper showed superior antibody preservation when compared to plain 
paper at RHs higher than 39% at 37°C and compared to samples on filter paper treated 
with different concentrations of casein and albumin stored at 79% RH.  Results from 
frozen serum samples were comparable to those from samples stored on PCB-treated 
filter paper with or without desiccant for up to 6 weeks at 39 and 79% RH, though 
ELISA ODs dropped rapidly at 96% RH from samples on both treated and plain filter 
paper.  This may be partially due to microbial overgrowth which obscured the serum 81 
 
spots within 7-10 days.  No false positive results were obtained from samples stored on 
any of the filter paper types. 
Test variation between samples, laboratories and laboratory technologists is a common 
phenomenon.  The use of dried blood spots can introduce additional problems because 
of the variation in the host haematocrit (high PCV means a smaller plasma percentage 
from a dried blood spot), the size of the blood spot and especially the area from which 
sections  are  cut,  the  elution  technique  including  its  duration  and  the  buffers  used 
(Chace, Adam et al. 1999) and the age of the sample and conditions of storage.  Blood 
constituents, including antibodies, are not evenly dispersed throughout the sample when 
large amounts of serum are applied to the filter paper (Adam, Alexander et al. 2000).  
This problem was largely overcome in this study by the use of known volumes of serum 
and elution of the entire sample.  The effect of variability in sample volume can be 
minimised if samples from filter paper are routinely cut from the same location of blood 
spots (Mei, Alexander et al. 2001).   
Whole blood samples gave comparable results to frozen serum using this ELISA, which 
is in agreement with previous studies (Holland, Thanh et al. 2002).  It is possible that in 
some cases peroxidases from red cells may interfere with peroxidase-based substrate 
development (personal communication Graham Burgess). 
In conclusion, the shelf-life of serum samples was significantly increased by placing 
them on cotton lint filter paper (Whatman
® #903) impregnated with post coating buffer 
(TropBio, Queensland) especially at high relative humidity and temperature.  Serum and 
whole blood eluted from treated paper gave similar results to those from equivalent 
frozen serum samples.  The specificity of this ELISA was not affected when used to test 
samples eluted from paper impregnated with post coating buffer. 82 
 
4  Evaluation of alternative serological tests to detect 
antibodies to Trypanosoma evansi 
4.1  Introduction 
Antibody ELISAs offer useful screening tools for use in surveillance programmes for T. 
evansi in countries like Australia that are currently free from disease and where animals 
have not been treated.  Under these conditions the detection of animals with circulating 
anti-T.  evansi  antibodies  is  indicative  of  a  disease  incursion  because  self-cure  from 
trypanosomiasis is unlikely (Atarhouch, Rami et al. 2003).  A major disadvantage of 
Ab-ELISAs is that the detecting antigen is generally produced using crude whole cell 
lysates.  Because the crude antigen varies from batch to batch, standardisation of tests is 
difficult.  In addition, the large number of potential host species in Australia requires a 
test  that  can  detect  IgG  from  multiple  host  species.    Recombinant  proteins  offer 
advantages over crude lysates because they can be produced cheaply, safely and with 
little variation between batches (Urakawa, Verloo et al. 2001).  However, there are no 
commercially available Ab-ELISAs and no commercial source of recombinant proteins.  
In this chapter an attempt was made to optimise and validate a competitive ELISA to 
detect anti-T. evansi antibodies using recombinant RoTat 1.2 antigen and its monoclonal 
antibody.  Competitive ELISAs offer the potential to detect IgG from any host because 
the test format does not rely on the binding of specific conjugated secondary antibody 
for the final step in the assay.  In addition, recombinant GM6 non-variable antigen and 
PFRA were evaluated as alternative antigens to crude lysates. 83 
 
4.2  Materials and methods 
4.2.1  Animal serum and additional data 
Positive control serum was collected from a calf experimentally infected three times 
with  T.  evansi  at  the  Indonesian  Research  Institute  for  Veterinary  Science  (IRIVS) 
(Reid and Copeman 2003).  Negative control serum was prepared from a pooled sample 
from  five  uninfected  cattle  from  Townsville,  as  previously  described  (Reid  and 
Copeman 2003).  Test validation serum comprised a collection of 180 sera collected 
from T. evansi-infected Indonesian cattle slaughtered at an abattoir in Bogor, Indonesia 
and 90 sera from uninfected cattle from Townsville that were collected between 1996 
and  1999  during  a  survey  to  detect  T.  theileri,  stored  frozen  at  -20°C  (Reid  and 
Copeman 2003).  Three of the Australian cattle were infected with T. theileri confirmed 
by buffy coat culture in RPMI medium (Reid, unpublished data).  Additional serum 
samples were from 6 water buffaloes (Bubalus bubalis) experimentally infected with T. 
evansi and 6 uninfected buffalo from IRIVS, Indonesia (See 3.2.1), serum from 1 dog 
(Canis  familiaris),  6  pigs  (Sus  scrofa),  1  horse  (Equus  caballus),  2  agile  wallabies 
(Macropus agilis) and 3 dusky pademelons (Thylogale brunii) experimentally infected 
with T. evansi at IRIVS, Indonesia (Reid, Husein et al. 2001). 
4.2.2  RoTat 1.2-based competitive ELISA 
Recombinant  RoTat  1.2  and  an  anti-RoTat  1.2  monoclonal  antibody  were  kindly 
donated by Philippe Büscher (Unit of Parasite Diagnostics, Department of Parasitology, 
Institute of Tropical Medicine in Antwerp, Belgium).  The optimal concentration of 
antigen and antibody and the positive and negative bovine control sera were determined 
using a series of chequerboard titrations. 84 
 
One hundred microlitres of PBS pH 8 containing 100ng RoTat 1.2 antigen was added to 
each well of a Maxisorp 96 well plate (Nunc, USA) and incubated overnight in a humid 
chamber at 4°C.  The antigen was then discarded and each plate was washed three times 
in TEN-T.  After the final wash 150μl of Tris buffered saline containing 1% bovine 
serum albumin (Bethyl, USA) was added to each well and incubated for 1 hour in a 
humid chamber at room temperature (21°C).  Similar incubation conditions are used in 
subsequent steps of the assay.  The plates were then washed three times as before and 
100µl  of  control  and  test  bovine  serum  diluted  1/10  in  ELISA  diluent  (TropBio, 
Queensland) was added to each well and incubated for 90 minutes.  The plates were 
washed  three  times  and  100µl  of  RoTat  1.2  monoclonal  antibody  diluted  1/500  in 
ELISA diluent was added to each well and the plates incubated for 1 hour in a humid 
chamber at room temperature.  The plates were then washed three times as before and 
100μl of horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG (Sigma, USA) 
diluted 1/2000 in ELISA diluent was added and the plates incubated for 1.  The plates 
were  then  washed  5  times  and  100µl  of  ABTS  ELISA  substrate  (2,2'-azinobis[3-
ethylbenzthiazoline-6-sulfonate]) (KPL, USA) was added to each well and incubated for 
90 minutes.  The OD of each well was measured using a Bio-Rad 680 ELISA plate 
reader at 415 nm and 570nm wavelengths.  The final OD was calculated by subtracting 
the OD570nm from the OD415nm.  Each sample was tested in duplicate and each plate 
contained  control  wells  of  positive  bovine  serum,  negative  bovine  serum,  wells 
containing no serum for baseline values and wells containing no monoclonal antibody 
or serum to check for test uniformity.  The mean OD from wells with no monoclonal 
antibody or serum was subtracted from all other OD readings.  Sample values were 
expressed as a percentage of the baseline values (no serum) and the cut-off determined 
using receiver operating characteristic (ROC) curve analysis and frequency histograms. 85 
 
4.2.3  Indirect ELISA using the non-variant antigen GM6 
Recombinant  GM6  antigen  was  kindly  provided  by  the  International  Livestock 
Research  Institute  (ILRI),  Kenya.    The  optimal  concentration  of  the  antigen  and 
secondary  HRP-conjugated  antibody  was  determined  using  a  chequerboard  titration.  
Each  well  of  Ultra  High  Binding  96  well  ELISA  plates  (Dynex  4HBX,  Dynex 
Technologies Inc, USA) was coated by adding 100μl of GM6 antigen diluted 1/400 
(1μg/ml) in PBS pH 7.45 to each well and the plates were incubated for 2 hours at 
37°C.  The antigen was then discarded and the plates dried for a further 15 minutes at 
37°C.    The  plates  were  removed  from  the  incubator  and  150μl  of  PBS  pH  7.45 
containing 3% skim milk powder was added to each well and incubated for 30 minutes 
in a humid chamber at 37°C.  The plates were washed three times with PBS containing 
0.5% Tween 20 and 100μl of control serum and serum from infected and uninfected 
cattle were diluted 1/100 in ELISA diluent (TropBio, Queensland) and 100μl was added 
to duplicate wells and the plates incubated for 1 hour in a humid chamber at 37°C.  The 
plates  were  washed  3  times  as  before  and  100μl  of  goat  anti-bovine  IgG  (Jackson 
Scientific, USA) diluted 1/2000 in ELISA diluent was added to each well and the plates 
incubated 1 hour in a humid chamber for at 37ºC.  The plates were washed 5 times in 
PBS-Tween 20 and 100μl of ABTS added to each well and the plates covered and 
incubated for 90 minutes at room temperature.  The plates were read using a Bio-Rad 
680 ELISA plate reader at 415nm and 570nm wavelengths.  The final sample OD was 
calculated by subtracting the OD570nm from the OD415nm.  Each sample was tested in 
duplicate and each plate contained control wells with positive bovine serum, negative 
bovine serum and wells with no serum to check plate reproducibility.  Baseline values 
were subtracted from all sample ODs and the sample ODs expressed as a percentage of 86 
 
the  positive  control  OD.    The  cut-off  point  required  to  discriminate  negative  from 
positive was determined using ROC curve analysis and frequency histograms. 
4.2.4  PFRA 
The plasmid for pHisPFRA2 was provided by Dr Derrick Robinson from the University 
of Bordeaux.  This plasmid produces PFRA with a 6-Histidine tag attached at the N 
terminus, which has high sequence similarities to PFR2 of other trypanosome species,.  
It can be found in the Trypanosoma brucei genome database (GenDB Tb08.5H5.900).  
It is a 69 kDa paraflagellar rod protein located on chromosome 8 (Chr 8|TIGR) in the 
genome and is part of a complex structure called the paraflagellar rod in the flagellum 
(D. Robinson, personal communication). 
PFRA was produced according to a protocol from Dr Derrick Robinson.  Briefly the 
plasmid was used to transform BL21(DE3) calcium competent E. coli cells, which were 
grown up in LB media with kanamycin and plated on LB agar plates with kanamycin.  
Cells containing the plasmid grow in the presence of the antibiotic because the plasmid 
vector contains a kanamycin-resistance gene.  Six colonies were picked and individually 
grown up overnight in LB-kanamycin media at 37ºC, then used to seed new cultures the 
following morning.  These cultures were incubated for 3 hours at 37ºC, then induced 
with IPTG for 1 hour at 37ºC, centrifuged and resuspended in fresh LB medium.  Two 
western  blots  were  run  with  the  six  colonies  of  bacteria,  one  with  mouse  anti-his 
antibody (Sigma, USA) and the other with mouse L8C4 antibody specific for PFRA 
(kindly provided by Derrick Robinson, Bordeaux University).  From this one clone was 
selected that produced a strong band with a molecular weight of approximately 70kDa 
on both western blots. 87 
 
The plasmid from this clone was extracted using a QIAprep spin Miniprep kit (Qiagen) 
and  stored.    Insert  orientation  and  sequence  of  insert  was  checked  by  doing  a 
conventional  PCR  on  the  plasmid  using  primers  NdeI-Tbb-PFRA  and  Tbb-PFRA-
BamHI, then purifying and sequencing the products.  Sequencing of the purified PCR 
products  was  carried  out  with  the  Big  Dye  version  3.1  terminator  kit  (Applied 
Biosystems,  USA)  using  the  dideoxynucleotide  chain  termination  method  (Sanger, 
Nicklen et al. 1977; Sanger, Nicklen et al. 1977).  The sequence was determined using 
an ABI Prism Applied Biosystems 377 automatic DNA sequencer (Applied Biosystems, 
USA)  at  the  State  Agriculture  and  Biotechnology  Centre,  Perth,  Western  Australia.  
Chromatogram  sequencing  files  were  edited  using  Chromas  Lite  version  2.0 
(Technelysium  P/L,  Australia).    Sequence  information  obtained  was  compared  to 
sequence  information  previously  submitted  to  GenBank  using  BLAST  software 
available from http://www.ncbi.nlm.nih.gov. 
The optimal induction time for the culture was determined and then each pellet was 
sonicated in 50mM NaPi plus 150mM NaCl solution and centrifuged at 15,000 x g for 
10 minutes at 4°C to pellet the insoluble fraction.  The insoluble fraction containing the 
PFRA was dissolved in 8M urea and purified by nickel chelate affinity chromatography 
with  Ni-NTA  agarose  (Bio-Rad,  USA)  using  solutions  with  increasing  imidazole 
concentrations.  The fraction containing the most PFRA was determined by western blot 
using anti-his and L8C4 antibodies.  The urea was removed by dialysis at 4ºC using 
dialysis tubing with a cut-off of approximately 14kDa, quantified using the Bradford 
assay  on  the  NanoDrop  1000  spectrophotometer  (Thermo  Scientific,  USA)  and  the 
solution stored in aliquots with or without 50% glycerol at -80 ºC. 88 
 
PFRA protein (1800ng/μl) was electrophoresed on 10% SDS-polyacrylamide gels for 1 
hour at 200V and transferred onto a nitrocellulose membrane overnight.  Western blots 
were performed by blocking the membranes in TBS containing 5% skimmed milk at 
room temperature for an hour, then washing them in TBS-T.  The membranes were cut 
into strips and placed in separate wells.  Serum from 51 Indonesian cattle infected with 
T. evansi and 28 uninfected Australian cattle were diluted 1/100 in TBS-T and added to 
individual wells for1 hour at room temperature.  Serum samples from three cattle known 
to be infected with T. theileri and not T. evansi were also added to individual wells.  
Strips were washed three times in TBS-T as before and antibodies detected by adding 
goat anti-bovine IgG (Jackson Scientific) diluted 1/4000 in TBS-T for an hour at room 
temperature.    Strips  were  washed  3  times  as  before  and  developed  with  3,3’-
diaminobenzidine (DAB). 
The insoluble dialysed PFRA protein was diluted 1/2 to 1/100 in PBS pH 7, 8 and 9, 
PBS plus 1% Triton 114 (Sigma-Aldrich, USA), TBS pH 8, carbonate buffer pH 9.6 
and PBS plus 50% glycerol and 100μl added to each well of separate Maxisorp 96 well 
plates (Nunc, USA) and the plates incubated overnight in a humid chamber at 4°C.  An 
indirect ELISA was then performed following the protocol described for the western 
blot above with each incubation at 37°C.  An alternative method, performed in a humid 
chamber, using antigen capture involved incubating Maxisorp plates containing 100μl 
per well of mouse anti-his antibody (Sigma, USA) diluted 1/1000 in TBS or a 1/500 
dilution of L8C4 antibody overnight at 4ºC.  Each plate was then washed three times 
using TBS-T and 100μl of undiluted PFRA antigen in 2M urea was added to each well 
and the plates incubated for 1 hour at 37ºC.  Plates were then washed 3 times and serum 
from  infected  and  uninfected  cattle  diluted  1/100  in  ELISA  diluent  was  added  to 
duplicate wells and the plates incubated for 1 hour in a humid chamber at 37ºC.  Plates 89 
 
were then washed as  before  and 100μl  of goat anti-bovine  IgG (Jackson Scientific, 
USA) diluted 1/1000  was added to  each well and incubated for 1 hour in a humid 
chamber at 37ºC.  After a final wash 100μl of ABTS was added to each well and the 
plates covered and incubated for 90 minutes at room temperature.  Plates were read as 
before. 
4.2.5  Data analysis 
Readings from wells containing no serum or secondary antibody were subtracted from 
RoTat 1.2 ELISA sample results before further evaluation.  Baseline values (no serum) 
were subtracted from GM6 ELISA results before any calculations.  Receiver operating 
characteristic  (ROC)  curves  were  created  to  calculate  optimum  cut-off  values  for 
ELISA  sensitivity  and  specificity  using  MedCalc®  for  Windows,  version  9.5.0.0 
(MedCalc  Software,  Mariakerke,  Belgium)  (Hanley  and  McNeil  1983;  Stephan, 
Wesseling  et  al.  2003).    Frequency  histograms  were  created  using  Microsoft  Excel 
2007.  The agreement between infection status and ELISA results (kappa (κ) and its 
95%  confidence  intervals)  was  calculated  using  Win  Episcope  2 
(ftp://ftp.zod.wau.nl/pub/qve/wepi21.exe). 
Results obtained to new tests in this study using the cattle sera were compared to data 
generated  by  Reid  and  Copeman  (2003).    The  correlation  between  the  percentage 
inhibition observed in the RoTat 1.2 cELISA and the OD values generated by Reid and 
Copeman  (2003)  using  an  Ab-ELISA  were  determined  using  Pearson’s  ranked 
correlation coefficient.  The correlation between the RoTat 1.2 cELISA results and the 
parasitaemia detected by Reid and Copeman (2003) was determined by calculating the 
Spearman’s rank correlation coefficient (R
2).  All correlations were calculated using 
SPSS v.15 (SPPS Inc. California, USA). 90 
 
4.3  Results 
4.3.1  RoTat 1.2 competitive ELISA 
Using a ROC curve, an optimum cut-off value of 88.73% of the baseline value gave a 
test sensitivity and specificity of 75.7% (95% CI 67.8-82.6%) and 98.3% (95% CI 91-
99.7%) respectively.  A cut-off of 87% of the baseline value gave a sensitivity and 
specificity of 73.6% (95% CI 65.5-80.7%) and 100% (95% CI 94-100%) respectively, 
while a cut-off of 95% of the baseline value gave a sensitivity and specificity of 84.3% 
(95% CI 77.2-89.9%) and 78.3% (95% CI 65.8-87.9%) respectively (see Figure 4-1 and 
Figure 4.2). 
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Figure 4-1:  ROC curve showing the sensitivity and specificity, with 95% confidence 
intervals, of the RoTat 1.2 competitive ELISA at various cut-off points. 91 
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Figure 4-2:  Frequency histogram of the results obtained from the RoTat1.2 cELISA showing 
the distribution of results from testing serum from T. evansi-infected Indonesian cattle 
and uninfected cattle from Australia. 
There was moderate agreement between the results from the RoTat 1.2 cELISA and the 
animal  infection  status  determined  using  parasitological  tests  (κ=0.64).    There  was 
significant correlation between the Ab-ELISA results from Reid and Copeman (2003) 
and the RoTat 1.2 cELISA (R
2=0.823 p<0.01), and between patent infections and the 
RoTat 1.2 cELISA (R
2=0.65, p<0.01).  There was also moderate correlation between the 
crude  antigen  Ab-ELISA  (Reid  and  Copeman  2003)  and  patent  infections  for  the 
samples tested (R
2=0.65, p<0.01). 
There was no detectable inhibition noticed when serum from three dogs, a horse and 
five wallabies experimentally infected with T. evansi was tested.  There was no pattern 
in the inhibition detected using serum samples collected from six infected pigs every 
week for 120 days and from three uninfected pigs. 
4.3.2  GM6 indirect ELISA 
An  optimum  cut  off  of  30%  of  the  OD  value  of  the  positive  control  value  was 
established for the GM6 indirect ELISA using a ROC curve (see Figure 4-3).  A total of 92 
 
16 of 87 sera from uninfected cattle tested positive and 90 of 122 sera from infected 
cattle tested positive (see Figure 4-4).  The sensitivity and specificity using a 30% cut 
off was 73% (95% CI 64.2-80.6%) and 82.8% (95% CI 73.2-90%) respectively.  The 
OD values of the ELISA using serum from 3 Australian cattle that were infected with T. 
theileri but not T. evansi (unpublished data, S.A. Reid) was less than the cut-off value 
(8.5%, 11.6% and18.6%). 
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Figure 4-3:  ROC curve showing the sensitivity and specificity, with 95% confidence 
intervals, of the GM6 ELISA at possible cut-off points. 
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Figure 4-4:  Frequency histogram of the results obtained from the GM6 ELISA showing 
the distribution of results from testing serum from T. evansi-infected Indonesian cattle 
and uninfected cattle from Australia. 
There was moderate correlation between the indirect GM6 ELISA results using a 30% 
of positive control cut-off and the parasitologically determined infection status of the 
animal (κ=0.546, p<0.01). 
4.3.3  PFRA 
Recombinant  PFRA  protein  that  reacted  with  both  anti-his  and  L8C4  antibody  was 
successfully produced.  PFRA was difficult to solubilise in order to coat the ELISA 
plates, and recombinant PFRA protein was therefore not used to produce an ELISA. 
Identifiable bands were observed on Western blots using serum from 59 cattle infected 
with T. evansi in 40 cases.  No identifiable bands were detected in western blots using 
23 of the 37 serum samples from uninfected cattle.  The sensitivity and specificity of the 
Western blot using PFRA was 67.8% (95% CI 54.4-79.4%) and 62% (95% CI 44.8-
77.5%) respectively.  All three sera from cattle infected with T. theileri were shown to 
have cross-reacting antibodies with PFRA antigen on the western blot. 
4.4  Discussion 
This study focused mainly on the development of a cELISA to detect infection with T. 
evansi in a wide variety of mammalian hosts including Australian native animals, which 
are  highly  susceptible  to  infection  with  T.  evansi  (Reid,  Husein  et  al.  2001).    The 
hypothesis of this study was that a cELISA would provide a test that could be used in 
multiple host species without the need for adaptation.  This is an advantage compared to 
indirect  ELISA  formats  that  require  specific  secondary  antibodies  to  each  species 94 
 
because non-specific proteins such as Protein A and G do not bind to antibodies from all 
host species.  Recombinant RoTat 1.2 and its corresponding monoclonal antibody were 
used because RoTat 1.2 is the antigen used in the CATT/T. evansi, which is the only 
standardised and validated test available for the detection of infection with T. evansi.  
Further work was performed to explore the suitability of GM6 and PFRA as diagnostic 
antigens because GM6 had shown promise in preliminary studies and PFRA is a highly 
antigenic molecule that is well conserved in trypanosomes (Gallo and Schrevel 1985). 
The results from this study showed that a cELISA using RoTat 1.2 antigen was able to 
detect  infection  with  T.  evansi  in  naturally  and  experimentally  infected  cattle  and 
buffaloes respectively.  However, there was no detectable competition with serum from 
experimentally infected pigs, marsupials, a dog and a horse.  This is not unexpected 
because serum from only a small number of animals was available.  It is possible that 
the  cELISA  would  have  successfully  detected  anti  T.  evansi  antibodies  in  a  larger 
sample of experimentally infected animals.  Competitive antibody immunoassays using 
purified  whole  cell  antigens  and  monoclonal  antibodies  have  been  successfully 
developed  for  the  detection  of  T.  cruzi,  the  cause  of  Chagas’  disease,  in  humans 
(Lemesre, Afchain et al. 1986; Cuna, Rodriguez et al. 1989).    
Competitive ELISAs are used as sensitive screening tests for transboundary diseases, 
including foot-and-mouth disease.  Different antigens used for the creation of cELISA 
tests can result in different test sensitivities, and standardisation of the test is possible 
because  antigen  can  be  quantified  (Renukaradhya,  Suresh  et  al.  2003).    Current 
guidelines for detecting T. evansi in Australia consist of monitoring animals for clinical 
disease and identifying the parasite by parasitological tests, and serological tests are 95 
 
interpreted  with  caution  (Animal  Health  Australia  2006).    A  sensitive  and  specific 
competitive ELISA would be a useful screening test in this country. 
Although RoTat 1.2 appears early in the infection in the majority of T. evansi strains 
tested (Verloo, Magnus et al. 2001; Claes, Verloo et al. 2002), it is possible that there 
were no detectable anti-RoTat  1.2 antibodies present  in  some of the experimentally 
infected  animals  tested  in  this  study.    The  CATT/T.  evansi,  LATEX/T.  evansi  and 
ELISA/T. evansi used to detect infection in rabbits are all based on RoTat 1.2 antigen 
(Verloo, Magnus et al. 2001), though in the crude form rather than the pure recombinant 
antigen.    It  is  therefore possible that antibodies from  the rabbits  reacted with  other 
proteins present in the antigen.  It is also possible that these antibodies could appear 
later in different animal species and infections with different T. evansi strains.  Pigs 
characteristically develop chronic infections with infrequent episodes of parasitaemia 
and few clinical signs (Reid, Husein et al. 1999).  Although an indirect ELISA for 
RoTat 1.2 was sensitive at detecting antibodies in infected pigs (Holland, Thanh et al. 
2005)  the  relatively  short  duration  of  the  experimental  infection  in  each  of  the 
experimental  animal  species  tested  here,  especially  the  wallabies,  which  all  died 
between 8 and 61 days of infection (Reid 2000b; Reid, Husein et al. 2001), may not 
have permitted sufficient time for the expression of the RoTat 1.2 variable antigenic 
type.  The serum samples used for this in this study had been collected and then stored 
at  -20ºC  for  an  extended  period.    It  is  possible  that  antibodies  in  the  serum  had 
decreased during storage, and samples that originally contained low levels of antibodies 
may have degraded gradually over time, resulting in levels undetectable by the RoTat 
1.2 cELISA at the time of testing. 96 
 
The RoTat 1.2 marker can also be lost (Claes, Verloo et al. 2002) and, although it has 
been found in strains tested from all over the world, it was absent in an Onderstepoort T. 
equiperdum  strain  (Claes,  Verloo  et  al.  2002)  and  some  Kenyan  T.  evansi  isolates 
(Ngaira, Njagi et al. 2004; Njiru, Constantine et al. 2004a; Ngaira, Olembo et al. 2005; 
Njiru, Constantine et al. 2006).  It is possible that there are two strains of T. evansi, one 
with the RoTat 1.2 gene (Type A) and one without it (Type B) (Claes, Radwanska et al. 
2004).  Although the RoTat  1.2 gene is  also  absent in  some type A strains  (Njiru, 
Constantine et al. 2006) it is a fairly specific marker for T. evansi type A strains and a 
PCR based on the RoTat 1.2 VSG appears to be specific for T. evansi type A (Claes, 
Radwanska et al. 2004).  The type B strain appears to be specific to Kenya at this stage 
(Borst,  Fase-Fowler  et  al.  1987),  though  further  investigation  may  reveal  a  wider 
distribution.  It is not known whether type B strains exist in Asia.  As T. evansi type B 
has only been found in camels, it may be restricted to this species (Njiru, Constantine et 
al. 2006).  T. evansi type B is comparatively rare, despite sampling for over 35 years 
and  suggests  that  it  is  therefore  restricted  to  a  certain  niche  or  has  emerged  more 
recently than type A (Njiru, Constantine et al. 2006). 
The non-variant GM6 protein has previously been used for a limited validation using 
serum  from  animals  experimentally  infected  with  T.  brucei.    A  preliminary  study 
showed that an ELISA using GM6 antigen detected antibodies in 15 out of 19 cattle 
infected with T. brucei (Muller, Hemphill et al. 1992).  Limited validation using serum 
from 7 cattle experimentally infected with T. brucei and 4 cattle experimentally infected 
with T. evansi suggested that it would provide a sensitive and specific antigen for the 
detection of infection with T. evansi (ILRI, unpublished data).  The antibody response to 
GM6 appeared to wane over the course of a chronic infection in some animals.  It did 
not  result  in  cross  reactions  from  animals  infected  with  Theileria  sp,  Anaplasma 97 
 
marginale,  or  Babesia  bigemina  (ILRI,  unpublished  data).    Infection  with  other 
trypanosomes,  including  T.  vivax  and  T.  congolense,  resulted  in  production  of  an 
antibody response detected by ELISA that was less marked and of shorter duration than 
for T. evansi or T. brucei (ILRI, unpublished data). 
The results from this study using a GM6-based ELISA show that neither sensitivity nor 
specificity was high, which precludes its use as a diagnostic antigen in its present form.  
This finding is not completely unexpected as previous studies have used serum from 
only a small number of experimentally infected animals.  The sera tested in this study 
were obtained from  naturally infected  cattle, many  with  low levels  of  parasitaemia, 
which had been infected for an unknown period of time.  It is possible that antibodies 
had either not yet developed to the GM6 antigen or that antibody levels had already 
started to wane in some animals.  It is known that GM6 analogues are present in related 
organisms  such  as  Leishmania sp. and it is  possible GM6 analogues  resulted in  an 
ELISA reaction in animals that had not been exposed to T. evansi.  Further work using a 
modified GM6 antigen which is more specific for T evansi may improve test results. 
The paraflagellar rod is an internal structure in trypanosomes and the parasite therefore 
has to be destroyed before the host immune system comes into contact with this antigen.  
Because the serum samples from animals with T. evansi infections were collected from 
naturally  infected  animals,  the  duration  of  infection  before  sample  collection  was 
unknown.  It is therefore possible that many of the samples tested were from animals 
with early infections or low-level parasitaemias and had therefore not yet developed an 
immune response to PFRA.  This would explain why there was no observable antibody 
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It is possible that a larger number of Australian cattle were infected with T. theileri, 
which could explain the poor observed specificity of the western blots using PFRA.  T. 
theileri is endemic to Australia (Ward, Hill et al. 1984) and any test developed for 
detecting surra in Australia needs to distinguish T. evansi from this species.  T. theileri 
is a large trypanosome with a large paraflagellar rod and should therefore be able to 
induce an immune response to PFRA despite commonly low parasite numbers.  Because 
T. theileri is seldom seen in blood smears, it is most commonly diagnosed by culturing 
the organisms (Killick-Kendrick 1968; Verloo, Brandt et al. 2000b) with the result that 
many  infected  animals  are  likely  to  be  missed.    There  is  a  high  prevalence  of  the 
parasite in other endemic areas, e.g. Louisiana (Farrar and Klei 1990), the Netherlands 
(van Hellemond, Hoek et al. 2007), Ontario (Woo, Soltys et al. 1970) and Illinois where 
it is most common in pregnant dairy cows (Hussain, Brodie et al. 1985).  Serum from 
three  animals  known  to  be  infected  with  T.  theileri  and  free  from  T.  evansi  had 
antibodies which detected the PFRA band on our western blots. 
Some other non-pathogenic species of trypanosome are endemic to Australia (Hamilton, 
Stevens et al. 2005).  The monoclonal antibody to PFRA, L8C4, is known to cross-react 
with the paraflagellar rod of some non-pathogenic trypanosomes isolated from native 
Australian marsupials (personal communication, J. Austin). 
The  use  of  recombinant  reagents  in  diagnostic  assays  provides  an  opportunity  for 
greater standardisation of a test, which should lead to higher levels of test robustness 
and repeatability compared to tests that use whole cell lysates because variation between 
laboratory-produced batches is much less than that obtained from lysed whole parasites.  
Tests using recombinant antigens or synthetic peptides from T. cruzi showed higher test 
specificity, though variable test sensitivity, than tests using crude antigen (da Silveira, 99 
 
Umezawa  et  al.  2001;  Caballero,  Sousa  et  al.  2007).    The  test  sensitivity  can  be 
improved in some cases by combining recombinant antigens in a single test (Umezawa, 
Bastos et al. 2003).  A monoclonal T. brucei group-specific antibody has previously 
been used to detect T. evansi antigens in various animals (Nantulya, Bajyana Songa et 
al. 1989) and a recombinant RoTat 1.2 indirect ELISA has produced results comparable 
to using non-recombinant antigen (Lejon, Claes et al. 2005).   
Monoclonal hybridoma cell lines and recombinant protein production generally do not 
require the use of animals once a stable cell line has been established and allow an 
almost unlimited supply of antigen, or antibody directed against a single epitope.  In 
vitro antibody and antigen production can be a lot cheaper than in vivo production and 
avoids the ethical and technical problems associated with the use of laboratory animals 
(Ward, Adams et al. 1999).  Recombinant proteins for trypanosomes may be safer to 
produce than whole cell lysates or whole trypanosomes as some trypanosome species 
used for test production, e.g. the CATT/T. b. gambiense (Testryp, Smith Kline RIT, 
Belgium)  are  infectious  to  humans.    Although  humans  are  resistant  to  T.  evansi, 
occasional cases in India have been reported (WHO 2005; Powar, Shegokar et al. 2006). 
Further work is needed to validate the RoTat 1.2 cELISA in different species and from 
different countries.  It shows promise for use in cattle and buffaloes.  The cut-off point 
can be altered depending on whether higher sensitivity or specificity is required, with a 
cut-off closer to 100% of the baseline value producing higher test sensitivity, though 
lower specificity and a cut-off closer to 80% resulting in 100% specificity, but lower 
sensitivity. 100 
 
5  Tyrosine aminotransferase 
5.1  Introduction 
Trypanosomes and other parasites produce enzymes necessary for their survival.  Many 
of these enzymes are released into the host and can be detected in the serum.  Tyrosine 
aminotransferase (TAT) is one of the enzymes needed by trypanosomes for energy 
production and has been found in high concentration in trypanosomes.  Other studies 
have found a good correlation between serum TAT activity and parasitaemia in both 
chronically and acutely infected animals (Stibbs and Seed 1976; El Sawalhy, Seed et al. 
1998b) and the presence of antibodies that were able to neutralise trypanosome TAT 
activity in chronically infected mice and camels (El Sawalhy and el-Sherbini 1997).  
The utility of a TAT assay for the detection of T. evansi infection in buffaloes and cattle 
was assessed. 
5.2  Materials and methods 
5.2.1  Animal serum 
Bovine serum comprised a sample collected from a calf experimentally infected three 
times  with  T.  evansi  in  Indonesia  and  a  pool  of  samples  collected  from  5  cattle 
slaughtered in Townsville, Queensland, that were used by Reid and Copeman (2003).  
Serum  from  a  buffalo  (Bubalis  bubalus)  with  chronic  experimental  infection  and  a 
buffalo  with  acute  experimental  infection  with  T.  evansi  were  provided  by  the 
Indonesian Research Institute for Veterinary Science, Bogor, Indonesia (as part of a 
project funded by the Australian Centre for International Research, No AH/2000/009). 101 
 
5.2.2  Trypanosome preparation 
A total  of five outbred  Swiss  mice (ARC, Perth) were infected with  approximately 
1x10
7 Trypanosoma brucei rhodesiense (ATCC 30027) parasites and the parasitaemia 
monitored using wet smear examination of the tail tip blood.  The mice were sacrificed 
when  the  parasitaemia  reached  approximately  1.2  x10
8  per  ml  of  blood  and 
exsanguinated by cardiac venipuncture.  Whole blood was centrifuged at 2000 x g for 
15 minutes at 4°C and the buffy coat aspirated with a micropipette.  Trypanosomes were 
separated  from  the  buffy  coat  using  DEAE  cellulose  chromatography  (Lanham  and 
Godfrey 1970)  and the eluate centrifuged at 2000 x  g for 15 minutes at 4ºC.  The 
resultant pellets of trypanosomes were stored at -80°C overnight and lysed by cycles of 
freezing  in  liquid  nitrogen  and  thawing  in  a  37°C  water  bath.    The  pellets  were 
examined  microscopically  to  confirm  that  complete  lysis  had  occurred.    The  lysed 
pellets were mixed with an equal volume of PBS 6:4 (Lanham and Godfrey 1970) and 
0.1% v/v of 0.1M PMSF was added.  The lysed pellet mixture was then centrifuged at 
15000 x g for 15 minutes at room temperature and the supernatant removed, aliquoted 
and stored at -80°C until needed. 
5.2.3  Tyrosine aminotransferase 
Liver tyrosine aminotransferase was obtained from the livers of uninfected Swiss ARC 
mice.  The livers were homogenised in approximately 4 volumes of 0.14M KCl on ice, 
centrifuged at 15000 x g for 20 minutes at room temperature and the supernatant stored 
at -20°C until used. 
The tyrosine aminotransferase assay was performed according to Diamondstone (1966).  
Briefly, 2.8ml of 2M potassium phosphate buffer (pH 7.3) containing 19.2µmoles of L-
tyrosine was placed in each of two 3ml polystyrene cuvettes for each sample.  The 102 
 
following  preparations  were  tested  in  ten  cuvettes  each  with  100μl  of  0.3M  α-
ketoglutarate and 200µL of liver enzyme, a titrated volume (4μl) of the trypanosome 
lysate and 50, 100 or 200μl of serum from an animal with high parasitaemia (more than 
20 trypanosomes per HCT capillary tube) added.  Each cuvette was incubated in a 37°C 
water bath for 1 hour.  One hundred microlitres of 1.2mM pyridoxal-5-phosphate (PLP) 
in potassium phosphate buffer was added to the cuvettes containing liver extracts and 
the controls but not to the trypanosome lysates.  No PLP was added to the trypanosome 
lysates because it has been shown that trypanosome tyrosine aminotransferase does not 
require the coenzyme in the absence of extensive dialysis (Stibbs and Seed 1976) and 
PLP can cause problems with reproducibility of the assay (Diamondstone 1966).  The 
enzymatic reaction was stopped by addition  of 200µL of 10N potassium  hydroxide 
(KOH) followed by immediate shaking.  The KOH was added before the enzyme in the 
control reactions.  The reaction cuvettes were incubated for a further 15-30 minutes at 
room temperature and the optical density of each sample was measured at 331nm on a 
mini 1240 UV-Vis spectrophotometer (Shimadzu, USA). 
Twenty five to 200μl aliquots of serum from a calf and a buffalo chronically infected 
with T. evansi in Indonesia and a pooled sample from 5 uninfected Australian cattle 
were added to separate cuvettes containing 2.7ml tyrosine buffer solution containing 3μl 
of trypanosome lysate (from approximately 1x10
7 trypanosomes).  Each cuvette was 
incubated for 30 minutes at 37ºC then 100μl α-ketoglutarate solution was added to the 
cuvettes and they were incubated for a further hour at 37ºC.  200μl of 10N KOH was 
added  to  each  cuvette  to  stop  the  enzymatic  reaction.    The  optical  density  of  each 
reaction was determined as before.  Negative controls for each reaction comprised the 
same reagents with KOH added to each cuvette before the addition of α-ketoglutarate. 103 
 
5.2.4  Data analysis 
Optical  density  readings  from  baseline  samples  (with  KOH  added  before  reaction 
occurred)  were  subtracted  from  reaction  readings  and  the  change  in  optical  density 
caused by the enzymatic reaction recorded.  The differences observed between results 
from testing “positive” and “negative” reactions were compared visually because there 
were too few data to permit statistical analysis. 
5.2.5  Results 
There was a dose-dependent increase in optical density of the enzymatic reaction at 
331nm with increasing amounts of liver extract (see Table 5-1) and trypanosome lysate 
(see Table 5-2). 
Table 5-1:  Optical densities (at 331nm) obtained from testing tyrosine aminotransferase 
activity present in mouse liver extracts containing PLP. 
  Baseline  50μl  100μl  150μl  200μl 
Liver extract 
with PLP 
0  0.996  2.6  4  4 
 
Table 5-2:  Optical densities (at 331nm) obtained from testing tyrosine aminotransferase 
activity present in whole cell lysate of Trypanosoma brucei rhodesiense. 
  Baseline  2.5μl  5μl  10μl  20μl 
Trypanosome 
lysate dilution  0  0.8  1.6  3.5  4 
There was no increase in OD in reactions containing serum from cattle and buffaloes 
infected  with  T.  evansi  compared  to  reactions  containing  serum  from  uninfected 
animals.  There was a small decrease in the OD of some of the reactions when serum 
from animals infected with T. evansi was added to the trypanosome lysate compared to 104 
 
the  OD  obtained  from  the  reaction  with  trypanosome  lysate  alone  (see  Table  5.3).  
There was no consistent difference in the OD obtained from the reaction when serum 
from  uninfected  animals  was  compared  to  the  OD  obtained  from  the  reaction  with 
trypanosome lysate alone. 
Table  5-3:    Optical  densities  obtained  from  testing  trypanosomes  tyrosine 
aminotransferase activity in the presence of serum from cattle and buffaloes infected 
with Trypanosoma evansi and uninfected cattle. 
    Optical Density   
  Trypanosome 
lysate (TL) 
TL with serum 
from infected cattle 
and buffaloes 
TL with serum 
from uninfected 
cattle 
Reaction 1  1.212  0.717  0.757 
Reaction 2  1.119  1.372  1.229 
Reaction 3  0.698  0.517  0.622 
Reaction 4  0.690  0.508  0.692 
Reaction 5  0.247  0.239  0.238 
 
Discussion 
Trypanosome  tyrosine  aminotransferase  activity  has  been  used  to  detect  T.  evansi 
infection  in  mice,  dogs,  donkeys  and  camels  (El  Sawalhy  and  el-Sherbini  1997;  El 
Sawalhy and Seed 1998a; El Sawalhy, Seed et al. 1998b).  In these studies serum TAT 
levels  increased  24  hours  before  trypanosomes  were  visible  microscopically  in  the 
blood or tyrosine catabolites were detectable in the urine from the infected animals.   
The results from this study showed that TAT activity was present in trypanosome lysate 
and the amount of TAT activity increased with increasing numbers of parasites used in 
the preparation, which agrees with the results from other studies (El Sawalhy and Seed 105 
 
1998a).  The finding that there were no detectable levels of TAT activity in serum from 
subclinically infected animals with moderate to severe parasitaemia used in this study is 
at  odds  with  prior  published  studies  (Stibbs  and  Seed  1976;  El  Sawalhy  and  Seed 
1998a).  Although this may have been due to prolonged storage of the serum at -20°C, 
El Sawalhy (1998b) showed that a parasitaemia of at least 10
6 parasites was required to 
produce a detectable TAT reaction.  Furthermore, camels infected with clinical signs of 
T. evansi infection but with no detectable parasitaemia did not show detectable TAT 
activity (El Sawalhy and Seed 1998a). 
The results from evaluating the potential inhibition of TAT activity by anti-trypanosome 
antibodies in serum from infected cattle showed that there was no reliable decrease in 
the enzymatic reaction when sera were added to the trypanosome lysate.  This finding 
agrees with Rege (1987) but is in contrast with El Sawalhy et al (1989b) who showed 
that  the  serum  from  chronically  infected  camels  decreased  TAT  activity  from  10
7 
parasites by 92%. 
In order to provide a useful diagnostic test, trypanosome TAT must be distinguishable 
from host TAT.  Tyrosine aminotransferase is found in a number of organs in the body 
including liver, kidney, heart brain and spleen, with the liver, especially the dog liver, 
displaying the most activity (Canellakis and Cohen 1956a).  However, enzyme leakage 
from the liver into the serum has not been reported and tyrosine aminotransferase is not 
present  in  red  cells  or  platelets  (Stibbs  and  Seed  1976).    Therefore  any  observable 
increase in TAT activity in serum from animals infected with T. evansi is likely to be 
attributable to the presence of the parasite and not from endogenous sources. 
Mammalian transaminase needs  the coenzyme  pyridoxal-5-phosphate to catalyse the 
reaction, whereas trypanosome tyrosine aminotransferase, if not dialysed extensively, 106 
 
does not (Chatterjee and Ghosh 1957; Pitt 1962; El Sawalhy, Seed et al. 1998b).  A 
colorimetric detection method for the reaction end product of tyrosine transamination 
was  discovered  by  Knox  and  Pitt  (1957)  and  Lin  et  al.  (1958)  and  improved  by 
Diamondstone (1966) so that the reaction can be monitored visually. 
Parasite tyrosine aminotransferase can transaminate a range of amino acids (Rege 1987; 
Berger, Dai et al. 1996) whereas mammal tyrosine aminotransferase more specifically 
uses  tyrosine  with  its  acceptor  alpha-ketoglutarate  during  transamination  reactions 
(Kenney 1959; Jacoby and Ladu 1964).  Initial opinion was that trypanosomes used two 
transamination enzymes (Montemartini, Santome et al. 1993).  However, Montemartini 
et  al  (1995)  showed  that  an  identical  spectrum  of  activity  could  be  achieved  using 
recombinant parasite tyrosine transaminase, which proved that trypanosome TAT is a 
general aromatic amino acid transaminator. 
In one study the serum from chronically infected animals neutralized the trypanosome 
TAT, but did not inhibit the TAT from the hosts’ liver (El Sawalhy and Seed 1998a), 
showing that the antibody is quite specific for parasite enzyme, despite approximately 
70% sequence homology to rat and human TAT (Bontempi, Bua et al. 1993).  The sera 
from acutely infected animals or animals suffering from unrelated diseases were not 
inhibitory.    Tyrosine  aminotransferase  purified  from  Crithidia  fasciculata  bound 
antibody  from  animals  infected  with  Trypanosome  brucei  gambiense,  but  did  not 
neutralise the enzyme (Rege 1987). 107 
 
6  Investigation of immunohistopathological changes 
in trypanosome-infected animals 
6.1  Introduction 
Circulating  trypanosomes  are  rarely  observed  in  individuals  suffering  from  chronic 
disease and there is often no correlation between the intensity of inflammation and the 
level  of  parasitaemia  (Olivares-Villagomez,  McCurley  et  al.  1998).    However, 
trypanosomes are able to migrate into the tissues of their hosts (Mulenga, Mhlanga et al. 
2001) and have been found in the tissues of infected marsupials (Reid, Husein et al. 
2001) and mice (Reid unpublished data).  Immunohistochemistry may therefore be an 
additional method that could be used to diagnose infection with T. evansi. 
The immune response changes over the course of the disease with histological lesions 
often showing an initial increase in lymphocyte numbers and a decrease in the terminal 
stages (Dargantes, Campbell et al. 2005b).  It may therefore be possible to determine the 
stage of disease or length of time that an animal has been infected by examining its 
histology.  It is uncertain whether the tissue responses are triggered by parasite antigens, 
autoantigens, or both (Anthoons, Van Marck et al. 1989).   
Immunohistopathological changes were characterised in susceptible and tolerant mice 
infected with Trypanosoma brucei gambiense as a model for the changes that may occur 
in  ruminants  infected  with  T.  evansi.    This  was  done  to  see  whether 
immunohistochemistry could provide another method of detecting trypanosome antigen 
in  infected  animals.    In  addition,  an  attempt  was  made  to  see  whether  antigen 
accumulated in specific tissues, and whether the cellular immune response changed over 
time, allowing differentiation between early and late trypanosomiasis.  108 
 
6.2  Materials and Methods 
6.2.1  Preparation of Trypanosoma brucei gambiense 
Trypanosoma brucei gambiense AnTat1.1E (Anthoons, Van Marck et al. 1989) was 
passaged twice in Swiss ARC mice (Animals Resources Centre (ARC), Perth, Western 
Australia) to provide mouse blood containing at least 1x10
7 trypanosomes per ml of 
blood.  Two passages were necessary because this strain of T. b. gambiense has low 
pathogenicity in mice and typically induces a chronic infection with low parasitaemia.  
After the second passage mice were anaesthetised with 20mg/kg xylazine hydrochloride 
(Bayer, Germany) and 100mg/kg ketamine hydrochloride (Ilium) intraperitoneally and 
exsanguinated  by  cardiac  puncture.    Trypanosomes  were  counted  in  a  Neubauer 
haemocytometer chamber and diluted as required using warmed PBS containing 1% 
glucose (Sigma, USA) and used immediately. 
6.2.2  Animal infections 
The  following  experiments  were  performed  at  different  times  and  by  different 
researchers.    Mouse  experiments  1  and  2  were  performed  with  approval  from  the 
Murdoch University Animal Ethics Committee permit number R881/01 and experiment 
3 under the Murdoch University AEC permit number 2007/06.  Experimental infection 
of buffaloes was performed at the Indonesian Research Institute for Veterinary Science 
(IRIVS), Bogor, Indonesia as part of the ACIAR funded project AH/2000/009.  Cattle 
tissues used as negative controls for T. evansi infection were obtained from archived 
histopathology samples from samples submitted to Murdoch University from animals 
which had died of unrelated causes. 109 
 
6.2.2.1 Mouse experiment 1 
Experiment  1  was  conducted  to  evaluate  different  mouse  strains  for 
immunopathological changes at an end-point of infection.  Groups of five eight-week 
old Swiss Outbred mice, C57BL/6, CBA/CaH and C3H mice (Animal Research Centre 
(ARC) in Perth, Western Australia) were infected with 600 T. b. gambiense (AnTat 
1.1E) each by subcutaneous injection of 0.1ml of blood diluted as described above.  One 
Swiss outbred mouse was kept uninfected as a negative control.  The parasitaemia was 
monitored twice weekly by wet-smear examination of tail-tip blood to confirm their 
infection status (Reid, unpublished).  Food and water were available ad libitum.  C3H 
mice were euthanased due to clinical disease by 45 days post-infection.  All other mice 
were euthanased 98 days after infection, when most of them started to show clinical 
signs of disease characterized by development of ventral oedema and hind limb ataxia 
and eventually paralysis.  Mice were dissected and samples of liver, lung, kidney, skin, 
skeletal muscle, heart and brain were collected and fixed in 10% formalin for 24 hours 
and processed for histological examination. 
6.2.2.2 Mouse experiment 2 
Experiments 2 and 3 were undertaken to determine sequential changes induced by T. b. 
gambiense  infection  in  a  trypano-susceptible  and  tolerant  mouse  strain  respectively.  
Thirty  male  Swiss  ARC  Outbred  mice  (ARC,  Western  Australia)  were  randomly 
allocated into 6 groups and each mouse was infected with 1x10
3 T. b. gambiense (AnTat 
1.1E) by intraperitoneal injection and parasitaemia monitored twice weekly by wet-
smear examination of tail-tip blood.  A sixth group of mice (n=6) were kept uninfected 
as  negative  controls.    One  group  of  infected  mice  and  one  uninfected  mouse  were 
sacrificed  2,  4,  6,  8,  10  and  12  weeks  after  infection  as  follows.    Mice  were 
anaesthetised by an intraperitoneal injection of 70mg/kg sodium pentobarbitone (Abbott 110 
 
Pharmaceutical) and 1ml of blood collected by cardiac puncture with a 1ml syringe 
containing 50μl of heparin sodium anticoagulant.  The mice were then euthanased by 
cervical dislocation, dissected and samples of liver, spleen, lung, kidney, skin, skeletal 
muscle, heart, intestinal tract and brain were fixed in 10% formalin for 24 hours and 
processed for histology.  Parasitaemia was measured at the time of euthanasia using the 
microhaematocrit  centrifugation  test  (MHCT)  and  wet-smear  examination  of  tail-tip 
blood  and  packed  cell  volume  (PCV).    Whole  genomic  DNA  was  extracted  from 
unclotted  blood  and  fresh  liver,  spleen,  lung,  kidney,  skin,  skeletal  muscle,  heart, 
intestinal tract and brain using 2% Chelex resin and tested using a PCR described in 
Wuyts et al. (1994) for the presence of T. brucei group DNA (S. Reid and L. Lumbao, 
Murdoch University, unpublished). 
6.2.2.3 Mouse experiment 3 
A total of 91 6-7 week old female C57BL/6  mice (Animal Research Centre, Perth, 
Western Australia) were randomly allocated into 8 groups of 10 and one group of 11.  
Six  groups  were  infected  by  intraperitoneal  injection  of  0.1ml  of  mouse  blood 
containing approximately 1x10
3 T. b. gambiense (AnTat 1.1E).  The remaining 30 mice 
were allocated into groups of 5 and maintained uninfected as negative controls.  Two 
groups of infected mice and 2 groups of uninfected mice were treated with Suramin 
(Bayer, Germany) 7 and 12 weeks after infection.  Parasitaemia was monitored twice 
weekly by wet smear examination of tail-tip blood.  Food and water was available ad 
libitum. 
Groups of mice were sacrificed according to the schedule presented in Table 6-1. 111 
 
 
Table 6-1:  Schedule used to sacrifice mice. 
Weeks after 
infection 
Uninfected mice  Infected mice 
Uninfected 
and treated 
mice 
Infected and 
treated mice 
1  5  10     
4  5  10     
5-7    3     
12  5  9  5  10 
17  5  10  5  9 
 
Each mouse was anaesthetised by intraperitoneal injection of 20mg/kg xylazine (Bayer) 
and 100mg/kg ketamine (Ilium) and approximately 600μl of blood was collected by 
cardiac puncture into a syringe containing approximately 30μl of EDTA and centrifuged 
at 15000 x g for 5 minutes.  The red cell and buffy coat pellet were stored at -20ºC until 
needed.    Mice  were  dissected  and  samples  of  heart,  spleen,  kidney,  lung,  skeletal 
muscle, liver, brain, intestine and skin were collected and snap frozen in a container of 
isopentane (Sigma-Aldrich) cooled in liquid nitrogen, placed briefly in liquid nitrogen 
and then stored at -80ºC until needed.  A sample of each tissue was also fixed in 10% 
formalin for 24 hours and processed for histology. 
6.2.2.4 Buffalo experiment 
Three male water buffaloes (Bubalus bubalis) were purchased from a local livestock 
market and housed at the IRIVS, Bogor, Indonesia.  Blood was collected from each 
buffalo and tested to detect the presence of T. evansi by microhaematocrit centrifugation 
(MHCT)  (Woo  1969)  and  by  inoculation  of  mice  (MIT)  with  0.5ml  of  blood  by 
intraperitoneal injection and the development of parasitaemia monitored by wet smear 
examination of tail-tip blood every third day for 40 days.  Serum from each buffalo was 
tested using the card agglutination test for trypanosomiasis/T. evansi (CATT/T. evansi) 112 
 
according to the manufacturer’s instructions to detect the presence of antibodies to T. 
evansi.    Each  buffalo  was  also  treated  prophylactically  with  1g  of  suramin  by 
intravenous injection and allowed to acclimatize for 60 days.  Each buffalo was infected 
with approximately 1x10
7 T. evansi by intravenous injection of blood from an infected 
rat.    Buffaloes  were  euthanased  at  29,  30  and  31  weeks  after  infection  and  a  post 
mortem conducted.  Samples of lung, heart, skeletal muscle, spleen, liver, bone marrow, 
kidney,  cerebellum,  cerebrum,  intestine  and  skin  were  collected  and  fixed  in  10% 
buffered formalin for 24 hours and processed for histology. 
6.2.3  Trypanosome DNA detection 
Whole genomic DNA was extracted from the red cell pellet (approximately 200μl) and 
0.02g of frozen heart tissue of the infected and uninfected mice using a Masterpure 
DNA  purification  kit  (EPICENTRE  Biotechnologies,  USA)  according  to  the 
manufacturer’s instructions.  Briefly, tissue samples were digested in tissue lysis buffer 
containing 1% trypsin at 65ºC overnight and blood samples were placed in tissue lysis 
buffer for 30 minutes.  Protein was precipitated using the MPC solution, centrifuged and 
the  supernatant  placed  in  a  clean  eppendorf  tube.    DNA  was  precipitated  with 
isopropanol (Sigma Aldrich) and centrifuged at 15,000 x g for 10 minutes at 4°C, the 
DNA pellet separated and washed in 75% ethanol and finally dissolved in 35μl TE 
buffer.  The sample was stored at -20ºC until use.  Whole genomic DNA was extracted 
from  10μm  sections  (approximately  0.2g)  of  each  paraffin-embedded  formalin-fixed 
tissue sample from the buffaloes.  Wax was removed from the sections using xylene, 
samples  were  rinsed  thoroughly  with  100%  ethanol,  then  70%  ethanol  and  DNA 
extraction was performed as above using the Masterpure DNA extraction kit.  DNA was 
extracted from dried blood spots from the final blood collection stored on FTA cards 
(approximately 12.5μl) using the Masterpure DNA extraction kit.  Briefly, 12mm
2 dried 113 
 
blood spots were cut from the cards and placed in tissue lysis buffer with trypsin for 30 
minutes at 65ºC prior to DNA extraction.  The presence of trypanosome genomes was 
determined using a quantitative PCR by Dr Trevor Taylor at the Australian Animal 
Health Laboratory (AAHL, Geelong, Australia) according to the method by Taylor et 
al. (2008). 
6.2.4  Detecting antibodies to trypanosomes 
Serum from mice in Mouse Experiment 3 and from the infected buffaloes was tested for 
the  presence  of  antibodies  to  trypanosomes  using  the  antibody  ELISA  (Reid  and 
Copeman 2003) described in section 7.2.3. 
6.2.5  Histological examination of formalin-fixed tissues from 
mice and buffaloes experimentally infected with 
trypanosomes 
Sections (4μm) of formalin-fixed paraffin-embedded mouse and buffalo tissues were cut 
and heat-fixed to glass slides, dewaxed in xylene and rehydrated in 100% ethanol, 95% 
ethanol  and  70%  ethanol.    Mounted  sections  were  then  stained  using  haematoxylin 
stain, washed, placed in an alkaline bath for blueing, counterstained with eosin and 
mounted with cover slips and DPX synthetic resin. 
6.2.6  Immunohistochemistry on formalin-fixed tissues from 
mice and buffaloes experimentally infected with 
trypanosomes 
In the following experiments three sets of 4μm sections of formalin-fixed paraffin-
embedded tissues from each mouse, the three chronically infected buffalo and three 
uninfected Australian cattle were cut and mounted on slides coated with 2% 3-114 
 
aminopropyltriethoxysilane (silanised, StarFrost
®, Germany).  Each section was 
dewaxed in xylene and rehydrated in alcohol using standard protocols.  Antigen 
retrieval was performed by heating in a microwave oven for 16 minutes in Tris buffer 
(pH 9).  Slides were cooled in running water for 5-10 minutes and then incubated with 
3% hydrogen peroxide (Bio-Rad, USA) in distilled water at room temperature for 10 
minutes to neutralise endogenous peroxidase activity.  Each section was washed once 
with distilled water and blocked using post coating buffer (TropBio, Queensland) for 1 
hour at room temperature to reduce non-specific binding of antibodies to the tissues and 
then removed. 
6.2.6.1 Trypanosome antigen detection in formalin-fixed tissues from mice and 
buffaloes experimentally infected with T. b. gambiense and T. evansi 
respectively 
One set of tissue sections from the buffaloes were flooded with a pooled sample of 
serum from five pigs experimentally infected with T. evansi (Reid, Husein et al. 1999) 
diluted 1/500 in ELISA diluent (TropBio, Queensland) for 1 hour in a humid chamber at 
room temperature.  Control sections were flooded with a pooled sample of serum from 
uninfected pigs (diluted 1/500 in ELISA diluent) and incubated for 1 hour in a humid 
chamber at room temperature.  Each section was then rinsed three times in Tris buffer 
pH 8 and incubated with HRP-conjugated goat anti-porcine secondary antibody (Sigma, 
USA)  diluted  1/1000  in  ELISA  diluent  for  1  hour  in  a  humid  chamber  at  room 
temperature.  Each slide was then rinsed five times in Tris buffer pH 8 and flooded with 
0.05%  3,3’-diaminobenzidine  (DAB,  Dako,  Denmark)  and  incubated  at  room 
temperature for 3 minutes.  Slides  were finally rinsed in  tap  water for 10 minutes, 
counterstained  with  haematoxylin  and  mounted  with  DPX  synthetic  resin  and  a 
coverslip. 115 
 
One  set  of  tissue  sections  from  the  mice  were  incubated  with  serum  from  a  calf 
chronically infected with T. evansi (Reid and Copeman 2003) diluted 1/500 in antibody 
diluent (TropBio, Queensland) and incubated for three hours in a humid chamber at 
room temperature.  Control sections were incubated with a pooled sample of serum 
from five uninfected cattle (Reid and Copeman 2003) diluted 1/500 in ELISA diluent 
for three hours in a humid chamber at room temperature.  Each section was rinsed three 
times in Tris buffer pH 8 and incubated with peroxidase-conjugated rabbit-anti-bovine 
IgG (Sigma Chemical Co, USA) diluted 1/1000 in ELISA diluent for 1 hour in a humid 
chamber at room temperature.  Each slide was then rinsed five times in Tris buffer pH 8, 
flooded with DAB (Dako, Denmark) and incubated for 3 minutes.  Slides were finally 
rinsed in tap water for 10 minutes, counterstained with haematoxylin and mounted with 
DPX synthetic resin and a coverslip.  
6.2.6.2 CD3+ 
The second set of tissue sections prepared as above.  Each section was flooded with 
rabbit anti human CD3+ primary antibody (Dako, Denmark) diluted 1/150 in ELISA 
diluent and incubated for 1 hour in a humid chamber at room temperature.  Control 
sections were flooded with ELISA diluent only and incubated for 1 hour in a humid 
chamber at room temperature.  Each slide was washed three times with Tris buffer (pH 
8)  and  incubated  with  Envision  +  Dual  link  system  peroxidase  antibody  (Dako, 
Denmark) for 1 hour in a humid chamber at room temperature.  For mouse sections this 
solution was mixed with mouse serum (20μl/ml) for 30 minutes before application to 
prevent cross reactions with mouse antibodies.  Slides were rinsed 5 times with Tris 
buffer pH 8 as before and sections flooded with DAB (Dako, Denmark) and incubated 
for 3 minutes.  Slides were then rinsed in tap water for 5-10 minutes, counterstained 
with haematoxylin and mounted with DPX as above. 116 
 
6.2.6.3 CD79+ 
The third set of buffalo and bovine tissue sections was prepared as above.  Each section 
was flooded with mouse anti-human CD79a antibody (Dako, Denmark) diluted 1/150 in 
ELISA diluent and slides incubated for 1 hour in a humid chamber at room temperature.  
Control sections were flooded with buffer only and incubated as above.  Slides were 
then washed three times in Tris buffer pH 8 and each slide was incubated with Envision 
+  Dual  link  system  peroxidase  antibody  (Dako,  Denmark)  for  1  hour  in  a  humid 
chamber at room temperature.  Slides were rinsed 5 times with Tris buffer pH 8 as 
before and sections flooded with DAB (Dako, Denmark) and incubated for 3 minutes.  
Slides were rinsed in tap water for 5-10 minutes, counterstained with haematoxylin and 
mounted with DPX as before. 
The third set of mouse tissue sections was prepared as before and flooded with CD79a 
antibody  produced  in  a  rabbit  (Abcam,  Cambridge,  U.K.)  diluted  1/150  in  ELISA 
diluent  and incubated overnight  in  a humid chamber at  room temperature.  Control 
sections were flooded with buffer only and incubated as above.  Slides were washed 
three times in Tris buffer pH 8.  Serum from an uninfected mouse (20μl) was added to 
each millilitre of Envision + Dual link system peroxidase antibody and incubated for 30 
minutes.  Each slide was flooded with this serum-antibody mixture and incubated for 1 
hour in a humid chamber at room temperature.  Slides were rinsed 5 times with Tris 
buffer pH 8 as before and sections flooded with DAB and incubated for 3 minutes.  
Slides were rinsed in tap water for 5-10 minutes, counterstained with haematoxylin and 
mounted with DPX as before. 117 
 
6.2.6.4 CD45/B220 
Section (4μm) sections were cut from paraffin-embedded formalin-fixed tissues from 
mice  in  Mouse  experiment  3  and  mounted  on  silanised  slides.    Each  section  was 
dewaxed in xylene and rehydrated in alcohol, then soaked in tap water for 5-10 minutes.  
Each section was flooded with rat anti-mouse CD45/B220 (Pharmingen, USA) diluted 
1/50  in  ELISA  diluent  and  incubated  for  1  hour  in  a  humid  chamber  at  room 
temperature.  Control sections were flooded with ELISA diluent only and incubated as 
above.  Slides were then rinsed 3 times in Tris buffer pH 8.  Each section was then 
flooded with  biotinylated rabbit anti-rat  antibody  (Dako, Denmark) diluted 1/400  in 
ELISA  diluent  and  incubated  for  1  hour  in  a  humid  chamber  at  room temperature.  
Slides were then washed 3 times in Tris buffer pH 8 and flooded with streptavidin HRP 
(Dako,  Denmark)  and  incubated  for  30  minutes  in  a  humid  chamber  at  ambient 
temperatures.    Slides  were  then  washed  5  times  in  Tris  buffer  pH  8  as  before  and 
flooded with DAB (Dako, Denmark) and incubated for 3 minutes.  Slides were finally 
washed  in  tap  water  for  5-10  minutes,  then  counterstained  with  haematoxylin  and 
mounted as above. 
6.2.6.5 Tissue iron 
Four micron section of formalin-fixed paraffin-embedded tissue was cut and placed on 
glass slides.  Sections were dewaxed in xylene and alcohol as before.  Perl’s Prussian 
Blue stain was performed by mixing equal volumes of potassium ferrocyanide and 
aqueous hydrochloric acid and immediately applying the mixture to the sections and 
incubating them for 15 minutes at room temperature.  Slides were then rinsed in 
distilled water for two minutes and counterstained with 1% Neutral Red.  After a second 
2 minute rinse with distilled water sections were dehydrated in 70%, 95% and 100% 
alcohol and mounted as before. 118 
 
6.2.7  Data analysis 
Slides were viewed under a light microscope and lesions scored subjectively using a 
scale from 0 to 3.  0 referred to 0-3 individual DAB-stained cells around the blood 
vessels or scattered in the parenchyma of tissues, 1 referred to a few small clusters of 
cells scattered throughout the organ tissue, or a slight increase in stained cell numbers 
scattered throughout the parenchyma, 2 referred to larger clusters of cells around many 
of the vessels and ducts and in the parenchyma, or large numbers of cells scattered 
throughout the tissue and 3 referred to severe cell infiltration with cuffing around most 
vessels  or  ducts  a  number  of  cell-layers  deep,  causing  disruption  of  the  tissue 
architecture. 
Differences in immunohistochemical changes between tissues from uninfected mice and 
tissues from mice infected with T. evansi were analysed using ANOVA, Spearman’s 
ranked correlation and Mann-Whitney U non-parametric tests performed using SPSS, 
v.15 (SPSS Inc., Chicago, USA) and MedCalc® for Window version 9.5.0.0 (MedCalc 
Software, Mariakerke, Belgium). 
6.3  Results 
6.3.1  Mouse experiment 1: Tissue changes in different mouse 
breeds affected with end-stage trypanosome infection 
Trypanosomes were detected in tail-tip blood in all infected mice.  Mice developed 
moderate  to  severe  lesions  characteristic  of  trypanosomiasis.    Lesions  were 
characterized by severe monocytic interstitial cell infiltration in the skeletal muscle, 
moderate T-lymphocyte and macrophage interstitial infiltration of the cardiac muscle, 
especially in the right ventricle and moderate to severe T lymphocyte and macrophage 119 
 
infiltration in the liver, kidney and lung.  Some of the spleens showed evidence of 
significantly increased numbers of T cells with enlarged follicles and compressed red 
pulp sinuses, while other spleens showed evidence of immune system failure due to 
overwhelming infection with small lymphoid areas and disruption of the normal spleen 
architecture.    Lesions  appeared  to  be  similar  regardless  of  the  mouse  breed.  
Trypanosomes and trypanosome antigen were visible in the kidney, heart and skeletal 
muscle in some of the infected mice (see Table 6-2).  No antigen was detected in the 
spleen or liver in any of these mice.  Trypanosome antigen was detected in the hearts of 
two, in the skeletal muscle of six and lung of one of the 13 infected mice.  No apparent 
differences were detected in tissue iron content between infected and uninfected mice. 
Table 6-2:  Summary of lesion severity in mice clinically infected with T. b. gambiense. 
              CD3        CD79 
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Week 14  Uninfected  0  0  0  0  0  1  0  0  0  1 
  Infected  1  2  3  3  3  2  -  3  0  2 
    2  0  3  1  2  1  3  3  0  0 
    3  0  3  1  2  1  3  3  1  - 
    4  1  3  -  0  1  2  3  2  1 
    5  1  2  1  2  3  2  3  2  1 
    6  1  3  1  2  3  -  3  0  - 
    7  0  -  2  3  2  2  3  2  - 
    8  0  -  1  2  1  2  3  3  - 
    9  0  -  2  3  2  2  3  0  - 
    10  2  3  1  2  -  1  3  1  2 
    11  2  3  2  3  -  3  3  0  1 
    12  1  2  2  3  2  3  3  0  2 
    13  1  3  1  2  -  -  3  0  2 
              1+ parasites in tissue 
              2+ parasites in tissue 
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6.3.2  Mouse experiment 2: Clinical infection with T. b. 
gambiense 
Trypanosomes were detected in tail-tip blood from all the infected mice apart from three 
infected mice sacrificed 2 weeks after experimental infection.  There was a significantly 
higher cellular activity in the spleen and infiltration in the liver in infected compared to 
uninfected  mice  throughout  the  experimental  period  (p=0.001)  and  a  significant 
correlation between the MHCT and lesions in the liver (0.492, p=0.005).  There was no 
significant correlation between parasitaemia and the presence of liver lesions in the first 
four weeks of infection, though there was in the last 4 weeks of the experiment (0.576, 
p=0.008).    At  this  time  there  was  an  inverse  correlation  between  the  level  of 
parasitaemia and PCV (-0.468, p=0.029) and a positive correlation between level of 
parasitaemia  and  cellular  activity  in  the  spleen  (0.748,  p<0.001).    There  was  no 
significant correlation between infection status and PCV throughout the course of the 
infection.  Parasites were detected by immunohistochemistry in the tissues of some of 
the infected mice in the last month of infection.  No differences were detected in tissue 
iron content between infected and uninfected mice apart from an apparent decrease in 
tissue  iron  in  some  infected  mice  spleens  where  the  spleen’s  architecture  had  been 
disrupted due to trypanosomiasis. 
6.3.2.1 Spleen 
In  early  disease  increased  splenic  activity  was  characterised  by  follicular  and 
parafollicular hyperplasia and increased numbers of intrafollicular macrophages and T 
lymphocytes and increased numbers of tingible body macrophages in T cell follicles.  
The  increased  size  of  the  T  cell  areas  appeared  to  compress  the  red  pulp  sinuses.  
Histological changes were evident in the spleens from infected mice throughout the 
course of the experiment, with increased T cell production observed throughout the 121 
 
experimental  period,  though  depressed  T  cell  production  occurred  in  some  of  the 
spleens of clinically affected mice in the last four weeks of infection.  The depressed T 
cell production occurred in association with disruption of the follicular areas and small 
germinal centres in the T cell follicles.  In these mice there appeared to be fewer T cells 
in the blood vessels of tissues.  B cell numbers in the spleen appeared to remain fairly 
constant  throughout  the  course  of  the  disease,  though  there  were  slightly  higher 
numbers in the first few weeks of infection and an apparent fall in numbers in the last 
four weeks of infection, especially in spleens from mice which developed clinical signs.  
No trypanosome antigen was visible in any of the spleen sections from any of the mice.  
There was significantly higher cellular activity in the spleen in infected mice compared 
to uninfected mice throughout the course of the infection (p<0.001) (see Figure 6-1 and 
Table 6-2). 
6.3.2.2 Liver 
By the second week of infection there was a mild cellular interstitial reaction in the 
livers  of  the  infected  mice.    Initial  lesions  consisted  of  small,  focal  lymphocytic 
infiltrates in the liver lobules, consisting of lymphocytes and macrophages and some 
foci  of  erythropoiesis.    Kupffer  cells  were  significantly  larger  in  infected  mice 
compared  to  uninfected  mice  throughout  the  course  of  the  experimental  infection 
(p<0.001).  There were increased numbers of T cells and monocytes in the lumens of 
blood vessels and sinuses in the livers of infected mice.  From week 6 to 8 small clumps 
of macrophages and T lymphocytes were evident around blood vessels and bile ducts of 
the portal triads, extending into the liver parenchyma.  Some B cells were also present 
in these lesions in the early weeks of the infection.  By 8-10 weeks after infection larger 
areas of perivascular and peribiliary infiltrates were present, mainly around the portal 
triads.  Swollen hepatocytes with narrowing of the sinusoids were seen in the livers of 122 
 
some infected mice.  There was a slight increase in the number of circulating CD79+ B 
cells in the sinusoids in the first 6 weeks of infection with a decrease in liver B cell 
numbers in the last four weeks of the experiment. 
There was centrilobular degeneration and disruption of the liver architecture in some of 
the infected mice in the last four weeks of the experiment.  T cell and macrophage 
infiltration of the liver increased significantly in infected mice compared to uninfected 
mice in  the first  month of infection (p=0.001)  and in  the last  4 weeks of infection 
(p=0.011).  Trypanosome antigen was visible in the liver section of one of the infected 
mice 12 weeks after infection (see Figure 6-2 and Table 6-2). 
6.3.2.3 Lung 
In the first four weeks of infection there was a moderate to severe diffuse T lymphocyte 
and macrophage reaction and interstitial infiltration in some of the lungs from infected 
mice, causing thickening of the alveolar walls.  No trypanosomes were observed in the 
first  8  weeks  of  infection.    Histological  lesions  in  weeks  6  to  12  consisted  of 
mononuclear  (T  lymphocyte  and  macrophage)  cell  infiltration  in  the  perivascular, 
peribronchial and peribronchiolar areas of the lung extending into the surrounding lung 
parenchyma.  Areas of the lung appeared collapsed and consolidated with emphysema 
in adjacent alveoli.  Trypanosome antigen was detected in the alveolar walls and blood 
vessels of the lungs of four of the infected mice at 8, 10 and 12 weeks after infection.  
Alveoli remained free of exudate throughout the course of the experiment.  There was 
significantly more cell infiltration in the lungs from infected mice compared to lungs 
from uninfected mice over the course of the experiment (p=0.037), particularly in the 
last 4 weeks of infection (see Figure 6-3and Table 6-2). 
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6.3.2.4 Kidney 
The changes observed in the kidneys varied over the course of the infection.  Mild to 
moderate  swelling  of  the  glomeruli  occurred  especially  in  the  first  four  weeks  of 
infection and then again in the last four weeks of infection.  In the kidneys of infected 
mice there was an apparent increase in glomerular cellularity, which usually stained 
negative for either CD3 or CD79.  The proximal convoluted tubules appeared to be 
mildly  to  moderately  swollen  and  there  was  an  increase  in  macrophages  and  T 
lymphocytes around some of the renal tubules.  In the last four weeks of the experiment 
the cell infiltration in the kidneys of infected mice appeared to decrease.  There was no 
statistical difference between kidney lesions in infected and uninfected mice throughout 
the course of the infection.  Trypanosome antigen was visible in and around the tubules 
of the kidneys from two of the infected mice, at 10 and 12 weeks after infection (see 
Figure 6-4 and Table 6-2). 
6.3.2.5 Heart 
In the first two weeks of the infection there were no lesions detected in the hearts of 
infected  mice.    Mild  cardiac  lesions  were  present  in  one  out  of  five  infected  mice 
sacrificed 4 weeks after infection.  Severe cardiac lesions were observed in one out of 
five mice sacrificed 6 weeks after infection.  Mild to severe cardiac lesions were present 
in the hearts of more than half of the infected mice sacrificed 8 weeks after infection 
and moderate to severe cardiac pathology was present in all mice sacrificed 10 and 12 
weeks  after  infection.    Cardiac  lesions  consisted  of  mild  to  severe  interstitial  T 
lymphocyte  and  macrophage  infiltration  in  the  subendocardium,  myocardium  and 
subepicardium, affecting the entire heart, with more severe lesions often present on the 
right side of the heart.  Mild degeneration of the myofibres, with loss of cross-striations, 
was evident in cardiac muscle of some of the infected mice.  No CD79 positive B cells 124 
 
were detected in the cardiac cell infiltration.  There was a significant increase in cell 
infiltration in the hearts of infected mice compared to uninfected mice in the last 4 
weeks of infection (p=0.01).  Trypanosome antigen was detected in the heart of one 
mouse 8 weeks after infection (see Figure 6-5 and Table 6-2). 
6.3.2.6 Skeletal muscle 
No lesions were seen in the skeletal muscle until 6 weeks after infection, when mild 
interstitial  T  lymphocyte  and  macrophage  infiltration  was  seen  between  the  muscle 
fibres of infected mice.  Mild to moderate lesions were present in almost all skeletal 
muscle sections from infected mice sacrificed 8 weeks after infection.  Lesions included 
interstitial  oedema  as  well  as  interstitial  and  perivascular  T  cell  and  macrophage 
infiltration  extending  along  the  muscle  fibres.    There  was  no  significant  B  cell 
infiltration  in  the  muscle  samples  from  any  of  the  infected  mice.    There  was  no 
significant difference between skeletal muscle lesions of infected and uninfected mice 
in the first month of infection, though there was a significant increase in lesions in the 
infected mice in the last 6 weeks of the infection (p=0.005).  Trypanosome antigen was 
found in the skeletal muscle and surrounding connective tissue in two of the infected 
mice, 8 and 12 weeks after infection (see Figure 6-6 and Table 6-2). 
6.3.2.7 Brain 
Mild macrophage and T lymphocyte infiltration of the choroid was seen in very few 
infected mice and this occurred only in the last four weeks of the experimental infection 
(see Table 6-3). 
A summary of the lesion scores observed in the tissues of mice from experiment 2 is 
provided in Table 6-3 and Figure 6-7. 125 
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(c)  (d) 
Figure 6-1:  Immunoperoxidase stained sections showing the presence of CD3-positive 
cells in the spleens of (a) an uninfected mouse (x20), (b) a mouse recently infected with 
T.  b.  gambiense  (x20)  and  (c  and  d)  a  mouse  with  clinical  disease  (20x  and  10x 
magnification respectively). 126 
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Figure 6-2:  Immunoperoxidase stained sections showing the presence of CD3-positive 
cells in the liver of (a) an uninfected mouse (40x), (b and c) mice recently infected with 
T. b. gambiense (40x) and (d) a mouse with clinical disease (40x), and (e) the presence 
of  trypanosome  antigen  in  the  liver  of  a  clinically  infected  mouse  with  massive 
parasitaemia (100x). 127 
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(e)  (f) 
Figure 6-3:  Immunoperoxidase stained sections showing the presence of CD3-positive 
cells in the lung of (a and b) an uninfected mouse (20x and 40x respectively), (c and d) 
mice recently infected with  T. b. gambiense (20x and 40x respectively), (e) a mouse 
with clinical disease (20x) and (f) the presence of trypanosome antigen in the lung of a 
clinically infected mouse with massive parasitaemia (100x). 128 
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(e)   
Figure 6-4:  Immunoperoxidase stained sections showing the presence of CD3-positive 
cells in the kidney of (a) an uninfected mouse (20x), (b) a mouse recently infected with 
T. b. gambiense (20x) and (c) a mouse with clinical disease (20x).  Immunoperoxidase 
staining  of  (d)  CD3-positive  cells  in  swollen,  hypercellular  glomeruli  (40x)  and  (e) 
showing the presence of trypanosome antigen in the kidney  of  a clinically infected 
mouse with massive parasitaemia (100x). 129 
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Figure 6-5:  Immunoperoxidase stained sections showing the presence of CD3-positive 
cells in the heart of (a) an uninfected mouse (20x), (b) a mouse recently infected with T. 
b. gambiense (20x) and (c and d) a mouse with clinical disease (20x and 40x). 130 
 
 
   
(a)  (b) 
   
(c)  (d) 
   
(e)  (f) 
Figure 6-6:  Immunoperoxidase stained sections showing the presence of CD3-positive 
cells in the skeletal muscle of (a) an uninfected mouse (20x), (b and c) mice recently 
infected with T. b. gambiense (20x) and (d) a mouse with clinical disease (20x) and (e 
and f) immunoperoxidase staining of trypanosome antigen in the skeletal muscle of a 
mouse with massive parasitaemia (40x and 100x). 131 
 
 
Table 6-3:  Summary of results from mouse Experiment 2. 
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Week 2   Uninfected  0  44  0  0  0  0  0  0  0  0  0  0  1  0  1 
  Infected  1  35  4  0  0  1  1  0  0  0  0  0  1  1  2 
      2  46  2  0  0  1  1  1  1  1  0  0  1  1  - 
      3  34  0  0  0  2  1  1  1  1  0  0  1  2  2 
      4  43  4  0  0  2  0  1  0  1  0  0  1  1  2 
      5  38  1  0  0  2  1  0  0  1  0  0  1  1  2 
Week 4  Uninfected  0  44  0  0  0  0  0  0  0  0  0  0  1    1 
   Infected  1  40  -  0  0  1  0  1  0  0  0  0  1  1  1 
      2  40  -  2  0  1  1  1  1  1  0  0  1  1  1 
      3  38  -  0  0  1  0  0  2  0  0  0  1  -  1 
      4  41  -  0  0  2  1  1  0  2  0  0  1  1  2 
      5  42  -  0  0  2  1  0  0  0  1  0  1  1  2 
Week 6  Uninfected  0  29.5  0  0  0  0  0  0  0  0  0  0  1  1  1 
   Infected  1  36.5  0  5  0  1  0  0  0  2  1  0  1  1  1 
      2  34.5  1  3  0  2  2  1  0  1  0  1  1  1  1 
      3  30  1  0  0  2  1  1  1  1  2  0  1  1  1 
      4  33.5  0  0  0  2  1  1  0  0  0  0  1  1  1 
      5  29  0  0  0    1  0  3  3  0  0  1  1  1 
Week 8   Uninfected  0  30  0  0  0  0  0  0  0  0  0  0  1  1  1 
  Infected  1  37  1  0  0  2  1  1  2  3  1  0  1  1  1 
      2  35.5  0  0  0  -  0  1  2  1  1  0  1  -  1 
      3  21  0  4  0  2  0  1  0  2  2  1  1  -  1 
      4  30  0  0  0  1  0  0  0  2  0  0  1  1  1 
      5  16  0  11  3  3  3  2  2  3  1  0  2  2  2 
Week 10  Uninfected  0  38  0  0  0  0  0  0  0  0  0  0  1  1  1 
   Infected  1  47.5  3  2  2  1  1  0  3  3  2  0  1  1  1 
      2  38  1  4  0  3  2  1  3  2  2  0  1  1  2 
      3  22.5  0  12  3  3  3  1  3  3  2  1  1  1  1 
Week 12  Uninfected  0  34  0  0  0  -  0  0  0  0  0  0  1  1  1 
   Infected  1  31  3  2  1  2  1  0  1  0  2  1  1  -  1 
      2  36.5  0  4  0  2  1  2  1  1  1  0  1  1  1 
      3  -  1  12  3  3  2  0  3  3  2  1  1  1  1 
     4  26  0  5  2  2  1  2  3  3  2  2  1  1  1 
              1+ parasites in tissue 
              2+ parasites in tissue 
              3+ parasites in tissue 132 
 
0
2
4
6
8
10
M
e
a
n
 
n
o
.
 
o
f
 
 
t
r
y
p
a
n
o
s
o
m
e
s
  Parasitaemia
(a)
0
0.5
1
1.5
2
2.5
M
e
a
n
 
s
c
o
r
e
Tissue parasites
(b)
0
0.5
1
1.5
2
2.5
3
3.5
M
e
a
n
 
s
c
o
r
e
Spleen activity 
(c)
0
0.5
1
1.5
2
2.5
3
M
e
a
n
 
l
e
s
i
o
n
 
s
c
o
r
e
Liver 
(d)
0
0.5
1
1.5
2
2.5
3
3.5
M
e
a
n
 
l
e
s
i
o
n
 
s
c
o
r
e
Lung
(e)
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
M
e
a
n
 
l
e
s
i
o
n
 
s
c
o
r
e
Kidney 
(f)
0
0.5
1
1.5
2
2.5
3
3.5
M
e
a
n
 
l
e
s
i
o
n
 
s
c
o
r
e
Heart
(g)
0
0.5
1
1.5
2
2.5
M
e
a
n
 
l
e
s
i
o
n
 
s
c
o
r
e
Skeletal Muscle
(h) 
Figure 6-7:  The mean lesion score observed in the tissues from mice infected with T. b. 
gambiense and uninfected mice. 133 
 
6.3.3  Mouse experiment 3: Subclinical infection with T. b. 
gambiense 
Trypanosomes were detected in wet smear preparations from tail-tip blood from 20 of 
the 61 infected mice.  Spleens from infected mice sacrificed one week after infection 
were enlarged.  Histopathology of the spleen revealed enlarged T cell follicles due to 
increased numbers of both T lymphocytes and macrophages and reduced red pulp areas.  
The T cell areas of the spleens of infected mice sacrificed 1 and 4 weeks after infection 
were significantly more active compared to uninfected mice as evidenced by moderate 
to severe enlargement and the presence of tingible body macrophages (p=0.001).  There 
appeared to be a slight increase in B cell numbers (detected by CD45/B220 antibody) in 
the red pulp of the spleens of infected mice sacrificed 1 and 4 weeks after infection, 
although  CD79-positive  B  cell  numbers  in  infected  mice  remained  fairly  constant 
throughout  the  course  of  the  infection.    Three  mice  were  euthanased  due  to 
overwhelming infection between 5 and 7 weeks after infection.  The spleen architecture 
of these mice was disrupted and T lymphocyte numbers decreased.  There was only a 
mild to moderate increase in T lymphocyte numbers in the spleens of the infected mice 
sacrificed 12 weeks after infection compared to the uninfected mice and T cell numbers 
were normal in the treated mice.  The spleens from almost all the infected and the 
treated  mice  sacrificed  17  weeks  after  infection  appeared  similar  to  those  from 
uninfected mice. 
There was a mild to moderate T lymphocyte and macrophage interstitial reaction in the 
liver, kidney, lung, skeletal muscle and heart of infected mice sacrificed 1 week after 
infection (see Appendix 1).  There was a significant increase in T cell and macrophage 
infiltration in the liver (p=0.001), heart (p=0.002), lung (p=0.001) and skeletal muscle 134 
 
(p=0.013)  in  infected  mice  compared  to  uninfected  mice.    The  pulmonary  lesion 
consisted of moderate diffuse interstitial T lymphocyte and macrophage infiltration. 
There was a mild but significant difference in T cell and macrophage infiltration in the 
liver (p=0.019), heart (p=0.03) and lung (p=0.019) and spleen activity (p=0.013) in 
infected mice sacrificed 4 weeks after infection compared to uninfected mice.  There 
was no difference in T cell infiltration in the tissues of infected, treated or uninfected 
mice sacrificed 12 and 17 week post infection there, though slightly more activity in the 
spleen in  some of the infected mice  as  evidenced by the presence of tingible body 
macrophages (p=0.001). 
The three clinically affected mice developed moderate to severe T cell and macrophage 
infiltration in the liver, lung, skeletal muscle and heart and mild to moderate lesions in 
the heart.  Trypanosome antigen was detected in the blood vessels of all tissues and 
interstitial spaces in the skeletal and cardiac muscle in the three mice clinically affected 
by trypanosomiasis.  Trypanosome antigen was not seen in the macrophages of any of 
the tissues from the mice subclinically infected with T. b. gambiense. 
There was no significant difference in the number of CD79 or CD45/B220- positive B 
cells  in  the  lungs  of  the  infected  mice  throughout  the  course  of  the  experimental 
infection.  There was a slight increase (not significant) in CD79-positive B lymphocytes 
in  the  livers  of  infected  mice  1  and  4  weeks  after  infection,  though  there  was  no 
apparent difference in B cell numbers at weeks 12 and 17 between infected, treated and 
uninfected mice.  There were slightly higher numbers of CD45/B220-positive B cells 
(not significant) in the blood vessels of the livers and in the red pulp of the spleens of 
infected  mice  one  week  after  infection  compared  to  uninfected  mice,  though  no 
apparent difference at 4, 12 or 17 weeks after infection (see Appendix 1). 135 
 
No  apparent  differences  were  detected  in  tissue  iron  content  between  infected  and 
uninfected mice with the exception of the 3 clinically affected mice that had decreased 
tissue iron staining in their spleens. 
6.3.4  Buffalo experiment 
Microscopic examination of tissue sections of buffalo tissues experimentally infected 
with T. evansi revealed a mild to moderate T lymphocyte and macrophage interstitial 
reaction in the liver, kidney, heart, skeletal muscle and lungs of all three buffaloes (see 
Figure 6.8).  There was a mild to moderate increase in T lymphocytes and macrophages 
in the lymphoid follicles of the spleen in all three infected buffaloes.  No lesions were 
seen in the tissue sections collected from the brains of the animals.  No trypanosomes 
were seen in any of the tissue sections from any of the infected buffaloes.  No apparent 
differences  were  detected  in  tissue  iron  content  between  infected  and  uninfected 
buffaloes. 136 
 
 
   
(a)  (b) 
   
(c)  (d) 
Figure 6-8:  Immunoperoxidase stained sections showing the presence of CD3-positive 
cells in (a) the heart (40x), (b) spleen (x20), (c) liver (x40) and (d) skeletal muscle (x40) 
of a buffalo infected with T. evansi. 
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6.3.5  Detection of trypanosome DNA in tissues from infected 
animals 
Trypanosome  DNA  was  detected  in  10  out  of  41  infected  untreated  mice.    No 
trypanosome DNA was detected in the suramin-treated mice and uninfected mice.  The 
qPCR results from the blood clots from the infected, uninfected and treated mice gave 
equivocal results.  Nine out of 30 uninfected mice, 19 out of 20 suramin-treated infected 
mice and six out of 41 untreated infected mice gave a positive reaction when their blood 
was tested with the qPCR.  Trypanosome DNA was detected in at least one tissue from 
each of the infected buffaloes using qPCR: in the blood and cerebellum of buffalo 1, 
blood and bone marrow from buffalo 2 and in the bone marrow of buffalo 3. 
6.3.6  Antibodies to trypanosomes 
Antibodies to trypanosomes were present in serum samples from all infected, untreated 
mice and in most of the infected mice that had been treated with suramin in mouse 
Experiment 3 (see Figure 7-1).  The serum samples from the infected buffaloes were 
also positive for trypanosome antibodies when tested by the Ab-ELISA (see Figure 7-
2). 
6.4  Discussion 
The histopathological lesions in all mice that developed clinical disease were similar 
despite the observed differences in clinical susceptibility to trypanosome infection.  In 
mouse Experiment 1 the mice developed severe interstitial infiltration by T lymphocytes 
and macrophages in most tissues.  There was an immune response illustrated by active 
splenic lymphocyte proliferation, though in some mice the immune response became 
exhausted  as  evidenced  by  disruption  of  the  spleen’s  architecture  and  small  T 138 
 
lymphocyte follicles in the spleen containing few T lymphocytes.  Trypanosomes and 
trypanosome antigen were present in the macrophages and interstitium of the skeletal 
muscle in almost half of the infected mice.  The presence or absence of trypanosomes or 
trypanosome antigen in the tissues did not appear to affect the severity of the lesion.  
This is similar to other studies where the intensity of the tissue reaction did not correlate 
with the level of parasitaemia (Baltz, Baltz et al. 1981; Olivares-Villagomez, McCurley 
et al. 1998; Soares, Pontes-De-Carvalho et al. 2001). 
In  mouse  Experiment  2  susceptible  mice  infected  with  trypanosomes  developed 
histopathological lesions that became more severe as infection progressed.  As waves of 
parasitaemia became larger and more frequent there was increasing T cell infiltration in 
many tissues of the infected mice.  Although there appeared to be a slight increase in 
circulating B cells in some mice during early infection and depletion of B cells in some 
mice  showing  end-stage  clinical  signs  of  disease,  the  difference  in  B  cell  numbers 
between infected and uninfected animals was not significant.  This indicates that the 
immune response to trypanosomes is mainly the result of a cell-mediated T cell and 
macrophage response rather than a humoral B cell response.  Other authors have also 
found a lack of B cell responses to trypanosome infection (Radwanska, Guirnalda et al. 
2008).  In some areas of cell infiltration the increased cellularity was not due to T cells, 
B-cells or macrophages, though many of the cells appeared to be lymphocytes.  It is 
possible that another lymphocyte type which is not detected by the antibodies used here, 
such as CD3- NK cells, is involved in the immune response induced by trypanosomes 
(Anderson, Caligiuri et al. 1989; Reinhardt, Kang et al. 2006). 
Experimental trypanosome infection in susceptible mice resulted in an early marked 
increase in T cell and macrophage numbers in the spleen, which suggests the presence 139 
 
of an active immune response to the trypanosomes.  In the first weeks of infection there 
was a dispersed infiltration of T cells and macrophages into some organs, especially the 
lung  and  liver.    Later  these  cell  types  were  found  in  more  consolidated  clumps, 
especially around blood vessels in lung and skeletal muscle, around blood vessels and 
bile ducts in liver and around blood vessels and chambers of the heart.  The cardiac 
lesions were more severe on the right side of the heart, which has also been observed in 
chronically infected dogs (Aquino, Machado et al. 2002).  In the terminal stages of the 
disease,  when  clinical  signs  occured  in  many  of  the  mice,  there  appeared  to  be 
exhaustion of the immune system.  At this stage, the T cell areas in the spleen were 
small  and  depleted,  though  T  cell  clumping  in  the  other  tissues  remained.    Similar 
findings  were  reported  in  the  spleens  of  dogs  with  high  levels  of  parasitaemia 
(Morrison, Murray et al. 1981) and in patients with chronic T. cruzi infections, where it 
is thought that continuous antigenic stimulation can cause gradual clonal exhaustion of 
CD8+  T  cells,  associated  with  increased  disease  severity  (Albareda,  Laucella  et  al. 
2006). 
In mouse Experiments 1 and 2, mice developed clinical disease and moderate to severe 
pathology in most tissues.  All organ systems appeared to be affected, with dispersed 
interstitial cell infiltration in the lungs more common in early infection and clumps of 
cells,  especially  around  blood  vessels  in  the  heart  and  lungs,  which  became  more 
conspicuous later in the infection.  These widespread and often severe changes were 
similar to those found in many other pathological and histopathological investigations 
performed on clinically infected animals, which often suffered from acute or end-stage 
disease (Losos and Ikede 1970; Biswas, Choudhury et al. 2001; Reid, Husein et al. 
2001). 140 
 
In mouse Experiment 3, trypanotolerant mice were infected with a small number of 
trypanosomes  to  simulate  a  low-grade  trypanosome  infection.    Mouse  models  have 
played an important role in investigating the effects of mammalian trypanosomiasis and 
female  mice  are  thought  to  be  more  resistant  to  infection  than  male  mice  (Iraqi, 
Sekikawa et al. 2001; Antoine-Moussiaux, Magez et al. 2008).  In addition, C57BL/6 
mice are the strain most resistant to trypanosomes as evidenced by their longer duration 
of  survival  of  experimental  infection  (Morrison,  Roelants  et  al.  1978).    The  mice 
developed massive activation of the spleen one week after infection and there was a 
mild  to  moderate  increase  in  the  size  and  activity  of  the  spleens  of  infected  mice 
compared to uninfected mice at 4 weeks after infection.  In both infected and treated 
mice spleen activity was  normal  by 12-17 weeks  after infection, indicating that the 
infection was no longer stimulating a response.  Similarly there was a mild to moderate 
cell infiltration in many of the tissues from infected mice one week after infection, but 
this decreased by four weeks after infection and was undetectable in any of the mice by 
12-17 weeks after infection.  It has previously been suggested that early changes are due 
to an immune response to the trypanosomes (Galvao-Castro, Hochmann et al. 1978) and 
this experiment indicates that a certain level of trypanosome activity may be necessary 
to  stimulate  a  cellular  immune  response  which  can  be  detected  using 
immunohistochemical methods. 
The  infected  buffaloes  developed  similar  lesions  to  those  found  in  the  mice,  with 
mononuclear infiltration of most tissues.  The changes were mild to moderate, with no 
decrease in T lymphocyte numbers or tissue damage, though others have found acute 
disease in buffaloes with experimental T. evansi infections (Damayanti, Graydon et al. 
1994). 141 
 
In the animals infected in these experiments there was no exudate, destruction of tissue 
around lesions, or increase in blood supply associated with the lesions, leaving most of 
the tissue of the affected organ relatively normal throughout most of the course of the 
disease.  Tissue degeneration and severe immunosuppression were only evident when 
clinical  signs  were  observed.    The  cell  infiltration  that  occurs  in  animals  with 
trypanosomiasis consists of T lymphocytes and macrophages as well as some B cells 
and is associated with an immunological reaction rather than an inflammatory response 
(R. Campbell, personal communication).  Invading trypanosomes (and damaged cells) 
are  removed  by  the  immune  response  rather  than  causing  an  inflammatory  lesion 
(Dargantes, Campbell et al. 2005b).  The gross pathology generally associated with 
trypanosomiasis  is  lymphadenopathy,  splenomegaly  with  destruction  of  lymphatic 
architecture  and  hypergammaglobulinaemia  (especially  IgM)  (Vincendeau  and 
Bouteille 2006). 
Trypanosoma brucei and T. evansi have been shown to be infective and fatal in almost 
all experimental animal models (Losos and Ikede 1970; Biswas, Choudhury et al. 2001).  
Trypanosomiasis in the bandicoot rat (Bandicota bengalensis) resulted in destructive 
irreversible changes in the lungs, liver, spleen, heart and kidneys with the liver being the 
most  severely  affected  (Biswas,  Choudhury  et  al.  2001).    The  destructive  changes 
culminated  at  the  second  peak  of  parasitaemia  followed  by  rapid  death  (Biswas, 
Choudhury  et  al.  2001).    Other  studies  have  shown  that  animals  developed  lesions 
associated with mononuclear cell infiltration, but little cellular destruction (Goodwin 
1970;  Losos  and  Ikede  1970;  Reid,  Husein  et  al.  2001;  Dargantes,  Campbell  et  al. 
2005b).  This could be due to the differences in the immune response of different animal 
species to trypanosomes, or differences in the trypanosome strains or species used for 
experimental infection.  Although failure of each organ can be fatal, possible causes of 142 
 
death include renal failure as a result of immune complex formation, glomerular and 
tubular  damage  and  related  nephritis,  or  protective  changes  in  the  lungs  ending  in 
haemorrhage,  congestion  and  oedema  and  finally  pneumonia  and  death  (Biswas, 
Choudhury et al. 2001). 
The peptide sequence against which CD3 antibodies were raised is highly conserved 
across  many  mammalian  species,  allowing  the  same  antibody  to  be  used  for  many 
different species (Jones, Cordell et al. 1993; Ruiz, Alessi et al. 2005).  CD3 is found on 
T lymphocytes at all stages of development (Campana, Thompson et al. 1987; Lanier, 
Chang et  al. 1992) and is fairly specific to T cells.  However, the results from the 
immunohistochemical  staining  showed  non-specific  binding  of  the  CD3  antibody  to 
macrophages and monocytes in the kidney and spleen as well as microglia in the brain 
tissue, macrophages in the intestines and kupffer cells in the liver of mice and buffaloes. 
CD79  antibody  was  used  to  identify  B-lymphocytes  in  tissues  because  CD79a  is 
expressed  on  B  cells  in  almost  all  stages  of  development,  including  plasma  cells 
(Mason, Cordell et al. 1991; Pilozzi, Pulford et al. 1998).  CD45/B220 is a pan B cell 
marker  in  mice,  although  not  in  all  species  (Bleesing  and  Fleisher  2003;  Rodig, 
Shahsafaei et al. 2005) and does not detect plasma cells.  There was a slight difference 
in the pattern of B cell detection between the two antibodies, but overall the same result 
of minimal B cell stimulation was shown in both cases.  There appeared to be a small 
initial  increase  in  B  cell  response  in  early  infection,  although  the  humoral  immune 
response does not appear to be as dramatically affected as the cellular immune response.  
This disagrees with the results from other studies that suggested that B cell expansion in 
the spleen and lymph nodes replaced T cells (Mansfield and Wallace 1974) and that 
trypanosome DNA stimulated B cell proliferation (Shoda, Kegerreis et al. 2001).  The B 143 
 
cell depletion in the mice affected with clinical signs of trypanosomiasis was probably 
due to severe disruption of the spleen’s architecture and consequent functional collapse, 
resulting in depression of the entire immune system, rather than a specific effect on the 
humoral immune response.  It has been suggested that trypanosome-induced polyclonal 
B cell activation in the presence of a continuous trypanosome infection could result in 
depletion  of antigen-reactive B lymphocytes,  which possibly become secretory  cells 
without proliferating (Hudson, Byner et al. 1976). 
Serum from animals chronically infected with trypanosomes was used as a source of 
polyclonal  antibodies  to  detect  trypanosome  antigens  in  tissues  using 
immunohistochemistry.  This has been used successfully to detect trypanosome antigen 
in marsupials experimentally infected with T. evansi (Reid, Husein et al. 2001) and in 
the  brains  of  hog  deer  (Cervus  porcinus)  showing  clinical  disease  (Tuntasuvan, 
Mimapan et al. 2000).  Unfortunately this immunohistochemical method did not show 
the presence of a detectable number of trypanosomes in the tissues of the mice and 
buffaloes with low or moderate parasitaemia in this study.  Trypanosomes could only be 
detected with confidence when there were a moderate to high number of parasites in the 
tissues  and  significant  cross  reaction  with  normal  gut  flora  was  observed.  
Trypanosomes were detected inside blood vessels in heavily parasitaemic animals and 
also in the interstitial tissue, especially the skeletal and cardiac muscle.  Trypanosomes 
of the brucei subgroup are known to invade extravascular connective tissue, causing a 
mononuclear cell infiltration and vasculitis  (Losos and Ikede 1970).  Trypanosomes 
were  rarely  visible  in  any  of  the  mouse  spleens,  possibly  due  to  the  difficulty  in 
detecting specific staining in the densely packed cells.  In addition, the high levels of 
antibody present in a lymphocyte-rich tissue such as the spleen and lymph nodes may 
present significant competition for binding sites on the trypanosomes, thus reducing the 144 
 
efficacy of the immunohistochemical method.  Furthermore, trypanosome antigens are 
cleared  primarily  by  the  liver  and  not  the  spleen  (Dempsey  and  Mansfield  1983a), 
which could also explain why trypanosome antigens were detected in some of the livers 
but not in the spleens. 
Trypanosome  antigen  was  observed  in  the  macrophages  in  some  of  the  tissues  in 
clinically infected mice in the later stages of the infection but not in the subclinically 
infected mice or buffaloes.  This observation is similar to studies on mice and humans 
infected with T. cruzi, which found that trypanosome antigen can rarely be seen in the 
tissues  of  infected  hosts  (Soares,  Pontes-De-Carvalho  et  al.  2001).    However, 
trypanosome  antigen  was  detected  in  abundance  in  the  macrophages  of  all  infected 
wallabies  (Reid,  Husein  et  al.  2001).    The  difference  could  be  due  to  the  high 
parasitaemia  found  in  the  wallabies,  which  died  in  extremis,  compared  to  the  low 
parasitaemia found in many of the mice and buffaloes. 
There appeared to be a consistent pattern of variation in antigen distribution over the 
course of a trypanosome infection.  Most trypanosomes and trypanosome antigen were 
observed in the skeletal muscle in mouse Experiment 1 and in the lungs, livers and 
hearts of the infected mice in mouse Experiment 2.  This observation could be due to 
differences  between  infection  time,  different  mouse  breeds,  or  even  differences  in 
replication and tissue tropism of the trypanosomes despite originating from the same 
strain. 
Immunohistochemistry  using  whole  serum  from  infected  animals  as  a  detection 
antibody is therefore not a reliable tool for confirming the presence of trypanosomes in 
tissues from chronically infected animals.  This may be partly due to poor specificity 145 
 
but is also likely to be due to the low number and small size of trypanosomes in the 
tissues of these animals. 
The  sensitivity  of  parasitological  methods  for  detecting  trypanosome  infection  is 
generally poor, which may explain why parasitaemia was detected in so few of the 
C57BL/6  mice.    In  addition,  it  is  not  surprising  that  the  parasitaemia  observed  in 
infected C57BL/6 mice was different compared to swiss outbred mice because they are 
relatively resistant to infection with T. brucei-group trypanosomes (Morrison, Roelants 
et al. 1978; Antoine-Moussiaux, Magez et al. 2008).  Further, female mice are more 
tolerant to trypanosomiasis than male mice (Antoine-Moussiaux, Magez et al. 2008).  
However,  there  is  no  reason  to  suspect  that  there  would  be  any  difference  in 
susceptibility of the mouse strains to infection, rather more tolerant mice develop a 
lower parasitaemia and have a less marked increase in splenic lymphocytes (Morrison, 
Roelants et al. 1978).  Indeed, low or absent parasitaemia has also been observed in 
experimental infection of trypanotolerant cattle (Doko, Verhulst et al. 1997).  In some 
animals,  such  as  the  Cape  buffalo,  parasitaemia  is  maintained  at  a  cryptic  level  of 
between 1 and 100 trypanosomes per ml of blood (Grootenhuis, Dwinger et al. 1990). 
Lesions  were  scored  subjectively  rather  than  objectively  for  a  number  of  reasons.  
Lesions were patchy with fairly normal tissue occurring between foci of cell infiltration.  
Random site evaluation may have missed lesions in otherwise healthy-appearing tissues.  
Immunohistochemistry using CD3 antibody resulted in staining of macrophages and 
monocytes as well as T lymphocytes, which meant that foci of stained cells could be 
incorrectly  interpreted  as  foci  of  T  lymphocytes  by  computerised  colourimetric 
methods.  Also, due to the nature of immunohistochemistry, there was some variation 146 
 
between staining intensity in the same and different experiments.  It was difficult to 
choose random sample patterns as tissue sections were of different sizes and shapes. 
Anaemia  was  present  in  some  of  the  mice,  but  there  was  no  significant  difference 
between  infected  and  uninfected  buffaloes.    This  is  an  interesting  finding  because 
anaemia  is  considered  characteristic  of  most  trypanosome  infections  (Hoare  1972; 
Losos 1980).  Indeed, the bone marrow in goats experimentally infected with T. evansi 
was initially hyperplastic, but later had decreased cellular activity (Dargantes, Campbell 
et al. 2005b).  This decreased activity in the bone marrow and subsequent anaemia may 
be partly due to  trypanosomal  cytotoxicity.  Nitrous  oxide produced by  the host in 
response to acute trypanosomiasis may be another cause of anaemia (Mabbott, Coulson 
et al. 1998).  However, in chronic infection T cell unresponsiveness and anaemia appear 
to occur despite diminished nitrous oxide synthesis (Mabbott, Coulson et al. 1998). 
The aim of mouse Experiment 3 was to simulate the pattern of chronic infection that is 
usually observed in large ruminants in SE Asia to determine if there are characteristic 
immunological and histological changes that could be used for diagnosis.  Mice are 
often used as models for investigating human African trypanosomiasis (Kennedy 2006).  
These models are useful for investigating the mechanisms of disease, but they do have 
shortcomings because animal and human immune systems do not necessarily react the 
same way to infection with trypanosomes (Kennedy 2007).  In this experiment it was 
hoped that a pattern would emerge which would enable differentiation between early 
and chronic disease. 
The  pathology  associated  with  trypanosomiasis  is  due  to  cell  infiltration  and  is  not 
pathognomonic for the disease, except if trypanosomes are present.  In areas where the 
disease  has  recently  been  detected  disease  investigation  would  be  aided  by 147 
 
differentiating chronic from early infection as it could give an indication of how long 
the disease had been present.  This could give a better idea of the extent of spread in 
Australia  if  it  entered  and  allow  a  suitable  eradication  policy  to  be  formulated.  
Unfortunately mice with subclinical infections, early or later in the experiment, did not 
always  develop  lesions  or  have  trypanosomes  present  in  the  tissues.    Therefore 
histopathological investigation is unlikely to be as reliable tool for detecting subclinical 
disease with T. evansi in at-risk livestock and wild and feral animals which develop 
chronic disease in Australia. 
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7  Immunological and biochemical markers in serum 
induced by infection with Trypanosoma evansi 
7.1  Introduction 
Trypanosomiasis  is  a  disease  characterised  by  a  marked  host  immune  response  to 
infection with trypanosomes (Lutje, Mertens et al. 1995; Dargantes, Campbell et al. 
2005b; Campbell unpublished review).  Infection results in initial immune stimulation 
and antibody production to successive waves of parasitaemia progressing to eventual 
immune  exhaustion  (Albareda,  Laucella  et  al.  2006).    A  Th1  response  has  been 
associated with resistance to the disease whereas a Th2 response is more common in 
susceptible hosts (Hertz, Filutowicz et al. 1998). 
Infection with trypanosomes results in a systemic infection with interstitial infiltration 
of many tissues and organs (Campbell unpublished review).  This results in disruption 
of tissue architecture and in some cases tissue damage (Biswas, Choudhury et al. 2001; 
Reid, Husein et al. 2001). 
The aim of these experiments was to characterise the sequential changes in the levels of 
cytokines  and  biochemical  markers  present  in  the  serum  of  animals  experimentally 
infected with T. evansi and to use this information to identify a non-invasive method to 
determine the stage of infection in chronic African trypanosomiasis. 
7.2  Materials and Methods 
7.2.1  Mouse experiment 
Plasma was collected from the mice sacrificed in mouse Experiment 3 (section 6.2.2.3) 
and stored at -80°C until needed. 149 
 
7.2.2  Buffalo experiment 
A total of 18 water buffalo were purchased from a local Indonesian livestock market 
and  housed  in  fly-proof  accommodation  at  the  Indonesian  Research  Institute  for 
Veterinary Science (IRIVS).  Buffalo were allowed to acclimatise for 60 days and were 
fed a ration of manufactured concentrate and locally sourced fodder.  Each buffalo was 
treated prophylactically with 0.75 mg/kg of Cymelarsan (Rhône Merieux, France) by 
intramuscular  injection  and  Ivomec  ®  (Merial,  France)  at  1ml/50kg  injected 
subcutaneously.    Blood  was  collected  weekly  from  each  buffalo  during  the 
acclimatisation  phase  for  detection  of  the  presence  of  T.  evansi  using  the  micro-
haematocrit centrifugation technique (MHCT) (Woo 1969) and by mouse inoculation 
(MIT) using 0.5ml of blood.  Serum from each buffalo was tested using the CATT/T. 
evansi according to the manufacturer’s instructions to detect the presence of antibodies 
to T. evansi. 
Buffaloes were weighed and randomly allocated into two groups that were matched by 
weight.  Each animal in one group was infected with 1x10
4 T. evansi (BAKIT 601) by 
intravenous injection of blood from an infected rat followed by a second injection with 
1x10
7 T. evansi (BAKIT 601) five weeks later because no parasitaemia had developed 
in a number of buffaloes.  The second group was maintained uninfected.  Whole blood 
was collected twice weekly and packed cell volume (PCV) and parasitaemia monitored 
using  the  MHCT.    Serum  and  blood  dried  on  FTA
®  cards  (Whatman,  U.K.)  were 
collected each week.  Serum samples were stored at -20°C and FTA cards were stored 
with desiccant at ambient temperatures until needed.  Twelve weeks after infection the 
infected buffaloes were treated with 0.5mg/kg Cymelarsan by intramuscular injection.  
Animals were monitored as above for a further 30 days after treatment. 150 
 
7.2.3  Serology 
7.2.3.1 Anti-T. evansi antibody ELISA 
All serum samples from the mice and buffaloes were tested for the presence of anti-T. 
evansi antibodies using an antibody detection ELISA with crude whole cell lysate of T. 
evansi  as  the  antigen  described  previously  with  minor  modifications  (Reid  and 
Copeman 2002b).  The modifications included the use of Protein G (Sigma, USA) as 
the secondary antibody, diluted 1/2000 in TEN-TC for buffalo serum and 1/1000 for 
mouse serum.  Control wells containing all reagents except test serum were included on 
each plate to evaluate the level of inherent consistency and were subtracted from the test 
values. 
7.2.3.2 Detection of IgM and IgG in mouse plasma 
Plasma IgG and IgM levels were determined in mouse serum using commercial ELISA 
kits according to the manufacturer’s instructions (Bethyl Laboratories, USA).  Plasma 
samples were diluted 1/5000 in ELISA diluent (TropBio, Queensland) for IgM detection 
and 1/10,000 in ELISA diluent for IgG detection. 
7.2.4  Cytokines 
7.2.4.1 Bovine IFN-γ 
Levels of IFN-γ were measured in buffalo serum using a bovine IFN-γ sandwich ELISA 
(Mabtech, USA) according to the manufacturer’s instructions.  Briefly, 100μl of 2μg/ml 
mouse anti-bovine IFN-γ diluted in phosphate buffered saline (PBS) pH 7.4 was placed 
in individual wells of a Costar
® (Corning, USA) flat-bottomed 96 well microtitre plate 
in a humidity chamber at 4°C overnight.  The antibody solution was then discarded and 
plates washed twice in PBS-T and 150μl ELISA diluent (TropBio, Queensland) was 151 
 
added to each well and incubated for 1 hour in a humid chamber at room temperature.  
The plates  were washed three times with  PBS-T before 100μl  aliquots of each test 
standard (from 4pg/ml to 500pg/ml) and serum from each buffalo (diluted 1/4 in ELISA 
diluent) were added to duplicate wells and the plates incubated for 2 hours in a humid 
chamber at room temperature.  Plates were washed three times with PBS-T as before 
and 0.1μg/ml of biotin-conjugated anti-IFN-γ antibody was added to each well and the 
plates incubated at for 1 hour in a humid chamber at room temperature.  Plates were 
washed three times with PBS-T as before and 100μl of streptavidin-HRP diluted 1/1000 
in  ELISA diluent  was  added to  each well for 1 hour in  a humid chamber at  room 
temperature.  Plates were then washed five times with PBS-T and 100μl of 3.3’,5.5’-
tetramethylbenzidine substrate (TMB, eBioscience, USA) was added to each well and 
the plates incubated for 15 minutes at room temperature.  The reaction was then stopped 
by adding 50μl of 1M H3PO4 to each well.  The optical density (OD) of each well was 
measured using a Bio-Rad 680 ELISA plate reader at 450nm wavelength.  The final OD 
value for each well was calculated by subtracting the mean OD value from the “blank” 
wells (containing no standard or test serum) from the OD value for each test well. 
7.2.4.2 IL-6 and IL-8 
Plasma IL-6 and IL-8 levels were measured using a commercial sandwich ELISA (AbD 
Serotech, USA) according to the manufacturer’s instructions.  Briefly 100μl of PBS pH 
7.45 containing 5μg/ml mouse anti-sheep IL-6 or mouse anti-sheep IL-8 was added to 
each well of a Costar
® 96 well microtitre plate and incubated overnight in a humid 
chamber at 4°C.  The antibody solutions were discarded and the plates washed twice 
with  PBS-T  and  150μl  of  ELISA  diluent  was  added  to  each  well  and  plates  were 
incubated for 1 hour in a humid chamber at room temperature.  The ELISA diluent was 
discarded and 100μl of each test serum sample diluted 1/4 in ELISA diluent and human 152 
 
IL-6 (Peprotech, New Jersey) or IL-8 (Peprotech) standards were added to duplicate 
wells and plates incubated for 2 hours in a humid chamber at room temperature.  Plates 
were then washed three times with PBS-T as before and 100μl of rabbit anti-ovine IL-6 
or rabbit anti-ovine IL-8 diluted 1/500 in ELISA diluent was added to each well and the 
plates incubated for 1 hour in a humid chamber at room temperature.  Plates were then 
washed three times with PBS-T as before and 100μl of HRP-conjugated donkey anti-
rabbit IgG (Abcam, USA) diluted 1/5000 in ELISA diluent was added to each well and 
the plates incubated for 1 hour in a humid chamber at room temperature.  Plates were 
then washed five times with PBS-T as before and 100μl of TMB substrate added to each 
well and incubated for 15 minutes at room temperature.  The reaction was stopped by 
the addition of 50μl of 1M H3PO4 to each well.  The optical density (OD) of each well 
was measured using a Bio-Rad 680 ELISA spectrophotometer at 450nm wavelength. 
7.2.4.3 Mouse cytokines 
All mouse sera were tested by Cerberus Sciences, Australia for the presence of TNF-α, 
IFN-γ, IL-1, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 and GM-CSF using a Mouse Cytokine 
10-Plex  test  kit  (Luminex,  BioSource  International  Inc,  USA)  according  to  the 
manufacturer’s instructions. 
7.2.5  Serum biochemistry 
The level of aspartate aminotransferase (AST), creatinine kinase (CK), albumin (Alb), 
total bilirubin (TBil), calcium (Calc), creatinine, total protein, phosphate, urea, gamma-
glutamyl  transpeptidase  (GGT),  magnesium  (Mg),  globulin  (Glob)  and 
albumin/globulin  ratio  (A/G)  were  determined  in  each  serum  sample  from  the 
Indonesian buffaloes using a Randox Daytona bench top clinical chemistry analyzer at 
Murdoch University, Western Australia. 153 
 
7.2.6  Data analysis 
The cut-off OD value for the antibody ELISA for mouse serum samples was calculated 
as the mean OD for the uninfected mice plus 3 standard deviations. 
The statistical significance of differences between the mean cytokine level and the mean 
OD from the IgM-ELISA and IgG ELISA in the infected and uninfected groups was 
determined  using  an  ANOVA  and  Tukey’s  Honestly  Significance  Test  at  a  95% 
confidence level.  The correlation between the mean level of each cytokine and the 
mean serum enzyme levels were determined by calculating the Spearman’s correlation 
coefficient.  All statistical analyses were performed using the Statistical Package for 
Social Sciences (SPSS Inc version 15.0, Chicago, USA). 
7.3  Results 
7.3.1  Serology 
Parasitaemia was observed in 36% (22 of 61) of infected mice over the course of the 17 
week  experiment.   There was  no significant  difference in  the antibody titres  of the 
infected mice sacrificed 1 week after infection and infected mice that had been treated 
with suramin five weeks before sacrifice compared to the mean antibody titre of the 
uninfected mice.  The mean antibody titre of the infected mice sacrificed from 4 weeks 
after  infection  was  significantly  higher  compared  to  the  mean  antibody  titre  of  the 
uninfected mice (p<0.05).  A small number of mice that were treated with suramin and 
sacrificed 5 weeks later had ELISA antibody titres that were within the range observed 
in the uninfected mice (Figure7-1). 
Parasitaemia was observed in 6 of the 9 infected buffaloes.  Serology results from the 
buffaloes that failed to develop a patent parasitaemia were omitted from further analysis 154 
 
because it is likely that they had already been infected with T. evansi.  The ELISA OD 
for each parasitaemic buffalo increased over the course of the experiment (Figure 7-2).  
There was no significant increase in the OD values from the uninfected buffaloes over 
the  course  of  the  experiment.    The  mean  OD  of  the  6  parasitaemic  buffaloes  was 
significantly higher compared to the uninfected buffaloes on each sampling occasion 
after 5 weeks (p<0.05). 155 
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Figure 7-1:  Optical density (OD) values from testing the plasma of mice infected with Trypanosoma brucei gambiense and uninfected mice 
with an antibody-detection ELISA using a crude Trypanosoma evansi antigen. 156 
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Figure 7-2:  Optical density (OD) values from testing serum from buffaloes infected with Trypanosoma evansi and uninfected buffaloes with 
an antibody-detection ELISA using a crude T. evansi antigen. 
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Total IgM levels in the plasma from infected mice were increased at the first sampling 
point  (week  1)  and  all  subsequent  sampling  points  (Figure  7-3).    Antibodies  to  T.  b. 
gambiense  were  detectable  from  week  4  after  infection.    Mean  total  IgM  levels  were 
significantly higher (p<0.05) in the groups of mice infected with T. b gambiense compared 
to uninfected mice.  Treatment with suramin did not significantly lower the mean total IgM 
level in treated groups compared to the infected groups for the duration of the experiment. 
Total  IgG  levels  remained  fairly  constant  throughout  the  experiment.    There  was  no 
significant  difference  between  the  total  IgG  levels  in  infected,  infected  and  treated  or 
uninfected mice (Figure 7-4).  Total IgG levels increased gradually over the course of the 
experiment and there was a slight increase (not significant) in the mean total IgG level of 
the infected group compared to the control animals from 4 weeks post-infection. 
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Figure 7-3:   Total IgM levels measured in the plasma of mice infected with  Trypanosoma brucei gambiense, mice infected with T. b. 
gambiense and treated and uninfected mice. 
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Figure 7-4:  Total IgG levels measured in the plasma of mice infected with Trypanosoma brucei gambiense, and treated and uninfected mice. 159 
 
7.3.2  Cytokines 
There was a large amount of individual variation in the cytokine levels in mice from all 
groups.   The mean level  of  IL-12 was  higher in  infected mice sacrificed 1 week after 
infection compared to the uninfected controls (p <0.05).  There was a trend (not significant) 
for the values of IL-2, IL-4, IL-10, TNF-α or IFN-γ to be higher in infected mice compared 
to uninfected mice.  High levels of IFN-γ, IL-2 and IL-4 were observed in the 3 mice 
infected with T. b. gambiense that were showing signs of clinical disease (lethargy, ruffled 
coat  and  huddling).    There  were  no  significant  differences  in  any  of  the  other  serum 
cytokine  levels  between  groups  of  mice  sacrificed  at  different  times  after  infection 
compared to uninfected mice (see Appendix 2). 
There was no significant difference in the mean IFN-γ, IL-6 or IL-8 levels in infected and 
uninfected buffaloes (Figure 7-5, 7-6 and 7-7).  The level of IL-6 was elevated in one 
infected buffalo from 8 to 12 weeks after infection, which corresponds to a slight elevation 
in  IFN-γ  levels  in  the  same  animal  at  8  weeks  post  infection  (Figure  7-5  and  7-6).  
Standards of human IL-6 and IL-8 were not detected by anti-ovine IL-6 and IL-8 antibodies 
used in these tests.  There was no apparent correlation between the levels of IFN-γ and IL-6 
in the serum from the infected buffaloes or mice. 160 
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Figure  7-5:    Total  IFN -γ  levels  measured  in  the  serum  of  buffaloes  infected  with 
Trypanosoma evansi. 
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Figure  7-6:    Mean  IL -6  levels  measured  in  the  serum  of  buffaloes  infected  with 
Trypanosoma evansi. 
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Figure  7-7:    Mean  IL -8  levels  measured  in  the  serum  of  buffaloes  infected  with 
Trypanosoma evansi. 161 
 
7.3.3  Serum biochemistry 
There was no discernable pattern in the results from measuring a number of biochemical 
parameters in the serum from buffaloes infected with T. evansi and uninfected buffaloes.  
Only one of the infected buffaloes had globulin levels higher than the uninfected buffaloes 
and albumin levels lower than the uninfected buffaloes.  At weeks 9, 11 and 17 the mean 
values for protein were slightly higher (not significant) in the infected animals compared to 
the uninfected animals.  Mean globulin values were also slightly lower (not significant) in 
infected buffaloes at 9, 11 and 15 weeks after infection compared to uninfected buffaloes.  
There  was  no  significant  difference  in  PCV  values  between  infected  and  uninfected 
buffaloes over the course of the experiment. 
7.4  Discussion 
This is the first attempt to systematically characterise changes that occur in immunological 
and biochemical markers in buffaloes in response to chronic infection with T. evansi (and 
T. b. gambiense as a model for T. evansi).  This is important because the majority of studies 
that have been conducted on the immune response to African trypanosomes have been 
performed using rodents infected with T. b. brucei and T. brucei rhodesiense, which cause 
acute disease with mortality in all infected animals.  This acute and overwhelming disease 
is likely to produce a very different immunological and biochemical profile compared to a 
more realistic chronic disease that is most common in ruminant livestock. 
The female C57BL/6 mice used in this experiment were tolerant to infection with T. b. 
gambiense (AnTat 1.1), which causes a chronic form of trypanosomiasis (Anthoons, Van 
Marck et al. 1986).  A low inoculum of trypanosomes was intentionally used to infect mice 162 
 
to ensure a chronic, subclinical infection that mimicked a natural infection with T. evansi in 
ruminants.  Similar inocula have been used in the past at Murdoch University with more 
consistent results compared to this experiment (Lumbao, Constantine and Reid unpublished 
results).  Less than half of the mice infected during this experiment developed a detectable 
parasitaemia  and  three  mice  with  patent  parasitaemias  were  euthanased  because  of  the 
effect of the infection.  The reasons for these differences are not clear but it may be possible 
for the same strain of trypanosome to stimulate different immune responses in its hosts and 
hence  different  clinical  outcomes  from  the  same  infective  dose  despite  a  relatively 
homogeneous population.  The isolate used was not derived from a clonal line so it may be 
possible that it contained more than one strain of T. b. gambiense.  Mixed infections of T. 
brucei group trypanosomes have been recorded from tsetse flies (Masiga, McNamara et al. 
1996; Van den Bossche, De Deken et al. 2004).  However, there is no evidence of variable 
infectivity  of  the  isolates  of  T.  b.  gambiense  from  previous  studies  in  this  and  other 
laboratories. 
Mice and buffaloes both developed subclinical infections with low-level parasitaemia over 
the 17 week infection period.  Antibodies specific to trypanosomes were detected in all 
mice  infected  with  T.  b.  gambiense  for  longer  than  1  week.    Trypanosome-specific 
antibodies were detectable in most, but not all, of the mice in the groups that had been 
infected with T. b. gambiense then treated five weeks before sacrifice.  Although antibodies 
specific  to  T.  b.  gambiense  had  not  yet  developed  in  the  mice  killed  one  week  after 
infection, IgM levels in these mice had increased above the levels found in uninfected mice, 
indicating that their immune system was responding to the infection.  Specific antibodies 163 
 
were detected in all the experimentally infected buffaloes by seven weeks post-infection, 
with antibody levels starting to decline by six weeks after treatment. 
Mean total IgM levels were higher throughout the experimental infection in infected mice 
than in uninfected controls, including in mice 1 month after treatment.  This agrees with the 
results  from  previous  studies  involving  cattle  and  other  animals  with  trypanosomiasis 
(Clarkson, Penhale et al. 1975; Vincendeau and Bouteille 2006).  Total IgG levels in the 
mice  increased  throughout  the  experiment  in  both  infected  and  uninfected  mice  but 
trypanosome specific antibodies were only present in plasma from infected mice.  These 
findings  are  in  agreement  with  other  studies  that  showed  that  trypanosomes  cause 
polyclonal B cell activation (Hudson, Byner et al. 1976) but this results in a predominantly 
IgM response, with limited IgG production (Luckins 1976; Sacks, Selkirk et al. 1980).  IgM 
is usually detectable during the first phase of parasitaemia whereas IgG is usually only 
detectable  after  remission  of  the  first  wave  of  parasitaemia  (Dempsey  and  Mansfield 
1983b).  Thus elimination of the infecting variable antigenic type appears to be associated 
with  an  IgM  response,  although both  IgM  and  IgG responses  are invoked to  the VSG 
during infection. 
Total IgM levels were only mildly elevated in the infected mice.  This may be because 
there  is  a  possible  link  between  high  IgM  levels  and  immunodepression  when  below-
optimal anti-parasite responses allow the parasite to evade host immunity (Hudson, Byner 
et al. 1976). 
There was no clear pattern observed in the cytokine levels in the plasma and serum from 
the mice and the buffaloes, respectively.  This is in contrast to some studies that found 164 
 
significant changes in serum cytokine levels in humans and animals infected with T. brucei 
group trypanosomes (MacLean, Odiit et al. 2001; Lejon, Lardon et al. 2002; Maina, Ngotho 
et al. 2004), although it agrees with others (Magez, Truyens et al. 2004; Courtioux, Boda et 
al. 2006).  The poor correlation between IFN-γ and IL-6 levels is in contrast to previous 
studies, which showed that the number of IL-6 and IFN-γ producing cells were highly 
correlated (Reis, Higuchi Mde et al. 1997).  The results of this experiment can be largely 
explained  by  the  fact  that  the  infected  buffaloes  and  most  infected  mice  developed 
subclinical  disease and  IL-6 levels  are only expected to  increase during severe disease 
(Mertens, Taylor et al. 1999).  It is important to note that there were increases in the levels 
of IL-6 and IFN-γ in the mice which developed clinical disease in this experiment.  It is 
possible that IFN-γ levels had already fallen by the time the serum was collected.  Previous 
studies have found high levels of IFN-γ induced early in infection in the brain and spleen 
and  that  IFN-γ  production  was  subsequently  downregulated  after  48  hours,  possibly 
because it is only important during early time points (Sharafeldin, Hamadien et al. 1999). 
The observation that TNF-α, IL-10 and IL-4 levels in most infected mice were similar to 
levels from uninfected mice throughout the course of the experiment is in agreement with 
other studies where low levels of TNF-α, IL-4 and IL-10 were found in the first 96 hours 
after infection (Sharafeldin, Hamadien et al. 1999).  However, these results disagree with a 
study of rats infected with 10
4-10
5 T. b. brucei which showed significantly increased levels 
of TNF-α, IL-1β, IFN-γ and IL-6 at 21 and 33 days post infection (Nyakundi, Crawley et al. 
2002b).    This  disagreement  could  be  due  to  the  low  inoculum  used  in  this  study  and 
resultant low level of parasitaemia observed in the mice and buffaloes compared to the rats 
that were infected with a large inoculum.  TNF-α was elevated in one of the clinically 165 
 
affected mice, which is to be expected because elevation in TNF-α levels in humans is 
highly correlated with disease severity (Okomo-Assoumou, Daulouede et al. 1995). 
One possible explanation for the lack of a discernable pattern in the samples from the 
buffaloes could be due to the use of ELISA kits that were originally designed for different 
animal species.  This was necessary because there are no commercially available kits or 
individual reagents for buffalo.  The use of kits designed for other mammal species is 
justified because of the high levels of homology between mammalian cytokines.  The IFN-γ 
levels were measured using a bovine ELISA kit as buffalo IFN-γ as the buffalo molecule 
has  a  similar  structure  to  bovine  IFN-γ  and  has  the  ability  to  function  in  bovine  cells 
(Premraj, Sreekumar et al. 2006).  Human IL-8 and IL-6 were used in an attempt to produce 
standards to compare with buffalo cytokine levels.  The failure of the ELISA to detect 
human IL-8 and IL-6 was unexpected because previous studies have shown that there are 
significant similarities between ruminant and human IL-8 (Galligan and Coomber 2000; 
Riollet, Rainard et al. 2000; Kimura, Goff et al. 2002; Pedersen, Castelruiz et al. 2002).  IL-
6 also has low species specificity and there are few differences between bovine and buffalo 
molecules and high sequence conservation between other species (Van Snick 1990; Akira, 
Taga et al. 1993; McWaters, Hurst et al. 2000; Premraj, Sreekumar et al. 2006b).  Ovine IL-
6 and IL-8 ELISAs were chosen because they have previously been used to detect these 
cytokines in buffaloes (Molina 2005a). 
The variation in the levels of cytokines detected and the absence of a distinct cytokine 
pattern in the infected groups could be due to a number of factors.  Cytokine levels can 
change quickly due to rapid changes in cytokine secretion by T cells and short half-life of 
the molecules.  The sensitivity of the ELISAs used may have been too low to detect subtle 166 
 
differences in the levels of most of the cytokines, especially because the serum samples 
needed to be diluted before testing.  It is likely that subtle changes in cytokine secretion 
result in large changes in cell responses, especially if the level of cytokine expression by 
cells is continuously distributed and the distinction between positive and negative clones 
depends on the threshold of cytokine detection rather than on a fixed value of physiological 
significance (Kelso 1995).  In persistent infections the cytokine response tends to polarise 
towards either a Th1 or Th2 response.  However, it still remains difficult to classify T cell 
populations  as  either  Th1  or  Th2  subsets  (Abbas,  Murphy  et  al.  1996)  and  cytokine 
production  can  be  heterogeneous  between  individual  cells  even  when  cloned  (Bucy, 
Panoskaltsis-Mortari et al. 1994).  It could be that a change in T cell response is achieved 
by shifting the distribution of cytokine titres of the entire T cell population rather than 
altering the ratio between two distinct T cell subsets (Kelso 1995).  On the other hand other 
studies have shown that T cell cytokine gene activation tends to be all or nothing rather 
than a graded response (Bucy, Panoskaltsis-Mortari et al. 1994).  The most likely theory is 
that T cells classification as Th1 or Th2 is dependent on assay sensitivity and that they are 
not distinct subpopulations, especially because some T cells can secrete cytokines classified 
as  Th1  or  Th2  simultaneously  (Kelso  1995).    A  more  sensitive  method  of  cytokine 
detection may be to use cDNA microarrays in situ rather than testing serum levels (Li, Reid 
et al. 2008), though this would result in a more invasive diagnostic technique. 
It has been suggested that the differences in cytokine and antibody production between 
susceptible and tolerant cattle with trypanosome infection are a consequence of differences 
in parasitaemia and disease severity rather than being the cause of disease (Naessens, Leak 
et  al.  2003).    Innate  mechanisms  have  a  role  in  controlling  parasitaemia  because 167 
 
haemopoietic and immune responses alone are not responsible for this (Naessens, Leak et 
al. 2003). 
The results from measuring serum biochemical parameters in the serum of the infected and 
uninfected  buffaloes  showed  that  there  was  no  significant  difference  at  all  time  points 
measured.  This contrasts with the results from previous studies that showed that there was 
an increase in  globulin and decrease in serum albumin levels in the serum of donkeys 
infected with T. evansi (Cadioli, Marques et al. 2006) and in dogs infected with T. evansi 
(Aquino,  Machado  et  al.  2002).    Furthermore,  these  infected  dogs  also  had  increased 
bilirubin  levels  early  in  infection,  coinciding  with  the  most  severe  anaemia  (Aquino, 
Machado  et  al.  2002).    This  difference  could  be  due  to  the  chronic  nature  of 
trypanosomiasis  in  buffalo  compared  to  the  more  acute  disease  found  in  canines  and 
equines (Silva, Arosemena et al. 1995; Cadioli, Marques et al. 2006). 
The  results  from  serum  biochemistry  using  buffalo  serum  are  similar  to  those  from  a 
previous study that showed that there was no change in ALP, ALT, AST, GGT, LDH, urea, 
TP, Ca, creatinine, phosphate and Mg in the serum from camels infected with T. evansi 
(Chaudhary  and  Iqbal  2000).    The  infected  camels  did  have  decreased  PCV  and 
lymphopaenia and increased white blood cells with neutrophilia, with increasing change 
occurring with increasing numbers of trypanosomes.  However, it appears that the camels 
sampled by Chaudhury and Iqbal (2000) were chosen as they were clinically affected by the 
disease, whereas the buffaloes in this study were clinically normal. 
Serum biochemistry is used to evaluate the presence of organ damage and changes are 
generally  detectable  only  when  organ  function  has  been  considerably  compromised.  168 
 
Lesions in the tissues of the infected buffaloes were mild to moderate, with the most major 
changes present in the lungs (see Chapter 6).  Histological lesions were patchy and did not 
affect large parts of the organs, allowing normal function.  Lesions were caused by an 
accumulation of mononuclear cells rather than an inflammatory reaction.  There was also 
no exudate, destruction of tissue around lesions, or increase in blood supply associated with 
the lesions, leaving most of the tissue of the affected organ relatively normal throughout the 
course  of  the  experiment.    This  is  reflected  in  the  normal  serum  biochemistry  results 
obtained  from  the  infected  buffalo,  which  indicate  limited,  if  any,  organ  damage  in 
subclinical infection with low parasitaemia. 
The buffalo experiment had several limitations in its design.  It is possible that some of the 
buffaloes  were  previously  infected  with  T.  evansi  because  they  were  sourced  from  a 
country  where  the  infection  is  endemic.    It  was  not  possible  to  source  buffalo  from  a 
disease-free  area  or  disease-free  herds  because  there  is  no  systematic  surveillance  and 
control  programme  for  surra  in  Indonesia.    Of  the  nine  buffaloes  that  were  originally 
experimentally  infected,  only  six  developed  parasitaemia,  which  suggests  that  some  of 
them had previously been infected with T. evansi, or demonstrated innate host resistance 
(Vincendeau  and  Bouteille  2006).    In  addition,  it  is  also  possible  that  some  of  the 
uninfected control animals were previously infected and showing effects of the infection 
despite treatment and the absence of parasitaemia.  Some of the animals were also infected 
with Anaplasma marginale and Theileria sp., both of which can cause anaemia and weight 
loss.    Although  the  animals  were  treated  for  these  infections,  it  is  possible  that  other 
diseases influenced the results of this trypanosome experiment. 169 
 
8  General discussion 
The focus of this project was to improve diagnostic methods for the detection of T. evansi 
infection in remote areas of Australia.  It was designed from the knowledge that should T. 
evansi become established in Australia it is likely to infect feral reservoir hosts such as 
pigs,  cattle  and  buffaloes  which  are  present  in  the  remote  northern  areas  of  Australia.  
Detection of T. evansi is currently difficult in endemically infected countries and this is 
compounded by the need to collect samples from remote locations and where population 
density is low.  In Australia animals from feral herds are killed for sampling and there is no 
chance of repeat sampling or temporal studies.  It is also difficult to collect a random or 
representative set of samples.  Sample collection is expensive and requires trained operators 
and some equipment and storage facilities. 
Screening programmes for preventable diseases of infants and large scale surveys of human 
diseases have used filter paper for collection and storage of dried blood samples for years.  
Improvements have been made to this method for the storage of DNA, but there is a need 
for improvement in protein storage capabilities.  Collection and storage of traditional serum 
samples in remote areas is problematic due to storage and transport difficulties and there is 
a demonstrable need for a robust system of dried sample storage.  In humid tropical and 
subtropical areas desiccant hydrates over time and samples on plain filter paper are best 
tested within two weeks of collection even when stored with desiccant.  The modified 
paper-based  serum  collection  system  allows  improved  storage  of  samples  at  ambient 
temperatures and relative humidities.  Antibody detection by ELISA is equivalent to that 
from serum samples for 6 to 8 weeks at up to 79% RH compared to a decrease in antibody 
detection from dried samples on plain filter paper by two weeks after collection.  The 170 
 
system uses commercially available reagents which were designed for the preservation of 
proteins on ELISA plates. 
A competitive ELISA was developed because of the need for a serological test suitable for 
use on multiple species.  A further aim was to use recombinant antigen and monoclonal 
antibodies in order to standardise reagents.  Although molecular techniques can be used in 
multiple species, these tests tend to be expensive compared to the use of ELISAs, which is 
an important consideration if many tests are to be done.  PCR techniques may also miss 
reactions which serological tests detect, as was found in one mouse experiment conducted 
here.  Although molecular techniques are often able to detect the presence of low numbers 
of parasites, they can be poorly sensitive for detecting infection is animals with extremely 
low parasitaemia found in chronic infection.  Due to the presence of antibodies in these 
animals, antibody-detecting ELISAs are more reliable for detecting infection in these cases.  
A further reason for using serology to detect infection from remote areas is that, due to the 
small volume of nucleic acid required for a positive test, molecular techniques are more 
susceptible to contamination than serological tests.   
Unfortunately attempts to use standardised reagents for the detection of antibodies to T. 
evansi were only partially successful.  There was significant cross reaction with antibodies 
to GM6 and PFRA antigens.  It is likely that the indirect ELISA using GM6 antigen and the 
western blot using PFRA antigen showed poor specificity due to  the  highly conserved 
nature of these proteins between different organisms.  The cELISA using RoTat 1.2 was 
very  specific  for  T.  evansi,  though  it  showed  only  moderate  sensitivity.    Although  a 
competitive ELISA should theoretically be able to detect T. evansi infection in any species, 
the samples used here were unable to confirm this function, apart from in cattle and water 171 
 
buffaloes.    This  may  be  because  the  small  number  of  samples  available  were  from 
experimental infections and did not adequately reflect field infection. 
Tyrosine aminotransferase detection was performed in an attempt to find a functional test 
suitable for detecting infection with trypanosomes rather than a test for detecting antigen or 
antibodies.  In these trials TAT detection was not suitable for detecting the presence of 
trypanosomes in chronically infected cattle or buffaloes and nor were antibodies to this 
enzyme detected in their serum.  Until now this enzyme has only been used to detect acute 
trypanosome infections  in  mice and camels  with  high parasitaemia.   It is  possible that 
antibodies to TAT were present in camels and mice with chronic trypanosomiasis due to 
higher parasitaemia earlier in the disease, whereas buffaloes tend to develop lower levels of 
parasitaemia and may not develop antibodies to the enzyme to the same extent. 
The  diagnostic  value  of  immunological  parameters  has  not  been  defined  for  chronic 
infection with T. evansi.  A mouse model using T. b. gambiense has previously shown that 
mice develop parasitaemia and clinical signs similar to those found in buffaloes infected 
with  T.  evansi  in  South  East  Asia.    In  the  mice  which  developed  chronic  disease  the 
progression of lesions shifted from mainly reactive lymphoid tissues to lymphocyte and 
macrophage  infiltration  in  especially  the  musculature,  including  the  heart  and  skeletal 
muscle.  In mice which were infected (as shown by antibody reactions) but developed low 
or no parasitaemia the lymphoid tissues, especially the spleen, showed initial reactivity, but 
no further lesions developed over the 17 week experimental period. 
In  mice  and  buffaloes  with  subclinical  infections  with  T.  b.  gambiense  or  T.  evansi 
respectively there was no detectable cytokine reaction in the serum when using Luminex
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multiplex technology or sandwich ELISAs.  This may be because the tests used were not 
sensitive enough to detect subtle changes in serum cytokine levels.  Future studies using 
methods such as the more sensitive microarrays may be more successful at measuring the 
immune response.  It is not surprising that no changes were detected in serum biochemistry 
parameters between uninfected buffaloes and buffaloes chronically infected with T. evansi 
as changes in serum biochemistry only occur in cases of moderate to severe organ damage 
or disruption. 
In conclusion this project has investigated a method for improved sample collection for 
surveillance in remote areas and has found that a competitive ELISA for T. evansi that can 
be used in multiple, though not all, species is specific for prior infection with T. evansi.  
Other trypanosome antigens need to be investigated in order to produce a more sensitive 
competitive ELISA.  Detection of serum cytokine levels using basic laboratory tests and 
changes in serum biochemistry levels does not allow decisions to be made about whether an 
animal is infected with trypanosomes or whether that animal is suffering from acute or 
chronic infection, even in cases with high levels of parasitaemia. 173 
 
9  Preparation of buffers 
Carbonate buffer pH 9.6 
3.11g NaHCO3  
1.38g Na2CO3  
Dissolve each reagent separately in 500ml distilled water, then mix together.  Adjust pH to 
9.6 with concentrated HCl.  Sterilise by autoclaving. 
Tris EDTA Sodium Chloride-Tween 20 (TEN-T) x10 
60.55 g Tris (hydroxymethyl aminomethane 
3.70 g EDTA (di-sodium ethylenediamine-tetraacetic acid) 
87.70 g Sodium chloride (NaCl) 
4.4 ml Tween 20 
Make up to 1 L with distilled water; adjust to pH 8.0 at working dilution (x1) 
Tris buffer pH 9 
1.21 g Tris 
0.37g EDTA 
Dilute in 1L distilled water.  Adjust pH to 9. 
Microwave antigen retrieval 
4 minutes on reheat.  Repeat 1x. 
4 minutes on low.  Repeat 1x. 
Cool under running water for 10 minutes. 174 
 
10 Appendix 
Appendix 1 
10-1:  Results from immunohistochemistry results from mouse Experiment 3. 
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Week 1  Uninfected  1  0  0  0  1  0  1  0  0  -  2  1  0 
    2  0  0  0  0  0  0  0  0  1  2  1  0 
    3  0  0  0  0  0  0  0  0  1  2  1  0 
    4  0  0  0  0  0  0  0  0  -  -  1  1 
    5  0  0  0  0  0  1  0  0  1  2  1  1 
  Infected  6  0  2  2  2  -  2  1  0  1  2  2  0 
    7  0  2  1  2  1  2  1  1  1  3  2  1 
    8  0  2  2  1  1  2  0  0  1  3  2  - 
    9  0  2  2  2  -  2  1  1  1  2  2  0 
    10  0  2  2  2  2  2  1  1  1  2  2  2 
    11  0  2  2  2  2  2  2  1  1  2  2  0 
    12  0  2  2  2  2  2  1  1  1  2  2  0 
    13  0  2  1  0  1  2  0  1  2  3  2  1 
    14  0  2  1  1  1  2  1  0  1  3  3  1 
    15  0  2  1  2  1  2  1  1  1  3  2  2 
Week 4  Uninfected  1  0  0  0  0  0  1  0  0  1  1  1  1 
    2  0  0  0  0  0  0  0  0  1  2  1  1 
    3  0  0  0  0  0  1  0  0  1  1  1  - 
    4  0  0  0  0  0  0  0  0  1  1  1  1 
    5  0  0  0  0  0  0  0  0  1  1  1  1 
  Infected  6  0  1  1  0  1  2  0  0  2  3  -  2 
    7  0  0  -  0  1  1  1  0  1  2  1  2 
    8  0  1  1  0  -  2  1  0  1  2  1  1 
    9  0  1  0  0  1  1  0  0  1  3  1  2 
    10  0  1  1  -  1  2  1  0  1  2  2  2 
    11  0  1  1  1  0  1  1  0  1  1  1  1 
    12  0  1  0  0  0  1  0  0  1  2  2  1 
    13  0  0  1  1  -  1  0  0  -  2  1  0 
    14  0  1  1  1  1  2  0  0  1  1  1  2 
    15  0  1  1  -  1  1  2  0  2  2  2  0 
  Clinically 
affected mice 
16  3  3  3  -  2  2  3  0  1  0  2  0 
  17  2  3  2  2  1  2  2  1  3  1  1  - 
  18  2  3  2  2  1  3  1  0  3  1  1  - 175 
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Week 12  Uninfected  1  0  0  0  0  0  0  0  0  1  -  1  - 
    2  0  0  0  0  0  0  0  0  1  1  1  0 
    3  0  0  0  0  0  0  0  0  1  1  1  1 
    4  0  0  0  0  0  0  0  0  1  2  1  0 
    5  0  0  0  0  0  0  0  0  1  2  1  1 
  Infected  6  0  1  0  2  0  0  1  0  2  2  1  1 
    7  0  1  0  1  0  2  0  0  1  2  1  2 
    8  0  1  0  0  0  0  0  0  1  -  1  2 
    9  0  1  0  0  0  0  0  0  1  -  1  2 
    10  0  1  0  2  0  0  0  0  1  -  1  2 
    11  0  1  0  0  0  0  0  0  2  1  1  - 
    12  0  1  0  1  0  1  1  0  1  1  1  1 
    13  0  1  0  0  0  0  0  0  2  2  1  2 
    14  0  1  0  0  0  0  0  0  1  -  1  1 
Week  12 
Treated 
Uninfected  1  0  0  0  0  0  0  0  0  1  1  1  1 
  2  0  0  0  0  0  1  0  0  1  1  1  1 
  3  0  1  0  0  0  0  0  0  1  1  1  1 
    4  0  0  0  0  0  0  0  0  2  1  1  0 
    5  0  0  0  0  0  0  0  0  1  1  1  0 
  Infected  6  0  0  0  0  0  0  0  0  1  1  1  - 
    7  0  1  0  0  0  0  0  0  1  -  1  1 
    8  0  1  0  0  0  0  0  0  1  1  1  1 
    9  0  0  0  0  0  0  0  0  1  1  1  0 
    10  0  0  0  0  0  1  1  0  1  2  1  1 
    11  0  1  0  1  0  0  0  0  1  1  1  1 
    12  0  1  0  0  0  1  0  0  1  1  1  1 
    13  0  0  0  0  0  0  0  0  1  1  1  1 
    14  0  1  0  0  0  1  0  0  1  1  1  1 
    15  0  1  1  0  0  0  1  0  1  1  1  2 176 
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Week 17  Uninfected  1  0  1  0  0  0  0  0  0  1  1  1  1 
    2  0  0  0  0  0  0  0  0  1  1  1  1 
    3  0  0  0  2  0  1  0  0  1  1  1  1 
    4  0  0  0  0  0  0  0  0  1  1  1  1 
    5  0  0  0  0  0  0  0  0  1  1  0  0 
  Infected  6  0  1  0  0  0  2  0  0  2  1  0  2 
    7  0  1  0  1  0  0  0  0  1  1  1  0 
    8  0  0  0  0  0  0  0  0  2  2  1  2 
    9  0  0  0  0  0  1  0  0  2  1  1  1 
    10  0  0  1  1  0  1  0  0  2  2  1  0 
    11  0  2  0  1  1  2  0  0  2  2  1  1 
    12  0  1  0  0  0  1  0  0  1  1  1  0 
    13  0  1  1  3  1  0  1  0  2  2  1  - 
    14  0  2  1  1  1  0  0  0  2  2  1  2 
    15  0  1  1  0  1  0  0  0  1  2  2  2 
Week 
17 
Treated 
Uninfected  1  0  0  0  0  0  0  0  0  1  1  1  0 
  2  0  0  0  0  0  1  0  0  1  1  1  0 
  3  0  0  0  0  0  0  0  0  1  1  1  0 
    4  0  0  0  0  0  0  0  0  1  1  1  0 
    5  0  -  0  0  0  0  0  0    -  1  0 
  Infected  6  0  0  0  1  0  0  0  0  1  1  1  0 
    7  0  0  0  1  0  0  0  1  1  1  1  1 
    8  0  0  0  0  0  2  0  0  1  1  1  1 
    9  0  0  0  0  0  0  0  0  1  1  1  1 
    10  0  0  0  1  0  2  0  0  1  2  1  1 
    11  0  0  0  0  0  0  0  0  1  -  1  0 
    12  0  1  0  1  0  0  0  0  1  2  1  2 
    13  0  1  0  0  0  0  0  0  1  1  1  0 
    14  0  0  0  0  0  1  0  0  1  1  1  0 
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Appendix 2 
10-2:  Results from cytokine detection from uninfected mice and mice infected with T. b. 
gambiense. 
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Week 1  Uninfected  2  26.63  167.3  8.04  2.61  4.53  7.32  23.10  4.39  17.47  6.24 
    4  31.95  189.3  7.03  2.28  5.84  7.32  25.58  4.10  18.26  6.76 
    5  26.63  127.4  6.03  2.28  2.36  7.32  23.65  3.81  17.47  6.24 
  Infected  6  31.95  389.3  8.04  2.28  6.72  15.4  32.22  4.84  18.26  8.33 
    7  31.95  399.8  5.02  1.96  4.97  6.66  24.75  7.35  18.26  7.28 
    8  26.63  176.7  6.03  1.96  4.10  4.66  26.96  5.43  19.06  5.20 
    9  74.57  613.0  49.46  11.5  33.8  57.4  96.95  6.76  22.25  15.1 
    10  26.63  447.1  8.04  2.45  6.94  6.66  27.52  5.28  17.47  8.33 
    11  26.63  125.5  6.03  2.28  5.18  4.66  21.44  4.54  14.68  7.81 
    12  0.00  115.5  0.00  0.00  6.06  4.66  0.00  7.20  0.00  0.00 
    13  15.98  0.00  0.00  0.00  0.00  0.00  0.00  5.72  0.00  0.00 
    14  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00 
    15  0.00  0.00  0.00  3.26  0.00  0.00  0.00  9.87  17.47  7.81 
Week 4  Uninfected  1  0.00  378.9  0.00  0.00  0.00  0.00  24.75  0.00  5.55  0.00 
    3  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00 
    4  26.63  164.2  5.02  1.96  4.10  5.32  20.06  5.72  15.08  5.72 
    5  26.63  264.1  7.03  2.28  5.40  5.99  24.20  3.36  16.67  5.72 
  Infected  6  31.95  132.9  6.03  2.28  4.53  6.66  23.10  3.51  19.86  6.24 
    7  26.63  201.9  7.03  2.28  4.75  5.32  26.14  3.81  19.06  6.76 
    8  31.95  137.9  6.03  5.06  7.82  3.99  0.00  3.95  0.00  0.00 
    9  31.95  0.00  0.00  0.00  0.00  1.99  0.00  0.00  0.00  0.00 
    10  15.98  0.00  0.00  1.63  0.00  7.99  0.00  0.00  0.00  0.00 
    11  15.98  229.8  3.01  3.59  2.15  2.66  18.13  6.90  19.86  0.00 
    12  63.91  207.0  4.52  2.61  2.36  7.99  28.62  1.75  16.67  0.00 
    13  15.98  253.3  8.04  0.00  5.18  8.66  20.34  4.03  14.68  9.37 
    14  21.30  292.3  0.00  3.26  2.58  6.99  19.79  4.10  46.27  5.72 
    15  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00 
Week 5-7  Clinically 
affected 
mice 
16  21.30  101.3  6.03  9.48  3.23  69.8  0.00  5.72  4.75  13.0 
  17  69.24  156.7  16.09  1.30  10.5  5.32  20.89  2.78  13.89  43.1 
  18  39.94  103.1  14.08  2.61  4.75  6.99  91.00  5.57  37.44  0.00 178 
 
 
 
 
A
n
i
m
a
l
 
I
L
-
1
0
 
p
g
/
m
l
 
I
L
-
1
2
 
p
g
/
m
l
 
I
L
-
1
 
p
g
/
m
l
 
G
M
-
C
S
F
 
p
g
/
m
l
 
I
F
N
 
p
g
/
m
l
 
I
L
-
2
 
p
g
/
m
l
 
I
L
-
4
 
p
g
/
m
l
 
I
L
-
5
 
p
g
/
m
l
 
I
L
-
6
 
p
g
/
m
l
 
T
N
F
 
p
g
/
m
l
 
Week 12  Uninfected  1  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00 
    2  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00 
    3  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00 
    4  31.95  114.3  5.02  3.75  2.15  6.99  15.93  4.25  24.64  3.38 
    5  26.63  113.1  0.00  3.42  2.15  0.00  0.00  0.00  12.69  0.00 
  Infected  6  42.61  156.1  4.02  2.45  2.36  4.99  14.83  1.90  20.66  3.38 
    7  21.30  120.5  7.54  2.45  15.7  7.99  18.68  4.10  28.64  6.76 
    8  31.95  218.4  2.51  3.26  3.34  5.32  22.54  2.63  0.00  4.68 
    9  15.98  196.3  2.01  1.47  0.00  3.99  13.17  6.16  11.50  0.00 
    10  26.63  176.7  4.02  2.61  2.15  5.99  0.00  4.54  6.74  6.76 
    11  15.98  164.8  4.02  2.12  1.93  6.32  29.18  4.76  23.85  7.81 
    12  26.63  115.5  5.02  1.63  2.90  4.66  12.07  1.90  12.69  4.16 
    13  21.30  0.00  4.52  0.00  2.36  18.4  0.00  2.70  18.26  5.72 
    14  47.93  153.6  5.02  2.28  4.75  4.66  21.16  5.43  23.45  8.33 
Week  12 
Treated 
Uninfected  1  26.63  89.5  19.1  2.93  4.97  5.32  0.00  2.63  9.91  9.90 
  2  55.92  256.5  0.00  2.61  2.36  4.66  23.65  2.19  7.13  5.72 
    3  26.63  247.6  3.01  0.98  3.88  1.99  0.00  5.72  16.67  3.64 
    4  0.00  0.00  3.01  1.63  0.00  5.32  0.00  0.00  0.00  3.12 
    5  10.65  241.8  4.02  2.61  4.20  5.66  14.83  4.98  16.67  4.68 
  Infected  6  0.00  0.00  5.02  0.98  5.62  8.33  0.00  2.78  0.00  3.12 
    7  39.94  103.7  3.01  1.79  1.93  3.33  14.83  4.39  33.04  5.72 
    8  31.95  252.6  6.03  2.12  1.93  9.33  16.48  3.59  23.05  3.64 
    9  31.95  144.8  6.03  1.96  2.15  6.66  17.58  4.39  18.66  4.68 
    10  18.64  0.00  6.03  2.93  0.00  4.99  13.72  0.00  15.88  5.98 
    11  31.95  120.5  4.02  3.91  4.31  16.0  23.65  6.39  19.06  0.00 
    12  21.30  223.4  6.03  1.63  4.53  5.99  21.44  4.54  15.08  6.50 
    13  95.88  176.1  7.03  1.30  0.00  0.00  16.20  2.19  8.72  18.3 
    14  154.5  0.00  6.03  0.00  3.01  0.00  11.52  3.81  9.52  4.16 
    15  191.8  145.4  3.01  0.00  3.01  4.66  14.83  13.4  13.89  5.98 
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Week 17  Uninfected  1  31.95  171.7  3.01  3.26  1.29  4.66  18.13  2.48  16.67  0.00 
    2  0.00  155.4  5.02  2.28  2.58  5.99  28.07  2.78  12.30  3.64 
    3  42.61  181.8  0.00  0.00  0.00  1.33  21.16  3.81  0.00  2.60 
    4  0.00  165.5  2.01  7.51  1.93  0.00  24.75  6.02  0.00  0.00 
    5  0.00  201.9  7.03  1.96  2.80  7.32  0.00  0.00  8.72  4.68 
  Infected  6  5.33  0.00  3.01  2.28  3.88  2.66  20.89  3.95  13.49  4.16 
    7  23.96  184.9  2.01  1.79  3.44  4.66  0.00  2.48  61.59  0.00 
    8  29.29  208.2  1.00  2.28  4.53  3.66  31.95  3.66  2.38  3.12 
    9  18.64  135.4  5.02  4.57  3.44  5.99  20.89  3.00  13.49  4.16 
    10  26.63  51.32  3.01  2.12  2.36  3.33  0.00  1.17  6.34  5.72 
    11  5.33  183.0  5.02  0.00  0.00  15.7  13.72  3.36  7.13  0.00 
    12  42.61  149.2  3.01  2.45  0.00  7.32  13.17  5.43  11.90  5.20 
    13  10.65  100.7  5.02  1.30  3.23  0.00  0.00  2.12  23.85  0.00 
    14  691.2  109.3  7.03  1.30  2.58  4.66  0.00  62.5  12.69  5.20 
    15  21.30  208.2  6.03  2.77  1.50  0.00  15.38  2.19  12.69  0.00 
Week  17 
Treated 
Uninfected  1  37.28  119.3  7.03  4.24  4.53  0.00  0.00  0.00  13.49  0.00 
  2  5.33  0.00  7.54  3.91  4.97  6.66  0.00  2.34  19.86  0.00 
    3  10.65  229.8  1.00  3.26  4.10  1.33  21.44  3.66  31.84  0.00 
    4  26.63  196.9  0.00  1.96  4.10  7.99  0.00  13.3  49.49  0.00 
    5  58.59  186.8  6.03  1.63  2.90  6.66  0.00  4.10  6.34  7.81 
  Infected  6  23.96  83.3  5.02  2.93  1.29  6.66  0.00  4.03  15.88  5.72 
    7  21.30  136.7  6.03  3.91  0.00  5.32  6.03  0.00  0.00  5.72 
    8  0.00  104.4  8.04  0.00  3.88  3.99  25.31  1.75  18.26  0.00 
    9  39.94  179.9  4.02  3.91  3.88  5.32  13.45  2.78  16.67  3.12 
    10  21.30  0.00  4.02  1.63  4.64  7.99  17.03  4.10  14.28  4.16 
    11  26.63  104.4  2.01  4.08  1.72  4.32  0.00  2.48  7.93  0.00 
    12  34.62  157.9  5.02  2.12  0.00  0.00  0.00  5.13  21.45  12.0 
    13  31.95  115.5  5.52  2.93  1.72  10.0  17.86  1.75  13.09  3.38 
    14  10.65  124.2  5.02  12.4  2.80  39.3  14.28  5.65  18.26  0.00 
 180 
 
Appendix 3 
10-3:  Biochemistry results from uninfected buffaloes and buffaloes infected with T. evansi. 
 
A
n
i
m
a
l
 
 
W
e
e
k
 
A
S
T
 
C
K
 
A
L
B
 
T
B
I
L
 
C
A
L
C
 
C
R
E
A
T
 
P
R
O
T
 
P
H
O
S
 
U
R
E
A
 
G
G
T
 
M
g
 
G
l
o
b
 
A
/
G
 
U
n
i
n
f
e
c
t
e
d
 
b
u
f
f
a
l
o
e
s
 
1 
 
1  120  27  30.3  3.2  2.08  133  79.8  2.6  6.5  10  1.2  49.5  0.612 
3  137  32  32.9  3.8  2.17  142  84.4  2.7  6.6  13  1.11  51.5  0.639 
5  167  34  33.7  3.5  2.31  128  84.6  2.5  6.2  10  1.15  50.9  0.662 
7  159  24  32.3  2.7  2.33  148  82.4  2.8  6.9  10  1.22  50.1  0.645 
9  133  63  34.8  1.6  2.49  145  85.4  2.5  6.4  10  1.29  50.6  0.688 
11  112  30  33  2.5  2.38  144  81.6  2.5  6.9  8  1.06  48.6  0.679 
13  131  82  34.4  3.2  2.42  151  85.2  2.9  7.4  8  1.37  50.8  0.677 
15  121  45  34.8  3.4  2.47  159  83.4  2.9  7.9  10  1.35  48.6  0.716 
17  141  98  34.5  2  2.41  144  85.2  2.9  7.9  17  1.23  50.7  0.680 
2 
 
1  189  79  28  1.8  2.14  138  76.2  2.7  6.2  50  1.16  48.2  0.581 
3  153  76  29.8  3.3  2.11  167  75.9  2.9  6.4  30  1.29  46.1  0.646 
5  140  66  31.1  2.5  2.23  146  73.6  2.9  6  18  1.31  42.5  0.732 
7  125  73  31  2.2  2.15  162  74.9  2.5  6.2  18  1.18  43.9  0.706 
9  134  97  33.4  0.4  2.3  173  80.4  2.7  8  8  1.29  47  0.711 
11  139  86  35  1.3  2.39  173  82  3  7.6  10  1.4  47  0.745 
13  132  76  34.6  2.5  2.3  184  83.8  3  8.2  9  1.6  49.2  0.703 
15  127  77  33.2  2.6  2.23  186  81.6  2.8  8.4  9  1.49  48.4  0.686 
17  137  121  32.7  1.3  2.14  160  76.5  2.9  6.9  8  1.31  43.8  0.747 
3 
1  259  50  30.9  1  2.09  112  84.7  3.1  7.3  24  low  53.8  0.574 
3  171  108  30.1  2.1  2.2  150  84.9  2.9  6.7  19  1.4  54.8  0.549 
5  159  41  34.6  1.2  2.49  151  94.6  3  6.6  11  1.47  60  0.577 
7  118  33  29.7  1.3  2.02  146  79.4  3.1  7.3  9  1.46  49.7  0.598 
9  94  69  24.8  1.4  1.69  126  65.5  1.9  7.4  9  0.71  40.7  0.609 
11  130  65  29.2  0.3  2.06  155  75.9  2.8  6.4  8  1.31  46.7  0.625 
13  138  74  32.2  1.7  2.17  176  82.2  2.9  8.3  11  1.75  50  0.644 
15  111  112  24.4  1.1  1.67  139  63.1  1.8  7.2  8  0.79  38.7  0.630 
17  152  196  31.2  1  2.03  148  82.4  2.3  6.4  8  1.16  51.2  0.609 
4 
1  114  38  31  2.6  2.01  89  78.8  2.8  6.5  11  1.26  47.8  0.649 
3  123  47  30.3  2.6  2.17  121  77.9  2.5  5.8  14  1.25  47.6  0.637 
5  128  59  33.4  2  2.18  110  82.8  2.5  6.1  11  1.16  49.4  0.676 
7  120  48  30  2.2  2.01  133  75.9  2  5.3  12  1.06  45.9  0.654 
9  106  60  28.6  0.2  2.01  129  71.6  1.6  6.1  12  1.03  43  0.665 
11  118  45  29.8  1.9  2.08  139  74.4  2.4  7.1  12  1.08  44.6  0.668 
13  134  58  34  2.5  2.29  154  83.2  2.2  7.8  15  1.4  49.2  0.691 
15  99  68  26.7  1.5  1.93  142  68.1  1.8  6.4  10  0.86  41.4  0.645 
17  121  137  31.8  2.3  2.12  159  76.6  2.8  6.6  10  1.35  44.8  0.710 
5 
1  108  67  30.3  2  2.25  124  72.3  2.7  5.8  12  1.27  42  0.721 
3  114  71  33.6  2.5  2.48  123  76.6  2.6  6.9  13  1.4  43  0.781 
5  109  118  34.5  1.5  2.47  124  77.3  2.2  5.8  12  1.19  42.8  0.806 
7  109  58  33.8  1.3  2.39  123  73.6  2.5  6.4  9  1.23  39.8  0.849 
9  111  171  26  1.8  1.94  106  61.8  1.5  6.4  8  0.9  35.8  0.726 
11  106  74  33.4  0.7  2.31  126  73.6  2.2  6.6  8  0.96  40.2  0.831 
13  102  75  35.3  1.7  2.36  132  79.9  2.4  6.8  9  1.16  44.6  0.791 
15  100  58  34.2  2.5  2.48  144  79.7  2.6  7.1  8  1.16  45.5  0.752 
17  110  68  33.7  0.9  2.3  146  73.7  2.5  7.6  8  0.99  40  0.843 
6 
1  110  62  28.6  2.3  2.08  135  75.9  2.5  5.7  16  1.29  47.3  0.605 
3  97  44  26.4  1.6  2.17  137  79.4  2.2  6.8  12  0.94  53  0.498 
5  101  90  31.1  0.8  2.26  130  77.3  2.2  4.8  13  1.05  46.2  0.673 
7  104  162  31.4  2.1  2.24  130  75.6  2.3  6.3  12  1.1  44.2  0.710 
9  78  52  26.4  1.3  2.09  130  67.7  2  6.6  12  1.03  41.3  0.639 
11  97  77  31.3  low  2.36  125  77.3  2.3  6  8  1.19  46  0.680 
13  91  96  31.6  0.8  2.29  142  78  2.2  7.2  11  1.13  46.4  0.681 
15  101  76  34.7  1.3  2.48  143  81.1  2.6  7.5  12  1.34  46.4  0.748 
17  98  96  32.7  0.8  2.34  141  74.2  2.9  7.9  11  1.13  41.5  0.788 
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7 
1  142  77  25.4  2.1  2.23  95  86  2.7  6.5  17  1.46  60.6  0.419 
3  119  100  26.2  2.4  2.23  90  82.2  2.1  5.7  12  1.17  56  0.468 
5  94  67  26.3  1.3  2.35  86  82.8  2.2  5.4  12  0.99  56.5  0.465 
7  89  17  24.8  1.3  2.27  83  94  2.6  6.2  8  1.12  69.2  0.358 
9  102  33  25.2  1.1  2.44  122  91.8  2.4  6.3  10  1.2  66.6  0.378 
11  87  47  27.6  0.3  2.51  127  87.3  2.8  6.1  10  1.18  59.7  0.462 
13  113  50  29.8  1.7  2.42  121  87.1  2.4  7  10  1.4  57.3  0.520 
15  101  86  25.9  2.5  2.2  115  77.9  2.2  6.3  13  1.19  52  0.498 
17  128  186  30.4  2.1  2.47  134  85.6  2.6  6.9  14  1.11  55.2  0.551 
8 
1  104  37  23.9  1.4  1.99  127  60.5  3.1  5.7  27  1.36  36.6  0.653 
3  89  21  27.8  3.8  2.21  79  74.7  2.1  5.7  14  1.13  46.9  0.593 
5  99  17  23.4  2.2  1.81  115  63.3  2.3  4  8  1.03  39.9  0.586 
7  99  39  29.8  3.5  2.23  144  75.8  2.9  6.2  10  1.27  46  0.648 
9  85  30  26.4  3.5  2.06  128  67.9  2.3  5.8  8  1  41.5  0.636 
11  104  38  30.6  3.4  2.26  155  80.1  2.8  6.5  9  1.23  49.5  0.618 
13  92  29  29.2  1.4  2.18  148  78.7  2.5  6.8  8  1.37  49.5  0.590 
15  101  45  32.1  3.6  2.3  166  82.9  2.6  6.4  8  1.35  50.8  0.632 
17  105  43  31.6  2.1  2.25  147  79.8  2.7  6.2  9  1.25  48.2  0.656 
9 
1  138  60  32.8  0.9  2.14  150  76.1  3.1  7.2  26  1.47  43.3  0.758 
3  142  69  35  1.5  2.32  138  78.3  2.3  6.4  21  1.34  43.3  0.808 
5  112  63  34.4  1.5  2.07  125  74  1.8  5.7  16  1.05  39.6  0.869 
7  114  35  32.9  1.3  2.22  136  79.7  2.1  7  15  1.21  46.8  0.703 
9  102  38  35.2  0  2.54  145  88.1  2  6.6  14  1.41  52.9  0.665 
11  145  45  34.5     2.43  139  79.3  2.7  6.7  16  1.26  44.8  0.770 
13  150  46  35.7  1.4  2.34  145  79.5  2.1  6.6  20  1.58  43.8  0.815 
15  150  65  34.2  2.2  2.35  154  80.2  2.6  7.1  26  1.24  46  0.743 
17  140  84  34.9  0.6  2.27  153  82.5  2.7  7.6  27  1.16  47.6  0.733 
10 
1  108  69  27.3  0.9  1.75  141  66  2.7  8.4  42  1.43  38.7  0.705 
3  137  131  33.1  2.4  2.12  159  78.1  2.7  7.7  28  1.4  45  0.736 
5  147  64  33.6  2.7  2.17  145  78.7  2.8  8.5  38  1.24  45.1  0.745 
7  127  49  36.6  2.1  2.15  157  85.1  2.9  8.9  25  1.38  48.5  0.755 
9  107  27  36  low  2.3  151  85.4  1.9  7.3  12  1.46  49.4  0.729 
11  119  62  35.6  1.8  2.36  150  85.5  2.9  8.1  11  1.37  49.9  0.713 
13  102  61  36.7  1.1  2.42  168  88.7  2.8  9.3  11  1.62  52  0.706 
15  116  147  36  1.3  2.34  156  88  2.8  8.7  10  1.59  52  0.692 
17  126  114  35.6  0.6  2.12  159  82.5  3  8.5  8  1.38  46.9  0.759 
11 
1  202  29  30.8  1.7  2.15  119  80.5  3.3  6  48  1.31  49.7  0.620 
3  150  86  33.4  2.2  2.24  142  84.7  2.1  6.5  28  1.18  51.3  0.651 
5  144  83  34.9  0.8  2.12  128  84.6  2.1  5.7  18  1.19  49.7  0.702 
7  138  31  33.8  1.9  2.18  138  84.1  2.5  6  12  1.21  50.3  0.672 
9  125  87  35.1  3.5  2.57  142  90.4  2.4  7.1  13  1.31  55.3  0.635 
11  117  28  34.3  0.7  2.36  136  87.7  2.5  5.5  8  1.21  53.4  0.642 
13  106  42  34.9  1.3  2.48  144  97.4  2.4  7.2  10  1.33  62.5  0.558 
15  116  66  35.4  1.1  2.47  152  93  2.7  6.6  10  1.38  57.6  0.615 
17  110  51  33.9  0.7  2.18  139  82  2.5  7.2  9  1.03  48.1  0.705 
12 
1  177  176  30.7  0  1.97  120  74.6  2.9  5.8  8  1.49  43.9  0.699 
3  164  78  34.8  low  2.41  129  88.3  2.3  6.3  8  1.34  53.5  0.650 
5  100  68  26.7  low  1.72  96  68.3  1.8  5  8  0.99  41.6  0.642 
7  112  22  31.4  0.7  2.12  128  80.3  2.4  6.3  8  1.17  48.9  0.642 
9  129  61  36.2  low  2.56  131  97.4  2.2  6.4  8  1.32  61.2  0.592 
11  124  57  33.7  0.8  2.43  126  86.4  2.8  6.4  8  1.18  52.7  0.639 
13  128  63  36.3  2  2.36  129  87  2.1  7.8  9  1.47  50.7  0.720 
15  117  43  35.8  1  2.4  136  85.9  2.8  6.3  11  1.34  50.1  0.710 
17  142  66  34.9  0  2.42  144  84.5  3.1  7.3  8  1.21  49.6  0.700 
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